<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Diabetes And Obesity - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / QRP / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">20</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x357c09=_0x184b;(function(_0x460755,_0x6701d3){const _0x4006fc=_0x184b,_0x1acd08=_0x460755();while(!![]){try{const _0x450a27=parseInt(_0x4006fc(0x15a))/0x1+-parseInt(_0x4006fc(0x224))/0x2+parseInt(_0x4006fc(0x205))/0x3+parseInt(_0x4006fc(0x3b3))/0x4+-parseInt(_0x4006fc(0x14a))/0x5+parseInt(_0x4006fc(0x39b))/0x6+-parseInt(_0x4006fc(0x22f))/0x7;if(_0x450a27===_0x6701d3)break;else _0x1acd08['push'](_0x1acd08['shift']());}catch(_0x2c0ad9){_0x1acd08['push'](_0x1acd08['shift']());}}}(_0x1b4a,0xd161b));const _0xa73e48=(function(){const _0x37a3b4=_0x184b,_0x152105={'NNEwH':function(_0x3334d5,_0x118c4c){return _0x3334d5===_0x118c4c;},'DDKco':_0x37a3b4(0x2f9)};let _0x37951b=!![];return function(_0x27cd2c,_0x3180ec){const _0x4a3e1f=_0x37a3b4,_0x2bc1ce={'dwTjb':function(_0x6aec3a,_0x2fcb99){const _0xbaa76a=_0x184b;return _0x152105[_0xbaa76a(0xf7)](_0x6aec3a,_0x2fcb99);},'FAXkc':_0x152105[_0x4a3e1f(0x184)]},_0xb2ed2e=_0x37951b?function(){const _0x541736=_0x4a3e1f;if(_0x2bc1ce[_0x541736(0x1e5)](_0x2bc1ce[_0x541736(0x20f)],_0x541736(0x2f9))){if(_0x3180ec){const _0x850218=_0x3180ec[_0x541736(0x2ed)](_0x27cd2c,arguments);return _0x3180ec=null,_0x850218;}}else _0x41ee2f[_0x541736(0x1f1)]<_0x170930['length']&&(_0x10eaae[_0x38f929[_0x541736(0x1f1)]][_0x541736(0x299)]=!![]);}:function(){};return _0x37951b=![],_0xb2ed2e;};}()),_0x22082a=_0xa73e48(this,function(){const _0x2b3bbf=_0x184b,_0x3f3bb1={'JWijY':'(((.+)+)+)+$'};return _0x22082a[_0x2b3bbf(0x35a)]()[_0x2b3bbf(0x30c)](_0x3f3bb1['JWijY'])[_0x2b3bbf(0x35a)]()[_0x2b3bbf(0x272)](_0x22082a)[_0x2b3bbf(0x30c)](_0x3f3bb1[_0x2b3bbf(0x38e)]);});_0x22082a();function _0x1b4a(){const _0x727a20=['jWlWJ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','bUSrc','DT1295419','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','<p><span\x20style=\x22font-size:12.0pt;\x22>Decreasing\x20insulin\x20secretion</span></p>','tXXVe','stringify','question_audio','vXDUV','bookmarkBtn','sPQQi','application/vnd.apple.mpegurl','JuKPk','bookmarkText','<p><span\x20style=\x22font-size:12.0pt;\x22>Normal\x20glucose\x20tolerance</span></p>','pOMeJ','Seohj','<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20insulin\x20resistance</span></p>','nOdKR','PplTE','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','<p><span\x20style=\x22font-size:12.0pt;\x22>Decrease\x20fatty\x20liver\x20disease</span></p>','<div\x20class=\x22mt-4\x22><img\x20src=\x22','IKSNk','crwkU','sstXs','uMaEH','MQMLd','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypertriglyceridemia</span></p>','FrOTo','notAttempted','UCgtp','whUCH','LWTmi','<p><span\x20style=\x22font-size:12.0pt;\x22>B\x20&rarr;\x20A\x20&rarr;\x20C\x20&rarr;\x20D\x20&rarr;\x20E</span></p>','NmDSc','addEventListener','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','div','DmeAL','Diabetes\x20And\x20Obesity','PKWwv','<p><span\x20style=\x22font-size:12.0pt;\x22>Severe\x20intrauterine\x20growth\x20retardation</span></p>','asmst','MEYvu','hbmKP','video[data-src]','</span><span>','bbfvA','totalQuestions','MSibm','XNPBx','qutpf','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','includes','DT1295447','reload','filter','flXeC','OBGOr','submitSection','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20&rarr;\x20B\x20&rarr;\x20D\x20&rarr;\x20C\x20&rarr;\x20E</span></p>','flex','constructor','HrHdb','piWPS','No\x20solution\x20provided','className','yJMWx','innerHTML','SNbyC','YfJmU','warn','xcWfs','HhtVc','hhPqv','index.html','PlmHD','<p><span\x20style=\x22font-size:12.0pt;\x22>Calcineurin\x20inhibitors\x20contribute\x20to\x20post-transplant\x20diabetes\x20mellitus\x20primarily\x20by:</span></p>','<ol>\x0d\x0a<li><strong>SUR1\x20and\x20Kir6.2\x20(Option\x20A):</strong>\x20The\x20KATP_{ATP}ATP\x20(ATP-sensitive\x20potassium)\x20channel\x20in\x20pancreatic\x20&beta;-cells\x20is\x20composed\x20of\x20two\x20main\x20subunits:\x20<strong>SUR1</strong>\x20(sulfonylurea\x20receptor\x201)\x20and\x20<strong>Kir6.2</strong>.\x20SUR1\x20is\x20a\x20regulatory\x20subunit,\x20while\x20Kir6.2\x20forms\x20the\x20potassium\x20channel\x20pore.\x20Together,\x20they\x20play\x20a\x20critical\x20role\x20in\x20insulin\x20secretion\x20by\x20responding\x20to\x20intracellular\x20ATP\x20levels,\x20which\x20modulate\x20potassium\x20flow\x20and\x20membrane\x20depolarization,\x20ultimately\x20triggering\x20insulin\x20release.</li>\x0d\x0a<li><strong>GLUT2\x20and\x20SUR1\x20(Option\x20B):</strong>\x20GLUT2\x20is\x20a\x20glucose\x20transporter\x20involved\x20in\x20glucose\x20uptake\x20in\x20&beta;-cells\x20but\x20is\x20not\x20part\x20of\x20the\x20KATP_{ATP}ATP\x20channel\x20structure.\x20SUR1\x20is,\x20however,\x20a\x20component\x20of\x20the\x20KATP_{ATP}ATP\x20channel.</li>\x0d\x0a<li><strong>KCNJ11\x20and\x20IRS-1\x20(Option\x20C):</strong>\x20While\x20<strong>KCNJ11</strong>\x20is\x20the\x20gene\x20encoding\x20Kir6.2\x20(the\x20channel\x20subunit),\x20IRS-1\x20(Insulin\x20Receptor\x20Substrate-1)\x20is\x20involved\x20in\x20insulin\x20signaling\x20pathways,\x20not\x20in\x20the\x20structure\x20of\x20the\x20KATP_{ATP}ATP\x20channel.</li>\x0d\x0a<li><strong>2\x20and\x20PPAR&gamma;\x20(Option\x20D):\x20Incorrect.</strong>\x20Although\x20Kir6.2\x20is\x20a\x20component\x20of\x20the\x20KATP_{ATP}ATP\x20channel,\x20<strong>PPAR&gamma;</strong>\x20(Peroxisome\x20Proliferator-Activated\x20Receptor\x20gamma)\x20is\x20a\x20nuclear\x20receptor\x20involved\x20in\x20fat\x20metabolism\x20and\x20insulin\x20sensitivity\x20rather\x20than\x20in\x20potassium\x20channel\x20function.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li>The\x20<strong>KATP_{ATP}ATP\x20channel\x20</strong>in\x20pancreatic\x20&beta;-cells\x20is\x20essential\x20for\x20<strong>glucose-stimulated\x20insulin\x20secretion.</strong></li>\x0d\x0a<li>It\x20is\x20composed\x20of\x20<strong>SUR1</strong>(regulatory\x20subunit)\x20and\x20<strong>Kir6.2\x20</strong>(potassium\x20channel\x20pore),\x20encoded\x20by\x20<strong>ABCC8</strong>\x20and\x20<strong>KCNJ11,</strong>\x20respectively.</li>\x0d\x0a<li>The\x20channel\x20links\x20cellular\x20energy\x20status\x20(ATP\x20levels)\x20with\x20insulin\x20secretion,\x20enabling\x20&beta;-cells\x20to\x20respond\x20to\x20blood\x20glucose\x20levels\x20effectively.</li>\x0d\x0a</ul>\x0d\x0a\x20','<ol>\x0d\x0a<li><strong>Mitochondrial\x20DNA\x20mutations\x20(Option\x20A):</strong>\x20Mitochondrial\x20DNA\x20is\x20maternally\x20inherited\x20and\x20thus\x20does\x20not\x20play\x20a\x20role\x20in\x20paternal\x20transmission\x20of\x20obesity\x20risk\x20to\x20offspring.</li>\x0d\x0a<li><strong>Changes\x20in\x20sperm\x20epigenetic\x20marks\x20(Option\x20B):\x20Epigenetic\x20changes</strong>\x20in\x20sperm,\x20such\x20as\x20DNA\x20methylation\x20and\x20histone\x20modifications,\x20can\x20be\x20influenced\x20by\x20environmental\x20exposures,\x20including\x20diet\x20and\x20lifestyle\x20factors\x20in\x20the\x20father.\x20These\x20changes\x20do\x20not\x20alter\x20the\x20DNA\x20sequence\x20itself\x20but\x20affect\x20gene\x20expression,\x20potentially\x20increasing\x20the\x20risk\x20of\x20obesity\x20and\x20metabolic\x20disorders\x20in\x20offspring.</li>\x0d\x0a<li><strong>Y-chromosome\x20deletions\x20(Option\x20C):</strong>\x20Y-chromosome\x20deletions\x20are\x20linked\x20to\x20male\x20infertility\x20but\x20are\x20not\x20directly\x20associated\x20with\x20the\x20transmission\x20of\x20obesity\x20risk.\x20Additionally,\x20obesity\x20inheritance\x20is\x20not\x20sex\x20chromosome-specific.</li>\x0d\x0a<li><strong>Maternal\x20imprinting\x20(Option\x20D):</strong>\x20Maternal\x20imprinting\x20refers\x20to\x20gene\x20expression\x20regulation\x20from\x20maternal\x20alleles.\x20Paternal\x20epigenetic\x20marks\x20on\x20sperm\x20are\x20responsible\x20for\x20the\x20father-to-offspring\x20transmission\x20of\x20obesity\x20risk\x20rather\x20than\x20maternal\x20imprinting.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Environmental\x20exposures\x20</strong>affecting\x20fathers\x20can\x20lead\x20to\x20<strong>epigenetic\x20modifications</strong>\x20in\x20sperm,\x20contributing\x20to\x20the\x20risk\x20of\x20obesity\x20and\x20related\x20metabolic\x20conditions\x20in\x20offspring.</li>\x0d\x0a<li>This\x20phenomenon\x20emphasizes\x20the\x20role\x20of\x20<strong>epigenetic\x20inheritance\x20</strong>and\x20highlights\x20how\x20lifestyle\x20factors\x20in\x20one\x20generation\x20can\x20influence\x20health\x20risks\x20in\x20subsequent\x20generations.</li>\x0d\x0a</ul>\x0d\x0a\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Premeal</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Evidence\x20of\x20insulin\x20resistance</span></p>','correct_choice_id','querySelectorAll','\x22\x20data-option-index=\x22','Bookmarked','MerfQ','red','kRPvA','EdnSe','YOdTB','hRCuH','<p><span\x20style=\x22font-size:12.0pt;\x22>1-H,\x202-F,\x203-G,\x204-D,\x205-A,\x206-I</span></p>','PPBji','oZZxl','yWqrT','GOtWB','CmKuG','click','<p><span\x20style=\x22font-size:12.0pt;\x22>In\x20patients\x20with\x20Donohue\x20syndrome,\x20episodes\x20of\x20fasting\x20hypoglycemia\x20occur\x20despite\x20severe\x20insulin\x20resistance\x20due\x20to:</span></p>','status','bookmarked','aERcp','KTCYI','SUUju','gAQvV','psvLM','PyNcR','dcxUc','Previous\x20progress\x20cleared.','zTycK','tTfUq','QoMxg','<ol>\x0d\x0a<li><strong>Decreased\x20glucagon\x20levels\x20(Option\x20A):</strong>\x20Glucagon\x20levels\x20are\x20typically\x20not\x20the\x20primary\x20factor\x20in\x20hypoglycemia\x20episodes\x20in\x20Donohue\x20syndrome.\x20These\x20patients\x20often\x20have\x20elevated\x20insulin\x20levels\x20despite\x20insulin\x20resistance.</li>\x0d\x0a<li><strong>Very\x20elevated\x20insulin\x20levels\x20(Option\x20B):</strong>\x20In\x20Donohue\x20syndrome,\x20patients\x20have\x20<strong>severely\x20elevated\x20insulin\x20levels</strong>\x20due\x20to\x20a\x20feedback\x20loop\x20resulting\x20from\x20insulin\x20receptor\x20mutations.\x20Despite\x20insulin\x20resistance,\x20the\x20pancreas\x20continues\x20to\x20secrete\x20excessive\x20insulin\x20in\x20an\x20attempt\x20to\x20regulate\x20blood\x20glucose.\x20These\x20very\x20high\x20insulin\x20levels\x20can\x20lead\x20to\x20<strong>hypoglycemic\x20episodes</strong>,\x20particularly\x20during\x20fasting\x20when\x20insulin\x20effects\x20are\x20less\x20opposed\x20by\x20dietary\x20glucose.</li>\x0d\x0a<li><strong>Impaired\x20gluconeogenesis\x20(Option\x20C):</strong>\x20Although\x20gluconeogenesis\x20may\x20be\x20impacted,\x20it\x20is\x20not\x20the\x20primary\x20reason\x20for\x20fasting\x20hypoglycemia\x20in\x20Donohue\x20syndrome.\x20The\x20excess\x20insulin,\x20even\x20if\x20functionally\x20ineffective\x20in\x20peripheral\x20tissues,\x20can\x20still\x20suppress\x20gluconeogenesis\x20to\x20some\x20extent.</li>\x0d\x0a<li><strong>Increased\x20insulin\x20sensitivity\x20(Option\x20D):</strong>\x20Donohue\x20syndrome\x20is\x20characterized\x20by\x20<strong>severe\x20insulin\x20resistance</strong>,\x20not\x20increased\x20insulin\x20sensitivity.\x20Insulin\x27s\x20effects\x20are\x20limited\x20due\x20to\x20receptor\x20mutations,\x20but\x20the\x20high\x20levels\x20can\x20cause\x20unpredictable\x20hypoglycemic\x20episodes,\x20particularly\x20during\x20fasting.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Donohue\x20syndrome,</strong>\x20also\x20known\x20as\x20<strong>leprechaunism,</strong>\x20is\x20a\x20rare\x20genetic\x20disorder\x20with\x20severe\x20<strong>insulin\x20resistance\x20</strong>due\x20to\x20mutations\x20in\x20the\x20insulin\x20receptor.</li>\x0d\x0a<li><strong>Elevated\x20insulin\x20levels\x20</strong>in\x20these\x20patients\x20can\x20lead\x20to\x20paradoxical\x20hypoglycemia,\x20particularly\x20in\x20fasting\x20states,\x20as\x20the\x20body\x20attempts\x20to\x20compensate\x20for\x20insulin\x20resistance\x20by\x20producing\x20excessive\x20insulin.</li>\x0d\x0a</ul>\x0d\x0a\x20','REJLN','<p><span\x20style=\x22font-size:12.0pt;\x22>Increase\x20circulating\x20triglyceride\x20levels</span></p>','selected','__proto__','wjAkT','lsAoD','<p><span\x20style=\x22font-size:12.0pt;\x22>Very\x20elevated\x20insulin\x20levels</span></p>','UqgtP','OXHsl','completed','custom_quiz.html','AWhAc','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','totalTimeResult','getItem','aVRlR','closest','<p><span\x20style=\x22font-size:12.0pt;\x22>Diabetes\x20mellitus</span></p>','gnUQl','yFDtL','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','ZBQBn','ntSJk','avgTimeResult','jjkwx','DT1295409','timed_study','title','JMNZB','questionNav','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','contains','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','customQuizData','<ol>\x0d\x0a<li><strong>Sulfonylureas\x20and\x20DPP-4\x20inhibitors\x20(Option\x20A)\x20-\x20Incorrect:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Explanation</strong>:\x20While\x20both\x20sulfonylureas\x20and\x20DPP-4\x20inhibitors\x20are\x20effective\x20in\x20lowering\x20blood\x20glucose,\x20they\x20generally\x20do\x20not\x20achieve\x20the\x20same\x20magnitude\x20of\x20glucose\x20reduction\x20as\x20GLP-1\x20receptor\x20agonists\x20or\x20insulin.\x20SGLT2\x20inhibitors,\x20however,\x20have\x20a\x20comparable\x20glucose-lowering\x20effect\x20to\x20these\x20agents.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>GLP-1\x20receptor\x20agonists\x20or\x20insulin\x20(Option\x20B)\x20-\x20Correct:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Explanation</strong>:\x20<strong>GLP-1\x20receptor\x20agonists</strong>(e.g.,\x20liraglutide,\x20exenatide)\x20and\x20<strong>insulin</strong>\x20are\x20more\x20potent\x20in\x20reducing\x20blood\x20glucose\x20compared\x20to\x20SGLT2\x20inhibitors.\x20Insulin\x20can\x20be\x20titrated\x20to\x20achieve\x20significant\x20glucose\x20control,\x20and\x20GLP-1\x20agonists\x20work\x20by\x20enhancing\x20glucose-dependent\x20insulin\x20secretion,\x20delaying\x20gastric\x20emptying,\x20and\x20reducing\x20appetite,\x20making\x20them\x20particularly\x20effective\x20at\x20lowering\x20both\x20fasting\x20and\x20postprandial\x20glucose\x20levels.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Metformin\x20alone\x20(Option\x20C)\x20-\x20Incorrect:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Explanation</strong>:\x20Metformin,\x20a\x20first-line\x20therapy\x20for\x20Type\x202\x20Diabetes,\x20generally\x20provides\x20a\x20modest\x20glucose-lowering\x20effect\x20compared\x20to\x20GLP-1\x20receptor\x20agonists\x20and\x20insulin.\x20SGLT2\x20inhibitors\x20offer\x20an\x20additive\x20effect\x20when\x20combined\x20with\x20metformin,\x20but\x20neither\x20alone\x20achieves\x20the\x20glucose\x20reduction\x20potential\x20of\x20GLP-1\x20receptor\x20agonists\x20or\x20insulin.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Alpha-glucosidase\x20inhibitors\x20(Option\x20D)\x20-\x20Incorrect:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Explanation</strong>:\x20Alpha-glucosidase\x20inhibitors\x20(e.g.,\x20acarbose)\x20primarily\x20lower\x20postprandial\x20glucose\x20but\x20are\x20less\x20effective\x20in\x20overall\x20glucose\x20reduction\x20than\x20SGLT2\x20inhibitors.\x20They\x20work\x20by\x20delaying\x20carbohydrate\x20absorption\x20in\x20the\x20intestine,\x20which\x20has\x20a\x20limited\x20effect\x20compared\x20to\x20insulin\x20or\x20GLP-1\x20receptor\x20agonists.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Examples\x20of\x20SGLT2\x20inhibitors:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Canagliflozin</strong></li>\x0d\x0a<li><strong>Dapagliflozin</strong></li>\x0d\x0a<li><strong>Empagliflozin</strong></li>\x0d\x0a<li><strong>Ertugliflozin</strong></li>\x0d\x0a</ul>\x0d\x0a<p><strong>Class\x20Mechanism:</strong></p>\x0d\x0a<ul>\x0d\x0a<li>SGLT2\x20inhibitors\x20block\x20the\x20<strong>SGLT2\x20protein\x20in\x20the\x20proximal\x20renal\x20tubules\x20</strong>of\x20the\x20kidneys,\x20which\x20is\x20responsible\x20for\x20reabsorbing\x20approximately\x2090%\x20of\x20filtered\x20glucose.</li>\x0d\x0a<li>By\x20inhibiting\x20SGLT2,\x20these\x20drugs\x20reduce\x20glucose\x20reabsorption,\x20leading\x20to\x20<strong>increased\x20glucose\x20excretion\x20in\x20the\x20urine</strong>(glucosuria)\x20and\x20a\x20reduction\x20in\x20blood\x20glucose\x20levels.</li>\x0d\x0a</ul>\x0d\x0a<p><strong>Mechanism\x20of\x20Action</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>Kidney\x27s\x20Role\x20in\x20Glucose\x20Regulation:</strong>\x0d\x0a<ul>\x0d\x0a<li>In\x20a\x20healthy\x20kidney,\x20SGLT2\x20transports\x20glucose\x20from\x20the\x20renal\x20tubules\x20back\x20into\x20the\x20bloodstream.</li>\x0d\x0a<li>In\x20patients\x20with\x20diabetes,\x20elevated\x20blood\x20glucose\x20levels\x20increase\x20the\x20load\x20on\x20SGLT2,\x20causing\x20the\x20kidneys\x20to\x20reabsorb\x20more\x20glucose,\x20which\x20worsens\x20hyperglycemia.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Effect\x20of\x20SGLT2\x20Inhibition:</strong></li>\x0d\x0a</ol>\x0d\x0a<p><strong>Benefits\x20of\x20SGLT2\x20Inhibitors</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>Glucose\x20Lowering:</strong>\x0d\x0a<ul>\x0d\x0a<li>SGLT2\x20inhibitors\x20provide\x20moderate\x20glucose-lowering\x20effects\x20and\x20are\x20effective\x20as\x20an\x20<strong><strong>add-on\x20therapy</strong></strong>to\x20metformin\x20or\x20other\x20antidiabetic\x20medications.</li>\x0d\x0a<li>They\x20are\x20particularly\x20useful\x20in\x20<strong>Type\x202\x20Diabetes\x20patients\x20with\x20cardiovascular\x20and\x20renal\x20comorbidities.</strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Cardiovascular\x20Benefits:</strong>\x0d\x0a<ul>\x0d\x0a<li>Studies\x20like\x20<strong>EMPA-REG\x20OUTCOME\x20(empagliflozin)\x20</strong>and\x20<strong>CANVAS\x20(canagliflozin)</strong>\x20have\x20shown\x20that\x20SGLT2\x20inhibitors\x20reduce\x20the\x20risk\x20of\x20<strong>cardiovascular\x20mortality,</strong>\x20especially\x20in\x20patients\x20with\x20heart\x20failure.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Renal\x20Protection:</strong>\x0d\x0a<ul>\x0d\x0a<li>SGLT2\x20inhibitors\x20help\x20in\x20reducing\x20albuminuria\x20and\x20delaying\x20progression\x20of\x20chronic\x20kidney\x20disease\x20(CKD).</li>\x0d\x0a<li><strong>DAPA-CKD\x20(dapagliflozin)\x20</strong>and\x20<strong>CREDENCE\x20(canagliflozin<strong>)</strong></strong>\x20trials\x20demonstrated\x20that\x20SGLT2\x20inhibitors\x20reduce\x20the\x20risk\x20of\x20worsening\x20kidney\x20function\x20and\x20provide\x20significant\x20renal\x20protection\x20in\x20diabetic\x20and\x20even\x20non-diabetic\x20CKD\x20patients.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Weight\x20Loss:</strong>\x0d\x0a<ul>\x0d\x0a<li>The\x20caloric\x20loss\x20due\x20to\x20glucose\x20excretion\x20can\x20lead\x20to\x20modest\x20weight\x20reduction,\x20beneficial\x20in\x20overweight\x20or\x20obese\x20Type\x202\x20Diabetes\x20patients.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Blood\x20Pressure\x20Reduction:</strong>\x0d\x0a<ul>\x0d\x0a<li>The\x20osmotic\x20diuresis\x20effect\x20also\x20leads\x20to\x20a\x20small\x20reduction\x20in\x20blood\x20pressure,\x20beneficial\x20for\x20hypertensive\x20patients.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Side\x20Effects\x20and\x20Precautions</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>Genitourinary\x20Infections:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Genital\x20and\x20urinary\x20tract\x20infections,</strong>\x20especially\x20fungal\x20infections.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Dehydration\x20and\x20Hypotension:</strong>\x0d\x0a<ul>\x0d\x0a<li>Osmotic\x20diuresis\x20may\x20lead\x20to\x20<strong>dehydration,</strong>\x20hypotension,\x20or\x20dizziness,\x20particularly\x20in\x20elderly\x20patients\x20or\x20those\x20on\x20other\x20diuretics.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Euglycemic\x20Diabetic\x20Ketoacidosis\x20(DKA):</strong>\x0d\x0a<ul>\x0d\x0a<li>Rarely,\x20SGLT2\x20inhibitors\x20can\x20lead\x20to\x20<strong>euglycemic\x20diabetic\x20ketoacidosis</strong>(DKA)\x20even\x20when\x20blood\x20glucose\x20levels\x20are\x20not\x20significantly\x20elevated.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Bone\x20Fracture\x20Risk:</strong>\x0d\x0a<ul>\x0d\x0a<li>Canagliflozin\x20has\x20been\x20associated\x20with\x20an\x20<strong>increased\x20risk\x20of\x20bone\x20fractures,&nbsp;</strong>likely\x20due\x20to\x20altered\x20calcium\x20and\x20phosphate\x20balance.\x20Patients\x20at\x20risk\x20of\x20osteoporosis\x20should\x20be\x20monitored\x20closely.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Amputation\x20Risk:</strong>\x0d\x0a<ul>\x0d\x0a<li>Canagliflozin\x20was\x20found\x20to\x20have\x20a\x20small\x20increased\x20risk\x20of\x20<strong>lower-limb\x20amputation&nbsp;</strong>in\x20some\x20studies,\x20especially\x20in\x20patients\x20with\x20peripheral\x20vascular\x20disease\x20or\x20neuropathy.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Renal\x20Impairment:</strong>\x0d\x0a<ul>\x0d\x0a<li>SGLT2\x20inhibitors\x20are\x20not\x20recommended\x20in\x20patients\x20with\x20<strong>significant\x20renal\x20impairment\x20(eGFR\x20&lt;\x2030\x20mL/min/1.73m&sup2;),\x20</strong>as\x20their\x20glucose-lowering\x20efficacy\x20diminishes\x20with\x20declining\x20kidney\x20function.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Comparison\x20with\x20Other\x20Antidiabetic\x20Agents</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109318a6102-ff8d-48b3-8786-18d50795251e.jpg\x22>\x0d\x0a<p><strong>Summary\x20of\x20Key\x20Points</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>SGLT2\x20inhibitors\x20</strong>are\x20effective\x20in\x20<strong>lowering\x20blood\x20glucose</strong>\x20and\x20provide\x20additional\x20benefits\x20in\x20<strong>weight\x20loss,\x20blood\x20pressure\x20reduction,\x20cardiovascular\x20protection,\x20and\x20renal\x20protection.</strong></li>\x0d\x0a<li><strong>Main\x20Side\x20Effects:</strong>\x20Genitourinary\x20infections,\x20dehydration,\x20and\x20a\x20risk\x20of\x20euglycemic\x20DKA.</li>\x0d\x0a<li><strong>Indicated\x20</strong>especially\x20in\x20Type\x202\x20Diabetes\x20patients\x20with\x20<strong>heart\x20failure\x20or\x20CKD.</strong></li>\x0d\x0a<li>They\x20are\x20best\x20used\x20in\x20combination\x20with\x20other\x20antidiabetic\x20agents\x20for\x20comprehensive\x20glucose\x20control\x20and\x20management\x20of\x20comorbidities.</li>\x0d\x0a</ul>\x0d\x0a\x20','FveqZ','xduqT','intermediate','WBcpH','getAttribute','questions','AtYhZ','PjHSe','CXErA','OZmDf','jYZbS','border-green-500','<ol>\x0d\x0a<li><strong>Elderly\x20patients\x20over\x2065\x20years\x20(Option\x20A):\x20</strong>Monogenic\x20diabetes\x20is\x20not\x20typically\x20diagnosed\x20in\x20the\x20elderly.\x20This\x20age\x20group\x20more\x20commonly\x20develops\x20Type\x202\x20Diabetes.</li>\x0d\x0a<li><strong>Middle-aged\x20adults\x20(Option\x20B):</strong>\x20Although\x20Type\x202\x20Diabetes\x20often\x20appears\x20in\x20middle-aged\x20adults,\x20monogenic\x20diabetes\x20usually\x20presents\x20much\x20earlier.</li>\x0d\x0a<li><strong>Younger\x20patients\x20in\x20the\x20first\x202\x20to\x203\x20decades\x20of\x20life\x20(Option\x20C):</strong>\x20Monogenic\x20forms\x20of\x20diabetes,\x20such\x20as\x20<strong>Maturity-Onset\x20Diabetes\x20of\x20the\x20Young\x20(MODY)</strong>,\x20are\x20typically\x20diagnosed\x20in\x20children,\x20adolescents,\x20and\x20young\x20adults,\x20often\x20before\x20the\x20age\x20of\x2025.\x20These\x20conditions\x20are\x20caused\x20by\x20single\x20gene\x20mutations\x20affecting\x20insulin\x20production.</li>\x0d\x0a<li><strong>Only\x20during\x20pregnancy\x20(Option\x20D):\x20</strong>While\x20<strong>Gestational\x20Diabetes\x20Mellitus\x20(GDM)</strong>\x20occurs\x20during\x20pregnancy,\x20monogenic\x20diabetes\x20is\x20not\x20limited\x20to\x20this\x20period.\x20Monogenic\x20diabetes\x20can\x20present\x20at\x20any\x20point\x20during\x20the\x20first\x20two\x20or\x20three\x20decades\x20of\x20life.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Monogenic\x20diabetes\x20</strong>is\x20distinct\x20from\x20Type\x201\x20and\x20Type\x202\x20Diabetes\x20and\x20typically\x20presents\x20in\x20<strong>younger\x20individuals,</strong>\x20often\x20in\x20childhood\x20or\x20early\x20adulthood.</li>\x0d\x0a<li>The\x20most\x20common\x20form\x20of\x20monogenic\x20diabetes\x20is\x20<strong>Maturity-Onset\x20Diabetes\x20of\x20the\x20Young\x20(MODY),</strong>\x20characterized\x20by\x20non-autoimmune,\x20inherited\x20defects\x20in\x20insulin\x20production.</li>\x0d\x0a</ul>\x0d\x0a\x20','correctResult','<p><span\x20style=\x22font-size:12.0pt;\x22>Normal\x20teeth\x20and\x20nails</span></p>','key','CQZCV','WZpXm','YrIIB','heVDO','RWgWz','bookmarkedQuestions','error','<p><span\x20style=\x22font-size:12.0pt;\x22>Impaired\x20fasting\x20glucose</span></p>','WgOIv','NYUcA','classList','quizFile','modeModal','DT1295444','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','MPSam','nav-btn-current','<p><span\x20style=\x22font-size:12.0pt;\x22>1-B,\x202-I,\x203-H,\x204-G,\x205-C,\x206-E</span></p>','hKHGD','bUUyX','apply','fill','DsPDJ','endsWith','xTgTK','qrRUp','Not\x20Attempted','testModeReviewLegend','jcWqR','prototype','<p><span\x20style=\x22font-size:12.0pt;\x22>When\x20glucose\x20control\x20is\x20poor,\x20initial\x20self-monitoring\x20of\x20blood\x20glucose\x20(SMBG)\x20should\x20concentrate\x20on\x20measuring\x20glucose\x20levels\x20at\x20what\x20times?</span></p>','Jlula','KxPjB','mwZHy','floor','SBGmm','DOMContentLoaded','axIfC','solution','navBtn_','bEACo','fPmFL','dByiL','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20KATP_{ATP}ATP\x20channel\x20in\x20pancreatic\x20&beta;-cells\x20is\x20composed\x20of\x20which\x20two\x20subunits?</span></p>','ORxld','TrVRE','JKCdZ','rSuSj','Vifuz','BZoTx','prevBtn','search','JwzTW','LArRH','xYheH','Marked','DYAsc','CJkXa','<p><span\x20style=\x22font-size:12.0pt;\x22>Human\x20placental\x20lactogen</span></p>','timed_exam','WtPii','statsBar','AQVju','<ol>\x0d\x0a<li><strong>Premeal\x20(Option\x20A):</strong>\x20For\x20patients\x20with\x20poor\x20glucose\x20control,\x20focusing\x20on\x20<strong>premeal\x20blood\x20glucose\x20measurements</strong>\x20provides\x20critical\x20information\x20about\x20baseline\x20glucose\x20levels.\x20Monitoring\x20premeal\x20glucose\x20helps\x20assess\x20the\x20effectiveness\x20of\x20basal\x20insulin\x20or\x20background\x20therapies\x20and\x20allows\x20adjustments\x20to\x20ensure\x20target\x20glucose\x20levels\x20before\x20meals,\x20which\x20can\x20improve\x20overall\x20glycemic\x20control.</li>\x0d\x0a<li><strong>Post-exercise\x20(Option\x20B):</strong>\x20While\x20post-exercise\x20glucose\x20levels\x20can\x20provide\x20insights\x20into\x20the\x20body\x27s\x20response\x20to\x20physical\x20activity,\x20they\x20are\x20not\x20the\x20primary\x20focus\x20in\x20cases\x20of\x20poor\x20baseline\x20glucose\x20control.\x20Exercise\x20can\x20cause\x20glucose\x20fluctuations,\x20so\x20premeal\x20readings\x20are\x20prioritized\x20for\x20initial\x20adjustments.</li>\x0d\x0a<li><strong>Bedtime\x20(Option\x20C):</strong>\x20Bedtime\x20readings\x20are\x20helpful\x20in\x20preventing\x20overnight\x20hypoglycemia,\x20but\x20focusing\x20initially\x20on\x20premeal\x20measurements\x20provides\x20more\x20actionable\x20data\x20for\x20establishing\x20control,\x20as\x20it\x20directly\x20impacts\x20postprandial\x20glucose\x20excursions.</li>\x0d\x0a<li><strong>Middle\x20of\x20the\x20night\x20(Option\x20D):</strong>\x20Middle-of-the-night\x20checks\x20may\x20be\x20necessary\x20for\x20patients\x20at\x20risk\x20of\x20nocturnal\x20hypoglycemia,\x20but\x20they\x20are\x20not\x20typically\x20the\x20focus\x20for\x20initial\x20SMBG\x20when\x20glucose\x20control\x20is\x20poor.\x20Premeal\x20monitoring\x20remains\x20the\x20priority\x20for\x20establishing\x20stable\x20control.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Premeal\x20glucose\x20monitoring\x20</strong>is\x20essential\x20when\x20glucose\x20control\x20is\x20poor,\x20as\x20it\x20provides\x20baseline\x20information\x20for\x20adjusting\x20insulin\x20or\x20other\x20treatments.</li>\x0d\x0a<li>Effective\x20premeal\x20monitoring\x20helps\x20reduce\x20<strong>postprandial\x20spikes\x20</strong>and\x20enables\x20more\x20stable\x20glucose\x20management\x20overall.</li>\x0d\x0a</ul>\x0d\x0a\x20','dHYlI','DlfFW','Zevdl','pgNjM','<ol>\x0d\x0a<li><strong>Mechanism\x20of\x20Calcineurin\x20Inhibitors\x20in\x20Post-Transplant\x20Diabetes\x20Mellitus\x20(PTDM):</strong>\x0d\x0a<ul>\x0d\x0a<li>Calcineurin\x20inhibitors,\x20including\x20<strong>tacrolimus\x20</strong>and\x20<strong>cyclosporine</strong>,\x20are\x20used\x20as\x20immunosuppressants\x20in\x20transplant\x20patients\x20to\x20prevent\x20organ\x20rejection.\x20However,\x20these\x20drugs\x20have\x20significant\x20metabolic\x20side\x20effects.</li>\x0d\x0a<li><strong>Calcineurin</strong>is\x20an\x20enzyme\x20crucial\x20for\x20insulin\x20gene\x20expression\x20and\x20&beta;-cell\x20function.\x20It\x20activates\x20the\x20<strong>NFAT\x20(nuclear\x20factor\x20of\x20activated\x20T-cells)</strong>\x20pathway,\x20which\x20is\x20vital\x20for\x20insulin\x20gene\x20transcription\x20and\x20&beta;-cell\x20survival.</li>\x0d\x0a<li>Calcineurin\x20inhibitors\x20<strong>block\x20calcineurin</strong>,\x20leading\x20to\x20decreased\x20activation\x20of\x20NFAT,\x20reducing\x20insulin\x20production\x20from\x20pancreatic\x20&beta;-cells\x20and\x20potentially\x20inducing\x20&beta;-cell\x20apoptosis.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Effects\x20on\x20Insulin\x20and\x20Glucose\x20Metabolism:</strong>\x0d\x0a<ul>\x0d\x0a<li>By\x20inhibiting\x20insulin\x20secretion,\x20these\x20drugs\x20can\x20lead\x20to\x20<strong>hyperglycemia</strong>,\x20increasing\x20the\x20risk\x20of\x20developing\x20PTDM.</li>\x0d\x0a<li>In\x20addition,\x20calcineurin\x20inhibitors\x20may\x20indirectly\x20cause\x20<strong>insulin\x20resistance\x20</strong>in\x20peripheral\x20tissues,\x20further\x20worsening\x20glucose\x20metabolism\x20in\x20transplant\x20recipients.</li>\x0d\x0a<li>This\x20combined\x20effect\x20of\x20<strong>reduced\x20insulin\x20secretion\x20and\x20peripheral\x20insulin\x20resistance\x20</strong>makes\x20calcineurin\x20inhibitors\x20a\x20significant\x20contributor\x20to\x20PTDM.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Clinical\x20Implications:</strong>\x0d\x0a<ul>\x0d\x0a<li>Patients\x20on\x20calcineurin\x20inhibitors\x20require\x20<strong>regular\x20monitoring\x20of\x20blood\x20glucose\x20</strong>levels,\x20especially\x20during\x20the\x20initial\x20post-transplant\x20period.</li>\x0d\x0a<li>Alternative\x20immunosuppressive\x20regimens\x20or\x20adjunctive\x20treatments\x20like\x20<strong>insulin\x20</strong>or\x20<strong>oral\x20hypoglycemic\x20agents</strong>\x20may\x20be\x20necessary\x20to\x20manage\x20hyperglycemia\x20in\x20patients\x20on\x20these\x20drugs.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Table:\x20Drugs\x20and\x20Their\x20Effects\x20on\x20Diabetes\x20and\x20Insulin\x20Metabolism</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010981569d3e-f489-487f-9ff6-1c9d889bc648.jpg\x22>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Calcineurin\x20inhibitors\x20</strong>contribute\x20to\x20PTDM\x20primarily\x20by\x20<strong>reducing\x20insulin\x20secretion</strong>\x20due\x20to\x20inhibition\x20of\x20the\x20calcineurin-NFAT\x20pathway,\x20which\x20is\x20essential\x20for\x20&beta;-cell\x20function.</li>\x0d\x0a<li>Various\x20drugs,\x20including\x20corticosteroids,\x20thiazides,\x20and\x20atypical\x20antipsychotics,\x20also\x20impair\x20insulin\x20secretion\x20or\x20increase\x20insulin\x20resistance,\x20contributing\x20to\x20diabetes\x20risk\x20in\x20predisposed\x20patients.</li>\x0d\x0a</ul>\x0d\x0a\x20','qgtup','AoslS','solutionImages','FfDeJ','<p><span\x20style=\x22font-size:12.0pt;\x22>SGLT2\x20inhibitors\x20are\x20less\x20effective\x20than\x20which\x20of\x20the\x20following\x20for\x20glucose\x20reduction?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Liver\x20and\x20muscle</span></p>','PrpZg','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','JPouU','IlRQu','VQxIq','No\x20solution\x20available.','<p><span\x20style=\x22font-size:12.0pt;\x22>Ectopic\x20fat\x20accumulation\x20in\x20which\x20organs\x20contributes\x20to\x20increased\x20insulin\x20resistance?</span></p>','aCTDI','toggle','timeSpent','<p><span\x20style=\x22font-size:12.0pt;\x22>Increasing\x20insulin\x20secretion</span></p>','DT1295396','xOICS','<p><span\x20style=\x22font-size:12.0pt;\x22>Only\x20during\x20pregnancy</span></p>','none','table','strokeDasharray','khBuR','VBPER','<p><span\x20style=\x22font-size:12.0pt;\x22>Lower\x20ectopic\x20fat\x20accumulation</span></p>','UOYoD','xmZgY','DocTutorial','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','wwGwL','DQJEQ','No\x20question\x20text\x20available','green','<p><span\x20style=\x22font-size:12.0pt;\x22>Brain\x20and\x20kidneys</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Enhancing\x20insulin\x20sensitivity</span></p>','npvQh','iRlib','SBpNb','WDcfU','doJFx','OYGxm','keydown','src','pfTgH','<ol><li><strong>Normal\x20Glucose\x20Tolerance\x20(Option\x20A)\x20-\x20Incorrect:</strong><ul><li><strong>Fasting\x20Blood\x20Glucose\x20(FBG):\x20</strong>Normal\x20FBG\x20is\x20<strong>&lt;100\x20mg/dL\x20(5.6\x20mmol/L)</strong>.</li><li><strong>2-Hour\x20OGTT:\x20</strong>For\x20normal\x20glucose\x20tolerance,\x20the\x202-hour\x20postprandial\x20glucose\x20should\x20be\x20<strong>&lt;140\x20mg/dL\x20(7.8\x20mmol/L)</strong>\x20following\x20a\x2075-gram\x20OGTT.</li><li>In\x20this\x20case,\x20the\x20patient\x27s\x20fasting\x20glucose\x20is\x20elevated\x20above\x20the\x20normal\x20range,\x20and\x20her\x202-hour\x20OGTT\x20value\x20of\x20150\x20mg/dL\x20exceeds\x20the\x20threshold\x20for\x20normal\x20glucose\x20tolerance.</li></ul></li><li><strong>Impaired\x20Fasting\x20Glucose\x20(Option\x20B)\x20-\x20Incorrect:</strong><ul><li><strong>Definition:\x20</strong>Impaired\x20fasting\x20glucose\x20(IFG)\x20is\x20a\x20state\x20of\x20<strong>pre-diabetes</strong>\x20characterized\x20by\x20mildly\x20elevated\x20fasting\x20blood\x20glucose\x20levels,\x20indicating\x20insulin\x20resistance\x20or\x20decreased\x20beta-cell\x20function.</li><li><strong>Diagnostic\x20Criteria\x20for\x20IFG:\x20</strong>Fasting\x20glucose\x20levels\x20between\x20<strong>100-125\x20mg/dL\x20(5.6-6.9\x20mmol/L)</strong>\x20indicate\x20IFG.</li><li><strong>2-Hour\x20OGTT:\x20</strong>For\x20a\x20diagnosis\x20of\x20isolated\x20IFG,\x20the\x202-hour\x20postprandial\x20glucose\x20should\x20be\x20<strong>&lt;140\x20mg/dL</strong>\x20following\x20OGTT.</li><li>While\x20the\x20patient\x27s\x20fasting\x20glucose\x20falls\x20within\x20the\x20IFG\x20range,\x20her\x202-hour\x20OGTT\x20result\x20of\x20150\x20mg/dL\x20is\x20higher\x20than\x20the\x20limit\x20for\x20IFG,\x20excluding\x20this\x20diagnosis.</li></ul></li><li><strong>Impaired\x20Glucose\x20Tolerance\x20(Option\x20C)\x20-\x20Correct:</strong><ul><li><strong>Definition:\x20</strong>Impaired\x20glucose\x20tolerance\x20(IGT)\x20is\x20another\x20form\x20of\x20<strong>pre-diabetes</strong>\x20and\x20is\x20diagnosed\x20based\x20on\x20elevated\x202-hour\x20glucose\x20levels\x20after\x20an\x20OGTT.</li><li><strong>Diagnostic\x20Criteria\x20for\x20IGT:\x20</strong>A\x202-hour\x20postprandial\x20glucose\x20level\x20of\x20<strong>140-199\x20mg/dL\x20(7.8-11.0\x20mmol/L)</strong>\x20following\x20a\x2075-gram\x20OGTT\x20indicates\x20IGT.</li><li><strong>Fasting\x20Glucose:\x20</strong>Individuals\x20with\x20IGT\x20may\x20have\x20normal\x20or\x20slightly\x20elevated\x20fasting\x20glucose\x20levels.\x20In\x20this\x20case,\x20the\x20patient\x27s\x202-hour\x20OGTT\x20result\x20of\x20150\x20mg/dL\x20fits\x20within\x20the\x20IGT\x20range,\x20making\x20this\x20the\x20correct\x20diagnosis.</li></ul></li><li><strong>Diabetes\x20Mellitus\x20(Option\x20D)\x20-\x20Incorrect:</strong><ul><li><strong>Diagnostic\x20Criteria\x20for\x20Diabetes:</strong><ul><li><strong>Fasting\x20Blood\x20Glucose:\x20</strong>&ge;126\x20mg/dL\x20(7.0\x20mmol/L)\x20on\x20two\x20separate\x20occasions.</li><li><strong>2-Hour\x20OGTT:\x20</strong>&ge;200\x20mg/dL\x20(11.1\x20mmol/L)\x20following\x20a\x2075-gram\x20OGTT.</li><li><strong>HbA1c:\x20</strong>An\x20HbA1c\x20level\x20of\x20&ge;6.5%.</li></ul></li><li>Since\x20the\x20patient\x27s\x20fasting\x20and\x202-hour\x20postprandial\x20glucose\x20levels\x20are\x20below\x20the\x20diabetic\x20thresholds,\x20a\x20diagnosis\x20of\x20diabetes\x20mellitus\x20cannot\x20be\x20made.</li></ul></li></ol><p><strong>Key\x20Diagnostic\x20Criteria\x20for\x20Glucose\x20Tolerance:</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010922fe896a-e794-4fe4-b3ef-70a1c2292645.jpg\x22><p><strong>Key\x20Takeaways:</strong></p><ul><li><strong>Pre-diabetes\x20</strong>includes\x20both\x20<strong>IFG</strong>\x20and\x20<strong>IGT</strong>.\x20Each\x20represents\x20an\x20elevated\x20risk\x20for\x20developing\x20Type\x202\x20diabetes\x20and\x20cardiovascular\x20disease.</li><li><strong>OGTT\x20</strong>is\x20the\x20preferred\x20test\x20for\x20diagnosing\x20IGT,\x20while\x20isolated\x20fasting\x20hyperglycemia\x20is\x20indicative\x20of\x20IFG.</li><li>An\x20<strong>HbA1c\x20of\x205.7-6.4%\x20</strong>indicates\x20pre-diabetes,\x20but\x20confirmation\x20with\x20fasting\x20glucose\x20or\x20OGTT\x20is\x20typically\x20recommended\x20for\x20accuracy.</li></ul>\x20','tUcfU','markedForReview','<p><span\x20style=\x22font-size:12.0pt;\x22>Decreased\x20insulin\x20resistance</span></p>','pEAhr','nav-btn-bookmarked','DT1295472','GQnSB','diabetes-and-obesity-549a4add.html','fromCharCode','No\x20questions\x20available\x20for\x20this\x20quiz.','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20hormone\x20is\x20one\x20placental\x20factor\x20that\x20contributes\x20to\x20maternal\x20insulin\x20resistance\x20during\x20pregnancy?</span></p>','location','UCgte','tqTVF','toString','MjeCQ','OuWwN','uUMTa','solutionAudio','add','jIrPD','cOVZO','\x20-\x20Brain\x20And\x20Scalpel','<ol>\x0d\x0a<li><strong>Tall\x20stature\x20(Option\x20A):</strong>\x20Patients\x20with\x20Rabson-Mendenhall\x20syndrome\x20typically\x20present\x20with\x20<strong>growth\x20retardation</strong>,\x20not\x20tall\x20stature,\x20as\x20a\x20result\x20of\x20severe\x20insulin\x20resistance\x20and\x20metabolic\x20dysregulation.</li>\x0d\x0a<li><strong>Protuberant\x20abdomen\x20(Option\x20B):\x20</strong>One\x20of\x20the\x20common\x20physical\x20features\x20in\x20patients\x20with\x20Rabson-Mendenhall\x20syndrome\x20is\x20a\x20<strong>protuberant\x20abdomen</strong>.\x20This\x20is\x20often\x20accompanied\x20by\x20insulin\x20resistance-related\x20visceral\x20fat\x20accumulation\x20and\x20metabolic\x20disturbances.</li>\x0d\x0a<li><strong>Normal\x20teeth\x20and\x20nails\x20(Option\x20C):</strong>\x20Rabson-Mendenhall\x20syndrome\x20is\x20associated\x20with\x20<strong>dental\x20abnormalities</strong>\x20and\x20<strong>abnormal\x20nails</strong>.\x20Patients\x20often\x20have\x20<strong>dysplastic\x20teeth</strong>\x20and\x20<strong>thick,\x20abnormal\x20nails</strong>\x20due\x20to\x20the\x20syndrome\x27s\x20effects\x20on\x20various\x20tissues\x20and\x20organs.</li>\x0d\x0a<li><strong>Early\x20onset\x20of\x20puberty\x20(Option\x20D):</strong>\x20Children\x20with\x20Rabson-Mendenhall\x20syndrome\x20often\x20have\x20<strong>delayed\x20development</strong>\x20and\x20growth\x20issues,\x20including\x20delayed\x20puberty\x20due\x20to\x20severe\x20insulin\x20resistance\x20and\x20metabolic\x20impairment.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Rabson-Mendenhall\x20syndrome\x20</strong>is\x20a\x20rare\x20form\x20of\x20severe\x20congenital\x20insulin\x20resistance\x20associated\x20with\x20growth\x20retardation,\x20<strong>dental\x20and\x20nail\x20abnormalities</strong>,\x20a\x20<strong>protuberant\x20abdomen,</strong>\x20and\x20metabolic\x20disturbances.</li>\x0d\x0a<li>It\x20is\x20caused\x20by\x20<strong>mutations\x20in\x20the\x20insulin\x20receptor\x20gene\x20</strong>and\x20is\x20part\x20of\x20a\x20spectrum\x20of\x20insulin\x20resistance\x20syndromes\x20that\x20also\x20include\x20Donohue\x20syndrome\x20(leprechaunism).</li>\x0d\x0a</ul>\x0d\x0a\x20','rWhkq','rsBPM','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','hoNSP','round','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','Kikbb','QKVNZ','incorrectAnswers','display','<p><span\x20style=\x22font-size:12.0pt;\x22>Maternal\x20imprinting</span></p>','SomnX','qwsUP','length','UviEY','dpAKO','oZMDR','ujMQh','DT1295401','PtBUX','notAttemptedResult','-600\x20text-white\x22>','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>B\x20&rarr;\x20C\x20&rarr;\x20A\x20&rarr;\x20D\x20&rarr;\x20E</span></p>','mWBrU','yfgNm','ftKhD','<p><span\x20style=\x22font-size:12.0pt;\x22>SUR1\x20and\x20Kir6.2</span></p>','nEZom','bfaec','\x22\x20data-src=\x22','NzfXC','not-attempted','PwLAn','totalAttempted','olGpl','solutionContainer','timeDisplay','Bookmark','<p><span\x20style=\x22font-size:12.0pt;\x22>Impaired\x20gluconeogenesis</span></p>','LEQbB','OPcwc','JWijY','bottom','TQYbf','sNxOs','<ol>\x0d\x0a<li><strong>Human\x20Placental\x20Lactogen\x20(HPL)</strong>:\x0d\x0a<ul>\x0d\x0a<li><strong>Primary\x20role:\x20</strong>HPL,\x20also\x20known\x20as\x20<strong>human\x20chorionic\x20somatomammotropin</strong>,\x20is\x20produced\x20by\x20the\x20placenta\x20and\x20plays\x20a\x20major\x20role\x20in\x20<strong>inducing\x20insulin\x20resistance</strong>\x20during\x20pregnancy.</li>\x0d\x0a<li><strong>Mechanism:\x20</strong>HPL\x20has\x20an\x20anti-insulin\x20effect\x20that\x20reduces\x20maternal\x20glucose\x20uptake\x20and\x20increases\x20glucose\x20availability\x20in\x20the\x20bloodstream\x20for\x20the\x20fetus.</li>\x0d\x0a<li><strong>Outcome:\x20</strong>By\x20decreasing\x20insulin\x20sensitivity\x20in\x20the\x20mother,\x20HPL\x20ensures\x20a\x20steady\x20supply\x20of\x20glucose\x20to\x20the\x20fetus,\x20which\x20is\x20crucial\x20for\x20fetal\x20growth\x20and\x20development.</li>\x0d\x0a<li><strong>Clinical\x20significance:\x20</strong>This\x20hormonal\x20effect\x20is\x20beneficial\x20for\x20fetal\x20development\x20but\x20can\x20predispose\x20some\x20women\x20(particularly\x20those\x20with\x20a\x20family\x20history\x20of\x20diabetes\x20or\x20obesity)\x20to\x20<strong>gestational\x20diabetes\x20mellitus\x20(GDM)</strong>.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Estrogen</strong>:\x0d\x0a<ul>\x0d\x0a<li><strong>Role\x20in\x20pregnancy:\x20</strong>Estrogen\x20levels\x20rise\x20during\x20pregnancy\x20to\x20support\x20uterine\x20growth\x20and\x20blood\x20flow\x20to\x20the\x20placenta.</li>\x0d\x0a<li><strong>Effect\x20on\x20insulin:\x20</strong>Estrogen\x20does\x20not\x20significantly\x20contribute\x20to\x20maternal\x20insulin\x20resistance.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Progesterone</strong>:\x0d\x0a<ul>\x0d\x0a<li><strong>Role\x20in\x20pregnancy:\x20</strong>Progesterone\x20maintains\x20the\x20endometrium\x20and\x20prevents\x20premature\x20uterine\x20contractions.</li>\x0d\x0a<li><strong>Effect\x20on\x20insulin:\x20</strong>Progesterone\x20does\x20not\x20play\x20a\x20primary\x20role\x20in\x20insulin\x20resistance\x20during\x20pregnancy.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Thyroid\x20Hormone</strong>:\x0d\x0a<ul>\x0d\x0a<li><strong>Role:</strong>Thyroid\x20hormones\x20are\x20essential\x20for\x20metabolism\x20and\x20fetal\x20brain\x20development.</li>\x0d\x0a<li><strong>Effect\x20on\x20insulin:\x20</strong>They\x20do\x20not\x20significantly\x20contribute\x20to\x20the\x20development\x20of\x20insulin\x20resistance\x20in\x20pregnancy.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>HPL\x20</strong>is\x20a\x20key\x20placental\x20hormone\x20that\x20promotes\x20<strong>maternal\x20insulin\x20resistance</strong>\x20to\x20increase\x20glucose\x20availability\x20for\x20the\x20fetus.</li>\x0d\x0a<li><strong>Gestational\x20diabetes\x20mellitus\x20(GDM)\x20</strong>is\x20a\x20potential\x20outcome\x20in\x20women\x20with\x20higher\x20susceptibility\x20to\x20insulin\x20resistance\x20during\x20pregnancy.</li>\x0d\x0a</ul>\x0d\x0a\x20','quizHierarchy','SVuDV','SzVhc','Incorrect','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','rcfZZ','QjzuH','pop','4380144IKDhmE','createElement','ZktgV','Option\x20','ORLnT','TFWwI','NHdnQ','data-option-index','OFRfi','RLUuo','onclick','explanationVideoPlayer','QnoUY','SXBoH','HrWbr','explanation_video','<p><span\x20style=\x22font-size:12.0pt;\x22>Changes\x20in\x20sperm\x20epigenetic\x20marks</span></p>','nejwi','Ydfgm','test','pOooh','gray','<p><span\x20style=\x22font-size:12.0pt;\x22>Pancreas\x20and\x20spleen</span></p>','JlMxA','4555576bNWRlh','fPaig','now','getElementById','ARWqH','block','Efymt','timerContainer','JAHhy','IxoMe','kZXua','<p><span\x20style=\x22font-size:12.0pt;\x22>KCNJ11\x20and\x20IRS-1</span></p>','explanation_images','toLowerCase','DT1295438','cLdgg','<ol>\x0d\x0a<li><strong>Brain\x20and\x20kidneys\x20(Option\x20A):</strong>\x20While\x20ectopic\x20fat\x20can\x20potentially\x20affect\x20various\x20organs,\x20fat\x20accumulation\x20in\x20the\x20brain\x20and\x20kidneys\x20does\x20not\x20play\x20a\x20major\x20role\x20in\x20the\x20development\x20of\x20insulin\x20resistance.</li>\x0d\x0a<li><strong>Liver\x20and\x20muscle\x20(Option\x20B):\x20Ectopic\x20fat\x20accumulation</strong>\x20in\x20the\x20<strong>liver</strong>\x20and\x20<strong>skeletal\x20muscle</strong>\x20is\x20a\x20major\x20contributor\x20to\x20<strong>insulin\x20resistance</strong>.\x20In\x20the\x20liver,\x20excess\x20fat\x20(hepatic\x20steatosis)\x20leads\x20to\x20increased\x20glucose\x20production\x20and\x20impaired\x20insulin\x20signaling.\x20Similarly,\x20fat\x20deposition\x20in\x20muscle\x20tissue\x20reduces\x20glucose\x20uptake,\x20leading\x20to\x20insulin\x20resistance.</li>\x0d\x0a<li><strong>Pancreas\x20and\x20spleen\x20(Option\x20C):</strong>\x20While\x20fat\x20deposition\x20in\x20the\x20pancreas\x20(pancreatic\x20steatosis)\x20can\x20impair\x20insulin\x20secretion,\x20it\x20is\x20not\x20a\x20primary\x20contributor\x20to\x20insulin\x20resistance.\x20The\x20spleen\x20is\x20not\x20typically\x20involved\x20in\x20insulin\x20resistance\x20related\x20to\x20ectopic\x20fat\x20accumulation.</li>\x0d\x0a<li><strong>Heart\x20and\x20lungs\x20(Option\x20D):</strong>\x20Ectopic\x20fat\x20in\x20the\x20heart\x20(myocardial\x20fat)\x20can\x20lead\x20to\x20cardiovascular\x20issues,\x20but\x20it\x20is\x20not\x20directly\x20related\x20to\x20insulin\x20resistance.\x20The\x20lungs\x20are\x20not\x20typically\x20affected\x20by\x20ectopic\x20fat\x20in\x20the\x20context\x20of\x20insulin\x20resistance.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Ectopic\x20fat\x20accumulation\x20</strong>in\x20<strong>liver</strong>\x20(hepatic\x20steatosis)\x20and\x20<strong>skeletal\x20muscle</strong>\x20contributes\x20significantly\x20to\x20the\x20development\x20of\x20<strong>insulin\x20resistance,</strong>\x20which\x20is\x20a\x20key\x20factor\x20in\x20metabolic\x20conditions\x20like\x20Type\x202\x20Diabetes.</li>\x0d\x0a<li>These\x20organs\x20play\x20a\x20central\x20role\x20in\x20glucose\x20metabolism,\x20and\x20fat\x20deposition\x20interferes\x20with\x20insulin\x20signaling\x20pathways,\x20leading\x20to\x20decreased\x20glucose\x20uptake\x20and\x20increased\x20glucose\x20production.</li>\x0d\x0a</ul>\x0d\x0a\x20','HGksj','href','return\x20(function()\x20','nav-btn-answered','cVMZq','PGkUk','NNEwH','iONQA','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','BRPEV','yOlwf','LqzkX','ICwXX','PWlTi','choices','MSfFw','<p><span\x20style=\x22font-size:12.0pt;\x22>Estrogen</span></p>','VHLoH','dataset','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','UQVxl','correctCount','KdzBw','AOsAO','DIGOT','<p><span\x20style=\x22font-size:12.0pt;\x22>Defective\x20insulin\x20secretion\x20in\x20response\x20to\x20glucose</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x20&rarr;\x20C\x20&rarr;\x20B\x20&rarr;\x20D\x20&rarr;\x20E</span></p>','WwCcO','Medicine','kLTiA','quizPerformanceData','cHTsC','parse','5|4|1|3|2|0','NZJls','startAt','NXdbs','oaMqn','YSZFY','<p><span\x20style=\x22font-size:12.0pt;\x22>GLUT2\x20and\x20SUR1</span></p>','ExhzG','correct','YQeUF','ivPQL','appendChild','userHistory','<p><span\x20style=\x22font-size:12.0pt;\x22>Rabson-Mendenhall\x20syndrome\x20is\x20associated\x20with\x20which\x20of\x20the\x20following\x20features?</span></p>','attachMedia','pjoxW','<p>The\x20progression\x20of\x20<strong>diabetic\x20nephropathy</strong>\x20in\x20patients\x20with\x20type\x202\x20diabetes\x20typically\x20follows\x20these\x20stages:</p>\x0d\x0a<ol>\x0d\x0a<li><strong><strong>Development\x20of\x20Glomerular\x20Hyperfiltration\x20and\x20Renal\x20Hypertrophy\x20(B)</strong></strong>:\x0d\x0a<ul>\x0d\x0a<li><strong>Initial\x20Phase:\x20</strong>In\x20the\x20early\x20years\x20after\x20the\x20onset\x20of\x20diabetes,\x20patients\x20experience\x20an\x20increase\x20in\x20<strong>glomerular\x20filtration\x20rate\x20(GFR)</strong>\x20and\x20kidney\x20size\x20due\x20to\x20<strong>hyperglycemia-induced\x20hemodynamic\x20changes</strong>.\x20This\x20stage,\x20known\x20as\x20glomerular\x20hyperfiltration,\x20is\x20often\x20asymptomatic\x20but\x20sets\x20the\x20stage\x20for\x20further\x20kidney\x20damage.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Onset\x20of\x20Microalbuminuria\x20(A):</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Microalbuminuria\x20Stage:\x20</strong>Approximately\x20<strong>5-10\x20years</strong>\x20after\x20diabetes\x20onset,\x20small\x20amounts\x20of\x20<strong>albumin</strong>\x20start\x20to\x20appear\x20in\x20the\x20urine,\x20detectable\x20as\x20<strong>microalbuminuria.</strong>\x20This\x20stage\x20is\x20a\x20crucial\x20marker\x20of\x20early\x20nephropathy\x20and\x20represents\x20damage\x20to\x20the\x20glomerular\x20filtration\x20barrier.\x20Microalbuminuria\x20is\x20defined\x20as\x20<strong>30-300\x20mg/day</strong>\x20of\x20albumin\x20in\x20the\x20urine.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Appearance\x20of\x20Overt\x20Proteinuria\x20(Macroalbuminuria)\x20(C):</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Progression\x20to\x20Macroalbuminuria:\x20</strong>Microalbuminuria\x20progresses\x20to\x20<strong>macroalbuminuria</strong>\x20(also\x20known\x20as\x20overt\x20proteinuria)\x20as\x20kidney\x20damage\x20becomes\x20more\x20pronounced.\x20Macroalbuminuria\x20is\x20defined\x20as\x20<strong>&gt;300\x20mg/day</strong>\x20of\x20protein\x20in\x20the\x20urine\x20and\x20indicates\x20significant\x20nephropathy\x20and\x20risk\x20of\x20further\x20kidney\x20function\x20decline.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Decline\x20in\x20GFR\x20Leading\x20to\x20Renal\x20Insufficiency\x20(D):</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Progressive\x20Renal\x20Dysfunction:\x20</strong>Persistent\x20proteinuria\x20eventually\x20leads\x20to\x20a\x20<strong>decline\x20in\x20GFR,</strong>\x20indicating\x20progressive\x20kidney\x20damage\x20and\x20renal\x20insufficiency.\x20This\x20stage\x20is\x20marked\x20by\x20a\x20gradual\x20reduction\x20in\x20the\x20filtering\x20capacity\x20of\x20the\x20kidneys,\x20resulting\x20in\x20an\x20increase\x20in\x20serum\x20creatinine\x20and\x20worsening\x20kidney\x20function.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Progression\x20to\x20End-Stage\x20Renal\x20Disease\x20(ESRD)\x20(E):</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Final\x20Stage:\x20</strong>Ultimately,\x20continued\x20decline\x20in\x20kidney\x20function\x20progresses\x20to\x20<strong>end-stage\x20renal\x20disease\x20(ESRD),</strong>\x20where\x20the\x20kidneys\x20fail\x20to\x20maintain\x20fluid\x20and\x20electrolyte\x20balance.\x20At\x20this\x20stage,\x20<strong>renal\x20replacement\x20therapy</strong>\x20(dialysis\x20or\x20transplantation)\x20is\x20required\x20to\x20sustain\x20life.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Points:</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>Glomerular\x20Hyperfiltration\x20(B):\x20</strong>The\x20earliest\x20stage\x20with\x20increased\x20GFR\x20and\x20kidney\x20hypertrophy\x20due\x20to\x20hyperglycemia-induced\x20hemodynamic\x20changes.</li>\x0d\x0a<li><strong>Microalbuminuria\x20(A):\x20</strong>The\x20initial\x20sign\x20of\x20diabetic\x20nephropathy\x20with\x20<strong>30-300\x20mg/day</strong>\x20albumin\x20in\x20urine,\x20marking\x20early\x20glomerular\x20damage.</li>\x0d\x0a<li><strong>Macroalbuminuria\x20(C):\x20</strong>Higher\x20levels\x20of\x20protein\x20in\x20urine\x20<strong>(&gt;300\x20mg/day),</strong>\x20indicating\x20significant\x20progression\x20of\x20nephropathy.</li>\x0d\x0a<li><strong>Decline\x20in\x20GFR\x20(D):\x20</strong>The\x20gradual\x20reduction\x20in\x20kidney\x20filtering\x20capacity\x20leading\x20to\x20renal\x20insufficiency\x20and\x20increased\x20serum\x20creatinine.</li>\x0d\x0a<li><strong>End-Stage\x20Renal\x20Disease\x20(E):\x20</strong>Final\x20stage\x20where\x20renal\x20replacement\x20therapy\x20(dialysis\x20or\x20transplant)\x20is\x20necessary\x20due\x20to\x20kidney\x20failure.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Additional\x20Notes:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Early\x20Detection:\x20</strong>Regular\x20screening\x20for\x20<strong>microalbuminuria</strong>\x20in\x20diabetic\x20patients\x20is\x20critical\x20for\x20early\x20intervention.</li>\x0d\x0a<li><strong>Management\x20Strategies:\x20</strong>Tight\x20<strong>glycemic\x20control,\x20blood\x20pressure\x20management</strong>\x20(preferably\x20with\x20ACE\x20inhibitors\x20or\x20ARBs),\x20and\x20<strong>lifestyle\x20modifications</strong>\x20can\x20slow\x20the\x20progression\x20of\x20diabetic\x20nephropathy.</li>\x0d\x0a<li><strong>Patient\x20Education:\x20</strong>Understanding\x20the\x20stages\x20of\x20diabetic\x20nephropathy\x20enables\x20patients\x20to\x20adhere\x20to\x20preventive\x20strategies\x20to\x20delay\x20or\x20avoid\x20progression\x20to\x20ESRD.</li>\x0d\x0a</ul>\x0d\x0a\x20','log','YGtbT','console','DT1295412','Mark\x20for\x20Review','IDVSE','dBOgd','remove','iWLre','eVdHR','questionReviewSection','</span></div>','VOGQA','studyModeLegend','<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperandrogenism</span></p>','mhmRW','CXWZS','gIMjf','Correct','text','currentQuestion','{}.constructor(\x22return\x20this\x22)(\x20)','aumjr','utCIo','sKXft','MgEya','<p><span\x20style=\x22font-size:12.0pt;\x22>Severe\x20insulin\x20resistance</span></p>','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','rqjrY','qJuVQ','<p><span\x20style=\x22font-size:12.0pt;\x22>Monogenic\x20forms\x20of\x20diabetes\x20are\x20usually\x20diagnosed\x20in:</span></p>','MAiph','JwHJO','toISOString','WRNXJ','forEach','join','YVbdq','<p><span\x20style=\x22font-size:12.0pt;\x22>Presence\x20of\x20pancreatic\x20autoantibodies</span></p>','6236995LhmzBi','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','KQXCV','QXuhv','push','KQPjA','GUnbr','doSkG','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20four\x20cardinal\x20abnormalities\x20consistently\x20demonstrated\x20in\x20persons\x20with\x20Type\x202\x20Diabetes\x20(T2D)\x20include\x20all\x20EXCEPT:</span></p>','JjTNA','DgWZb','<p><span\x20style=\x22font-size:12.0pt;\x22>Decreased\x20glucagon\x20levels</span></p>','markReviewBtn','USBCO','ArrowLeft','1650095QXEfFT','dQZFQ','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','iobqL','thLvc','target','GuWWp','RqAPI','xhbNR','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><strong>Comparison\x20Table</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501099da9596b-b9a7-4ce4-a4af-7a6a6764f5e8.jpg\x22>\x0d\x0a<p><strong>Key\x20Takeaways</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Metformin\x20</strong>is\x20a\x20first-line\x20agent\x20that\x20reduces\x20hepatic\x20glucose\x20production\x20and\x20increases\x20insulin\x20sensitivity,\x20with\x20a\x20favorable\x20effect\x20on\x20weight.</li>\x0d\x0a<li><strong>Sulfonylureas\x20(e.g.,\x20Glipizide)\x20</strong>promote\x20insulin\x20secretion\x20but\x20come\x20with\x20risks\x20of\x20hypoglycemia\x20and\x20weight\x20gain.</li>\x0d\x0a<li><strong>Thiazolidinediones\x20(e.g.,\x20Pioglitazone)\x20</strong>increase\x20insulin\x20sensitivity,\x20but\x20side\x20effects\x20include\x20weight\x20gain,\x20edema,\x20and\x20heart\x20failure\x20risk.</li>\x0d\x0a<li><strong>DPP-4\x20Inhibitors\x20(e.g.,\x20Sitagliptin)\x20</strong>are\x20often\x20add-ons\x20with\x20a\x20glucose-dependent\x20mechanism,\x20lowering\x20risk\x20of\x20hypoglycemia.</li>\x0d\x0a<li><strong>Alpha-Glucosidase\x20Inhibitors\x20(e.g.,\x20Acarbose)\x20</strong>are\x20beneficial\x20for\x20controlling\x20post-meal\x20glucose\x20but\x20cause\x20gastrointestinal\x20side\x20effects.</li>\x0d\x0a<li><strong>SGLT2\x20Inhibitors\x20(e.g.,\x20Canagliflozin)\x20</strong>enhance\x20glucose\x20excretion\x20through\x20the\x20kidneys,\x20with\x20added\x20benefits\x20for\x20cardiovascular\x20and\x20renal\x20health\x20but\x20have\x20risks\x20like\x20genitourinary\x20infections.</li>\x0d\x0a</ul>\x0d\x0a\x20','JTTDX','AolNf','yTMOH','WpjqV','njDzd','sRFlw','reduce','YfmVH','DT1295416','<p><span\x20style=\x22font-size:12.0pt;\x22>Improve\x20glycemic\x20control</span></p>','yotbE','uolHD','EKftl','yHYzI','incorrectCount','QKBum','StnTV','get','UorWD','exception','SfkpQ','Factual','qJRmG','kptDX','DgvbP','XFYjL','<p><span\x20style=\x22font-size:12.0pt;\x22>54\x20mg/dL\x20(3.0\x20mmol/L)</span></p>','testModeLegend','BaXMX','.m3u8','<p><span\x20style=\x22font-size:12.0pt;\x22>Protuberant\x20abdomen</span></p>','DDKco','question_video','QLSce','study','EbDaQ','LDrVx','<p><span\x20style=\x22font-size:12.0pt;\x22>Insulin\x20resistance\x20in\x20peripheral\x20tissues</span></p>','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','LGwit','EHaLC','imxya','WAQbU','Hyrwj','IwWrZ','<p><span\x20style=\x22font-size:12.0pt;\x22>Level\x202\x20hypoglycemia,\x20considered\x20clinically\x20significant,\x20is\x20defined\x20by\x20the\x20ADA\x20as\x20glucose\x20levels\x20at\x20or\x20below:</span></p>','COYdt','nav-btn-incorrect','bind','quizSidebar','xOOKs','incorrect','DT1295413','stats','mXHva','THnKj','loggo','textContent','hmhqG','Bzzmo','ElGDJ','<p><span\x20style=\x22font-size:12.0pt;\x22>Decreased\x20glucose\x20production\x20by\x20the\x20liver</span></p>','kztiR','ngdPK','optionsContainer','LTETe','DT1295463','GPTSM','APlip','niDZV','FNrwS','WqPJK','ePzTJ','wsVgr','LGHff','HOROu','open','questionText','padStart','currentQuestionIndex','WNFnm','DT1295440','scoreCircle','<p><span\x20style=\x22font-size:12.0pt;\x22>Loss\x20of\x20subcutaneous\x20fat</span></p>','replace','TEYVJ','qoWMz','QRTln','FCGsQ','split','abxBb','<p><span\x20style=\x22font-size:12.0pt;\x22>Early\x20onset\x20of\x20puberty</span></p>','QfRbG','selectedAnswer','<p><span\x20style=\x22font-size:12.0pt;\x22>Post-exercise</span></p>','HPYyg','CDspZ','YccSG','hBtNo','explanation_audio_eng','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','border-gray-600','skqhX','fLVQl','asEiz','nihuf','nknsA','pathname','vFRsf','totalTime','solutionText','faVJV','LvybJ','ZYQMK','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','ltzBu','NmePS','QtftN','igGHK','xXCNX','OrrZK','WPfAc','cbavO','PhfAD','solutionVideo','map','erWUk','hidden','dwTjb','<p><span\x20style=\x22font-size:12.0pt;\x22>Thyroid\x20hormone</span></p>','aXAyl','disabled','buHgY','<p><span\x20style=\x22font-size:12.0pt;\x22>Lipodystrophic\x20diabetes\x20is\x20characterized\x20by\x20all\x20of\x20the\x20following\x20EXCEPT:</span></p>','\x20>\x20','Progress\x20loaded.','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20passage\x20of\x20obesity\x20risk\x20from\x20father\x20to\x20offspring\x20due\x20to\x20environmental\x20exposures\x20is\x20mediated\x20by:</span></p>','koFzl','eZeOH','ulIab','questionIndex','qEsYJ','<p><span\x20style=\x22font-size:12.0pt;\x22>GLP-1\x20receptor\x20agonists\x20or\x20insulin</span></p>','aZvOa','ESJZP','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','YRUnf','true','BPDuQ','IeHxK','ygVYJ','tFRTP','currentMode','DT1295452','DT1295405','HaFza','cQpee','resume','markReviewText','<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20adiponectin\x20levels</span></p>','2131398zbEBjo','correctAnswers','ktDYC','UbJhj','<p><strong>Type\x20A\x20Insulin\x20Resistance</strong>:</p>\x0d\x0a<p>Type\x20A\x20insulin\x20resistance\x20is\x20a\x20rare\x20disorder,\x20predominantly\x20seen\x20in\x20<strong>young\x20women,</strong>\x20characterized\x20by\x20significant\x20<strong>insulin\x20resistance,\x20hyperinsulinemia,</strong>\x20and\x20<strong>hyperandrogenism.</strong>\x20It\x20is\x20caused\x20by\x20mutations\x20in\x20the\x20<strong>insulin\x20receptor\x20gene,</strong>\x20leading\x20to\x20impaired\x20insulin\x20signaling.</p>\x0d\x0a<p><strong>Key\x20Features:</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>Insulin\x20Resistance:</strong>\x0d\x0a<ul>\x0d\x0a<li>This\x20is\x20the\x20hallmark\x20of\x20the\x20condition.\x20Despite\x20high\x20circulating\x20levels\x20of\x20insulin,\x20target\x20tissues\x20(such\x20as\x20liver,\x20muscle,\x20and\x20fat)\x20are\x20unresponsive\x20to\x20insulin\x27s\x20action.</li>\x0d\x0a<li>This\x20results\x20in\x20hyperglycemia,\x20though\x20not\x20all\x20patients\x20develop\x20frank\x20diabetes\x20immediately.\x20The\x20body\x20compensates\x20for\x20this\x20insulin\x20resistance\x20by\x20secreting\x20more\x20insulin\x20(hyperinsulinemia).</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Acanthosis\x20Nigricans:</strong>\x0d\x0a<ul>\x0d\x0a<li>This\x20skin\x20condition\x20is\x20characterized\x20by\x20dark,\x20thick,\x20velvety\x20patches\x20of\x20skin\x20typically\x20found\x20in\x20body\x20folds\x20(e.g.,\x20neck,\x20armpits).\x20It\x20is\x20a\x20common\x20cutaneous\x20marker\x20of\x20<strong>hyperinsulinemia\x20</strong>seen\x20in\x20Type\x20A\x20insulin\x20resistance\x20and\x20other\x20insulin\x20resistance\x20syndromes.</li>\x0d\x0a<li>The\x20excess\x20insulin\x20stimulates\x20keratinocytes\x20and\x20dermal\x20fibroblasts,\x20leading\x20to\x20this\x20skin\x20change.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Hyperandrogenism:</strong>\x0d\x0a<ul>\x0d\x0a<li>Due\x20to\x20the\x20insulin\x20resistance\x20and\x20hyperinsulinemia,\x20there\x20is\x20an\x20overproduction\x20of\x20androgens\x20(male\x20hormones)\x20by\x20the\x20ovaries.\x20This\x20leads\x20to\x20<strong>hyperandrogenism,</strong>\x20resulting\x20in\x20signs\x20such\x20as:\x0d\x0a<ul>\x0d\x0a<li><strong>Hirsutism</strong>(excessive\x20hair\x20growth\x20in\x20a\x20male\x20pattern)</li>\x0d\x0a<li><strong>Acne</strong></li>\x0d\x0a<li><strong>Menstrual\x20irregularities</strong>(oligomenorrhea\x20or\x20amenorrhea)</li>\x0d\x0a<li>In\x20some\x20cases,\x20it\x20may\x20present\x20with\x20features\x20resembling\x20<strong>polycystic\x20ovary\x20syndrome\x20(PCOS).</strong></li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<ol\x20start=\x224\x22>\x0d\x0a<li><strong>Absence\x20of\x20Severe\x20Intrauterine\x20Growth\x20Retardation:</strong>\x0d\x0a<ul>\x0d\x0a<li>Unlike\x20more\x20severe\x20forms\x20of\x20insulin\x20receptor\x20defects,\x20such\x20as\x20<strong>Donohue\x20syndrome</strong>(leprechaunism)\x20and\x20<strong>Rabson-Mendenhall\x20syndrome,</strong>\x20Type\x20A\x20insulin\x20resistance\x20does\x20not\x20involve\x20<strong>severe\x20intrauterine\x20growth\x20retardation.</strong></li>\x0d\x0a<li><strong>Donohue\x20syndrome\x20</strong>is\x20much\x20more\x20severe,\x20often\x20resulting\x20in\x20death\x20in\x20early\x20infancy\x20due\x20to\x20extreme\x20insulin\x20resistance\x20and\x20associated\x20complications,\x20including\x20growth\x20retardation.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<ol>\x0d\x0a<li><strong>Insulin\x20resistance\x20(Option\x20A)-\x20Correct\x20characteristic.</strong>\x20Type\x20A\x20insulin\x20resistance\x20is\x20primarily\x20characterized\x20by\x20severe\x20insulin\x20resistance,\x20particularly\x20in\x20young\x20women.</li>\x0d\x0a<li><strong>Acanthosis\x20nigricans\x20(Option\x20B)-\x20Correct\x20characteristic.</strong>\x20Acanthosis\x20nigricans,\x20a\x20skin\x20condition\x20characterized\x20by\x20dark,\x20velvety\x20patches,\x20is\x20commonly\x20seen\x20in\x20patients\x20with\x20Type\x20A\x20insulin\x20resistance\x20due\x20to\x20chronic\x20hyperinsulinemia.</li>\x0d\x0a<li><strong>Hyperandrogenism\x20(Option\x20C)-\x20Correct\x20characteristic.</strong>\x20Women\x20with\x20Type\x20A\x20insulin\x20resistance\x20often\x20exhibit\x20hyperandrogenism,\x20leading\x20to\x20clinical\x20signs\x20such\x20as\x20hirsutism\x20and\x20menstrual\x20irregularities.</li>\x0d\x0a<li><strong>Severe\x20intrauterine\x20growth\x20retardation\x20(Option\x20D)-\x20Incorrect\x20characteristic.</strong>\x20Severe\x20intrauterine\x20growth\x20retardation\x20is\x20<strong>not</strong>\x20a\x20feature\x20of\x20Type\x20A\x20insulin\x20resistance.\x20It\x20is\x20characteristic\x20of\x20<strong>Donohue\x20syndrome,</strong>\x20a\x20rare\x20and\x20more\x20severe\x20insulin\x20resistance\x20disorder\x20caused\x20by\x20insulin\x20receptor\x20mutations,\x20also\x20known\x20as\x20<strong>leprechaunism.</strong></li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Type\x20A\x20insulin\x20resistance\x20</strong>is\x20characterized\x20by\x20severe\x20insulin\x20resistance,\x20acanthosis\x20nigricans,\x20and\x20hyperandrogenism,\x20predominantly\x20affecting\x20young\x20women.</li>\x0d\x0a<li><strong>Donohue\x20syndrome</strong>(leprechaunism),\x20on\x20the\x20other\x20hand,\x20presents\x20with\x20severe\x20intrauterine\x20growth\x20retardation\x20and\x20other\x20severe\x20insulin\x20resistance\x20features\x20from\x20infancy.</li>\x0d\x0a</ul>\x0d\x0a\x20','QRP','OYQWy','Swfjo','performanceModal','incomplete','FAXkc','reviewQuestionsContainer','iDSxT','<p><span\x20style=\x22font-size:12.0pt;\x22>Bedtime</span></p>','tXmjw','answered','removeItem','<p><span\x20style=\x22font-size:12.0pt;\x22>Positive\x20family\x20history\x20with\x20an\x20autosomal\x20dominant\x20pattern\x20of\x20diabetes\x20inheritance</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Middle\x20of\x20the\x20night</span></p>','SnErk','.option-button','PozCs','explanation_audio_hin','wWyKz','Ceday','Mbcez','accuracy','ssLHC','border-red-500','qnFci','question_images','3138908qZJlqm','ixdzL','<p><span\x20style=\x22font-size:12.0pt;\x22>1-F,\x202-D,\x203-A,\x204-B,\x205-E,\x206-J</span></p>','miWmM','CTHys','<p><span\x20style=\x22font-size:12.0pt;\x22>Y-chromosome\x20deletions</span></p>','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','setItem','<p><span\x20style=\x22font-size:12.0pt;\x22>Alpha-glucosidase\x20inhibitors</span></p>','style','ZXFiz','3884993WPAvzN','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?'];_0x1b4a=function(){return _0x727a20;};return _0x1b4a();}const _0xdb6be6=(function(){let _0x5f4a57=!![];return function(_0x1b021d,_0x26199a){const _0x1e7edc=_0x5f4a57?function(){const _0x506fe2=_0x184b;if(_0x26199a){const _0x44db5a=_0x26199a[_0x506fe2(0x2ed)](_0x1b021d,arguments);return _0x26199a=null,_0x44db5a;}}:function(){};return _0x5f4a57=![],_0x1e7edc;};}()),_0x1648b1=_0xdb6be6(this,function(){const _0x50e0eb=_0x184b,_0x4f5ead={'mXHva':_0x50e0eb(0x2e5),'FfDeJ':'none','kZXua':function(_0x482917){return _0x482917();},'Swfjo':_0x50e0eb(0x182),'APlip':function(_0x12cf97,_0x37dd01){return _0x12cf97===_0x37dd01;},'DYAsc':_0x50e0eb(0xe8),'zCvPw':function(_0x4eed2c,_0x48aae1){return _0x4eed2c(_0x48aae1);},'AtYhZ':function(_0x579d0e,_0x400c58){return _0x579d0e+_0x400c58;},'cQpee':_0x50e0eb(0x138),'xeBbT':_0x50e0eb(0x169),'lVUVD':_0x50e0eb(0x123),'oaMqn':'info','lFSxD':_0x50e0eb(0x2df),'olGpl':_0x50e0eb(0x333),'BYcHn':'trace','fiWmP':function(_0x3648a0,_0x52c7ec){return _0x3648a0<_0x52c7ec;}},_0x3aa2dd=function(){const _0x1808ec=_0x50e0eb,_0x1fa68c={'WNFnm':_0x4f5ead[_0x1808ec(0x20c)]};if(_0x4f5ead[_0x1808ec(0x1a9)](_0x4f5ead['DYAsc'],_0x4f5ead[_0x1808ec(0x311)])){let _0x4aceb2;try{_0x4aceb2=_0x4f5ead['zCvPw'](Function,_0x4f5ead[_0x1808ec(0x2cf)](_0x1808ec(0xf3)+_0x4f5ead[_0x1808ec(0x201)],');'))();}catch(_0x27af7d){_0x4f5ead['xeBbT']===_0x4f5ead['xeBbT']?_0x4aceb2=window:(_0x101579[_0x1808ec(0xe3)](_0x4f5ead[_0x1808ec(0x19b)])['style']['display']=_0x4f5ead[_0x1808ec(0x321)],_0x4f5ead['kZXua'](_0x56319d));}return _0x4aceb2;}else _0x48eaa1[_0x1808ec(0x287)](_0x1808ec(0x261))[_0x1808ec(0x146)](_0x5558f7=>{const _0x1ecc1b=_0x1808ec,_0x5df105=_0x5558f7[_0x1ecc1b(0x103)][_0x1ecc1b(0x349)];if(_0x5df105&&_0x5df105['includes'](_0x1fa68c[_0x1ecc1b(0x1b5)]))_0x51fa3d(_0x5558f7,_0x5df105);else _0x5df105&&(_0x5558f7[_0x1ecc1b(0x349)]=_0x5df105);});},_0x3bfe5c=_0x4f5ead[_0x50e0eb(0xea)](_0x3aa2dd),_0x24f846=_0x3bfe5c['console']=_0x3bfe5c[_0x50e0eb(0x125)]||{},_0x519f31=[_0x4f5ead['lVUVD'],_0x50e0eb(0x27b),_0x4f5ead[_0x50e0eb(0x116)],_0x4f5ead['lFSxD'],_0x50e0eb(0x178),_0x4f5ead[_0x50e0eb(0x387)],_0x4f5ead['BYcHn']];for(let _0x715151=0x0;_0x4f5ead['fiWmP'](_0x715151,_0x519f31[_0x50e0eb(0x371)]);_0x715151++){const _0xc61475=_0xdb6be6[_0x50e0eb(0x272)][_0x50e0eb(0x2f6)][_0x50e0eb(0x195)](_0xdb6be6),_0x56d61e=_0x519f31[_0x715151],_0x22dda2=_0x24f846[_0x56d61e]||_0xc61475;_0xc61475[_0x50e0eb(0x2a9)]=_0xdb6be6[_0x50e0eb(0x195)](_0xdb6be6),_0xc61475['toString']=_0x22dda2['toString'][_0x50e0eb(0x195)](_0x22dda2),_0x24f846[_0x56d61e]=_0xc61475;}});function _0x184b(_0x262a63,_0xb883ed){const _0xd4639e=_0x1b4a();return _0x184b=function(_0x1648b1,_0xdb6be6){_0x1648b1=_0x1648b1-0xe3;let _0x58a2b9=_0xd4639e[_0x1648b1];return _0x58a2b9;},_0x184b(_0x262a63,_0xb883ed);}_0x1648b1();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x357c09(0x16e)},{'id':0x2,'text':_0x357c09(0x248)},{'id':0x3,'text':_0x357c09(0x2a7)},{'id':0x4,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Decrease\x20insulin\x20resistance</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2048-year-old\x20female\x20presents\x20to\x20the\x20clinic\x20with\x20a\x20history\x20of\x20severe\x20insulin\x20resistance,\x20hyperglycemia,\x20and\x20hypertriglyceridemia.\x20Her\x20physical\x20examination\x20reveals\x20significant\x20loss\x20of\x20subcutaneous\x20fat\x20with\x20hepatomegaly.\x20She\x20has\x20been\x20started\x20on\x20leptin-replacement\x20therapy.<br>Which\x20of\x20the\x20following\x20is\x20NOT\x20a\x20benefit\x20of\x20leptin-replacement\x20therapy\x20in\x20patients\x20with\x20generalized\x20lipodystrophy?<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501096a8990fe-8110-4fb5-9cc8-df30824fa38d.jpg\x22></span></p>','unique_key':'DT1295394','question_audio':null,'question_video':null,'map_id':0x13c422,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol>\x0d\x0a<li><strong>Improve\x20glycemic\x20control\x20(Option\x20A)-\x20Correct\x20benefit.</strong>\x20Leptin-replacement\x20therapy\x20improves\x20<strong>glycemic\x20control</strong>\x20in\x20patients\x20with\x20generalized\x20lipodystrophy\x20by\x20reducing\x20insulin\x20resistance\x20and\x20enhancing\x20glucose\x20uptake\x20by\x20peripheral\x20tissues.</li>\x0d\x0a<li><strong>Decrease\x20fatty\x20liver\x20disease\x20(Option\x20B)-\x20Correct\x20benefit.</strong>\x20Leptin\x20therapy\x20has\x20been\x20shown\x20to\x20<strong>reduce\x20hepatic\x20steatosis</strong>\x20(fatty\x20liver\x20disease)\x20in\x20these\x20patients\x20by\x20normalizing\x20lipid\x20metabolism\x20and\x20reducing\x20fat\x20accumulation\x20in\x20the\x20liver.</li>\x0d\x0a<li><strong>Increase\x20circulating\x20triglyceride\x20levels\x20(Option\x20C)-\x20Incorrect\x20statement.</strong>\x20Leptin\x20therapy\x20<strong>decreases\x20circulating\x20triglyceride\x20levels,</strong>\x20improving\x20the\x20lipid\x20profile\x20in\x20patients\x20with\x20lipodystrophy.\x20The\x20loss\x20of\x20adipose\x20tissue\x20in\x20lipodystrophy\x20disrupts\x20normal\x20fat\x20metabolism,\x20but\x20leptin\x20therapy\x20helps\x20regulate\x20lipid\x20levels.</li>\x0d\x0a<li><strong>Decrease\x20insulin\x20resistance\x20(Option\x20D)-\x20Correct\x20benefit.</strong>\x20Leptin-replacement\x20therapy\x20helps\x20<strong>reduce\x20insulin\x20resistance,</strong>\x20which\x20is\x20a\x20major\x20contributor\x20to\x20the\x20metabolic\x20abnormalities\x20seen\x20in\x20generalized\x20lipodystrophy.\x20This\x20results\x20in\x20improved\x20glucose\x20metabolism\x20and\x20reduced\x20hyperglycemia.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Leptin-replacement\x20therapy\x20</strong>in\x20patients\x20with\x20generalized\x20lipodystrophy\x20helps\x20improve\x20metabolic\x20parameters\x20by\x20enhancing\x20<strong>glycemic\x20control,\x20reducing\x20fatty\x20liver\x20disease,\x20lowering\x20triglyceride\x20levels,</strong>\x20and\x20<strong>decreasing\x20insulin\x20resistance.</strong></li>\x0d\x0a<li>This\x20therapy\x20addresses\x20the\x20deficiency\x20of\x20leptin,\x20a\x20hormone\x20essential\x20for\x20regulating\x20energy\x20balance,\x20lipid\x20metabolism,\x20and\x20insulin\x20sensitivity.</li>\x0d\x0a</ul>\x0d\x0a\x20','correct_choice_id':0x3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20insulin\x20sensitivity</span></p>'},{'id':0xc,'text':_0x357c09(0x34e)},{'id':0xd,'text':_0x357c09(0x243)},{'id':0xe,'text':_0x357c09(0x337)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Individuals\x20with\x20high\x20levels\x20of\x20visceral\x20fat\x20are\x20generally\x20at\x20higher\x20risk\x20for\x20Type\x202\x20Diabetes\x20(T2D)\x20due\x20to:</span></p>','unique_key':_0x357c09(0x32f),'question_audio':null,'question_video':null,'map_id':0x13c424,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol>\x0d\x0a<li><strong>Increased\x20insulin\x20sensitivity\x20(Option\x20A):\x20</strong>\x20Insulin\x20sensitivity\x20refers\x20to\x20how\x20effectively\x20cells\x20respond\x20to\x20insulin.\x20In\x20people\x20with\x20high\x20visceral\x20fat,\x20insulin\x20sensitivity\x20is\x20generally\x20reduced,\x20not\x20increased.</li>\x0d\x0a<li><strong>Decreased\x20insulin\x20resistance\x20(Option\x20B):\x20</strong>\x20Insulin\x20resistance\x20refers\x20to\x20the\x20reduced\x20ability\x20of\x20cells\x20to\x20respond\x20to\x20insulin.\x20High\x20visceral\x20fat\x20is\x20associated\x20with\x20<strong>increased\x20</strong>insulin\x20resistance,\x20not\x20decreased.</li>\x0d\x0a<li><strong>Increased\x20insulin\x20resistance\x20(Option\x20C):\x20Visceral\x20fat</strong>\x20produces\x20various\x20adipokines\x20and\x20inflammatory\x20cytokines\x20that\x20contribute\x20to\x20<strong>increased\x20insulin\x20resistance,\x20</strong>a\x20key\x20factor\x20in\x20the\x20pathogenesis\x20of\x20Type\x202\x20Diabetes.\x20Increased\x20visceral\x20fat\x20leads\x20to\x20impaired\x20glucose\x20metabolism\x20and\x20higher\x20fasting\x20glucose\x20levels,\x20making\x20individuals\x20more\x20prone\x20to\x20T2D.</li>\x0d\x0a<li><strong>Lower\x20ectopic\x20fat\x20accumulation\x20(Option\x20D):</strong>\x20Ectopic\x20fat\x20accumulation\x20(fat\x20deposition\x20in\x20non-adipose\x20tissues\x20like\x20liver\x20and\x20muscle)\x20tends\x20to\x20increase\x20with\x20high\x20levels\x20of\x20visceral\x20fat,\x20further\x20promoting\x20insulin\x20resistance\x20and\x20metabolic\x20dysfunction.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Visceral\x20fat\x20</strong>is\x20metabolically\x20active\x20and\x20contributes\x20to\x20<strong>increased\x20insulin\x20resistance,</strong>\x20a\x20key\x20determinant\x20in\x20the\x20development\x20of\x20Type\x202\x20Diabetes.</li>\x0d\x0a<li><strong>Adipokines\x20</strong>and\x20<strong>pro-inflammatory\x20cytokines</strong>\x20secreted\x20by\x20visceral\x20fat\x20play\x20a\x20crucial\x20role\x20in\x20worsening\x20insulin\x20resistance\x20and\x20metabolic\x20syndrome.</li>\x0d\x0a</ul>\x0d\x0a\x20','correct_choice_id':0xd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x357c09(0x18a)},{'id':0x16,'text':_0x357c09(0x10a)},{'id':0x17,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Decreased\x20glucose\x20uptake\x20in\x20muscle</span></p>'},{'id':0x18,'text':_0x357c09(0x1a2)}],'text':_0x357c09(0x153),'unique_key':_0x357c09(0x376),'question_audio':null,'question_video':null,'map_id':0x13c429,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol>\x0d\x0a<li><strong>Insulin\x20resistance\x20in\x20peripheral\x20tissues\x20(Option\x20A):\x20Correct\x20abnormality.</strong>\x20Insulin\x20resistance,\x20particularly\x20in\x20muscle,\x20liver,\x20and\x20fat\x20cells,\x20is\x20a\x20hallmark\x20of\x20T2D,\x20contributing\x20to\x20impaired\x20glucose\x20uptake\x20and\x20metabolism.</li>\x0d\x0a<li><strong>Defective\x20insulin\x20secretion\x20in\x20response\x20to\x20glucose\x20(Option\x20B):\x20Correct\x20abnormality.</strong>\x20In\x20T2D,\x20pancreatic\x20beta\x20cells\x20show\x20impaired\x20insulin\x20secretion\x20in\x20response\x20to\x20glucose,\x20leading\x20to\x20inadequate\x20control\x20of\x20blood\x20sugar\x20levels.</li>\x0d\x0a<li><strong>Decreased\x20glucose\x20uptake\x20in\x20muscle\x20(Option\x20C):\x20Correct\x20abnormality.</strong>\x20In\x20T2D,\x20insulin\x20resistance\x20leads\x20to\x20reduced\x20glucose\x20uptake\x20by\x20muscles,\x20further\x20worsening\x20hyperglycemia.</li>\x0d\x0a<li><strong>Decreased\x20glucose\x20production\x20by\x20the\x20liver\x20(Option\x20D):</strong>\x20In\x20T2D,\x20the\x20liver\x20<strong>increases</strong>\x20glucose\x20production\x20due\x20to\x20insulin\x20resistance,\x20contributing\x20to\x20fasting\x20hyperglycemia\x20and\x20exacerbating\x20the\x20condition.\x20The\x20correct\x20abnormality\x20is\x20<strong>increased</strong>\x20glucose\x20production\x20by\x20the\x20liver.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li>The\x20<strong>four\x20cardinal\x20abnormalities\x20</strong>in\x20T2D\x20are\x20<strong>insulin\x20resistance,\x20defective\x20insulin\x20secretion,\x20decreased\x20glucose\x20uptake\x20in\x20muscle,</strong>\x20and\x20<strong>increased\x20hepatic\x20glucose\x20production.</strong></li>\x0d\x0a<li><strong>Increased\x20glucose\x20production\x20by\x20the\x20liver\x20</strong>is\x20a\x20major\x20contributor\x20to\x20the\x20fasting\x20hyperglycemia\x20observed\x20in\x20T2D.</li>\x0d\x0a</ul>\x0d\x0a\x20','correct_choice_id':0x18,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Elderly\x20patients\x20over\x2065\x20years</span></p>'},{'id':0x20,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Middle-aged\x20adults</span></p>'},{'id':0x21,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Younger\x20patients\x20in\x20the\x20first\x202\x20to\x203\x20decades\x20of\x20life</span></p>'},{'id':0x22,'text':_0x357c09(0x331)}],'text':_0x357c09(0x141),'unique_key':_0x357c09(0x1ff),'question_audio':null,'question_video':null,'map_id':0x13c42d,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x2d5),'correct_choice_id':0x21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Insulin\x20resistance</span></p>'},{'id':0x2a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Acanthosis\x20nigricans</span></p>'},{'id':0x2b,'text':_0x357c09(0x131)},{'id':0x2c,'text':_0x357c09(0x25d)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Type\x20A\x20insulin\x20resistance\x20is\x20characterized\x20by\x20all\x20of\x20the\x20following\x20EXCEPT:</span></p>','unique_key':_0x357c09(0x2bf),'question_audio':null,'question_video':null,'map_id':0x13c431,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x209),'correct_choice_id':0x2c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Tall\x20stature</span></p>'},{'id':0x34,'text':_0x357c09(0x183)},{'id':0x35,'text':_0x357c09(0x2d7)},{'id':0x36,'text':_0x357c09(0x1c0)}],'text':_0x357c09(0x11f),'unique_key':_0x357c09(0x126),'question_audio':null,'question_video':null,'map_id':0x13c434,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x357c09(0x363),'correct_choice_id':0x34,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x357c09(0x13d)},{'id':0x3e,'text':_0x357c09(0x1b8)},{'id':0x3f,'text':_0x357c09(0x24f)},{'id':0x40,'text':_0x357c09(0x204)}],'text':_0x357c09(0x1ea),'unique_key':_0x357c09(0x199),'question_audio':null,'question_video':null,'map_id':0x13c435,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol>\x0d\x0a<li><strong>Severe\x20insulin\x20resistance\x20(Option\x20A):\x20Correct\x20characteristic.</strong>\x20Lipodystrophic\x20diabetes\x20is\x20associated\x20with\x20<strong>severe\x20insulin\x20resistance</strong>\x20due\x20to\x20the\x20loss\x20of\x20adipose\x20tissue,\x20which\x20plays\x20a\x20key\x20role\x20in\x20storing\x20lipids\x20and\x20regulating\x20insulin\x20sensitivity.</li>\x0d\x0a<li><strong>Loss\x20of\x20subcutaneous\x20fat\x20(Option\x20B):\x20Correct\x20characteristic.</strong>\x20One\x20of\x20the\x20hallmark\x20features\x20of\x20lipodystrophy\x20is\x20the\x20<strong>loss\x20of\x20subcutaneous\x20fat</strong>.\x20This\x20leads\x20to\x20ectopic\x20fat\x20deposition\x20in\x20non-adipose\x20tissues\x20like\x20the\x20liver\x20and\x20muscles,\x20contributing\x20to\x20metabolic\x20dysfunction.</li>\x0d\x0a<li><strong>Hypertriglyceridemia\x20(Option\x20C):\x20Correct\x20characteristic.</strong>\x20Patients\x20with\x20lipodystrophy\x20frequently\x20exhibit\x20<strong>hypertriglyceridemia</strong>\x20because\x20of\x20defective\x20lipid\x20storage\x20and\x20metabolism,\x20leading\x20to\x20high\x20levels\x20of\x20circulating\x20triglycerides.</li>\x0d\x0a<li><strong>Increased\x20adiponectin\x20levels\x20(Option\x20D):\x20Incorrect\x20characteristic.</strong>\x20In\x20lipodystrophy,\x20<strong>adiponectin\x20levels\x20are\x20typically\x20low</strong>.\x20Adiponectin\x20is\x20a\x20hormone\x20produced\x20by\x20adipocytes\x20that\x20helps\x20improve\x20insulin\x20sensitivity.\x20The\x20loss\x20of\x20fat\x20tissue\x20in\x20lipodystrophic\x20patients\x20leads\x20to\x20reduced\x20adiponectin\x20production,\x20worsening\x20insulin\x20resistance\x20and\x20metabolic\x20syndrome.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Lipodystrophic\x20diabetes\x20</strong>is\x20characterized\x20by\x20<strong>severe\x20insulin\x20resistance,\x20loss\x20of\x20subcutaneous\x20fat,\x20hypertriglyceridemia,</strong>\x20and\x20<strong>low\x20adiponectin\x20levels.</strong></li>\x0d\x0a<li>The\x20lack\x20of\x20adipose\x20tissue\x20leads\x20to\x20<strong>ectopic\x20fat\x20deposition\x20</strong>and\x20metabolic\x20complications\x20such\x20as\x20insulin\x20resistance,\x20hyperglycemia,\x20and\x20dyslipidemia.</li>\x0d\x0a</ul>\x0d\x0a\x20','correct_choice_id':0x40,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':_0x357c09(0x340)},{'id':0x48,'text':_0x357c09(0x323)},{'id':0x49,'text':_0x357c09(0x3b1)},{'id':0x4a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Heart\x20and\x20lungs</span></p>'}],'text':_0x357c09(0x32a),'unique_key':_0x357c09(0x16d),'question_audio':null,'question_video':null,'map_id':0x13c438,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0xf0),'correct_choice_id':0x48,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':_0x357c09(0x156)},{'id':0x52,'text':_0x357c09(0x2ac)},{'id':0x53,'text':_0x357c09(0x38b)},{'id':0x54,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Increased\x20insulin\x20sensitivity</span></p>'}],'text':_0x357c09(0x297),'unique_key':_0x357c09(0x234),'question_audio':null,'question_video':null,'map_id':0x13c43b,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x2a5),'correct_choice_id':0x52,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x357c09(0x37f)},{'id':0x5c,'text':_0x357c09(0x118)},{'id':0x5d,'text':_0x357c09(0xeb)},{'id':0x5e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Kir6.2\x20and\x20PPAR&gamma;</span></p>'}],'text':_0x357c09(0x304),'unique_key':'DT1295428','question_audio':null,'question_video':null,'map_id':0x13c444,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x282),'correct_choice_id':0x5b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Mitochondrial\x20DNA\x20mutations</span></p>'},{'id':0x66,'text':_0x357c09(0x3ab)},{'id':0x67,'text':_0x357c09(0x229)},{'id':0x68,'text':_0x357c09(0x36e)}],'text':_0x357c09(0x1ed),'unique_key':'DT1295432','question_audio':null,'question_video':null,'map_id':0x13c448,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x283),'correct_choice_id':0x66,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x357c09(0x32e)},{'id':0x70,'text':_0x357c09(0x236)},{'id':0x71,'text':_0x357c09(0x341)},{'id':0x72,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Stimulating\x20beta-cell\x20proliferation</span></p>'}],'text':_0x357c09(0x281),'unique_key':_0x357c09(0xee),'question_audio':null,'question_video':null,'map_id':0x13c44e,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x31d),'correct_choice_id':0x70,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':_0x357c09(0x313)},{'id':0x7a,'text':_0x357c09(0x101)},{'id':0x7b,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Progesterone</span></p>'},{'id':0x7c,'text':_0x357c09(0x1e6)}],'text':_0x357c09(0x356),'unique_key':'DT1295439','question_audio':null,'question_video':null,'map_id':0x13c44f,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x392),'correct_choice_id':0x79,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x357c09(0x240)},{'id':0x84,'text':_0x357c09(0x2e0)},{'id':0x85,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Impaired\x20glucose\x20tolerance</span></p>'},{'id':0x86,'text':_0x357c09(0x2b7)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2050-year-old\x20woman\x20with\x20a\x20family\x20history\x20of\x20diabetes\x20presents\x20for\x20a\x20routine\x20check-up.\x20Her\x20fasting\x20blood\x20glucose\x20is\x20110\x20mg/dL,\x20and\x20her\x202-hour\x20postprandial\x20glucose\x20following\x20an\x20oral\x20glucose\x20tolerance\x20test\x20(OGTT)\x20is\x20150\x20mg/dL.\x20She\x20has\x20a\x20BMI\x20of\x2028\x20kg/m2\x20and\x20reports\x20no\x20symptoms\x20of\x20hyperglycemia.<br>What\x20is\x20the\x20most\x20likely\x20diagnosis\x20based\x20on\x20her\x20glucose\x20levels?</span></p>','unique_key':_0x357c09(0x1b6),'question_audio':null,'question_video':null,'map_id':0x13c450,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x34b),'correct_choice_id':0x85,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x357c09(0x149)},{'id':0x8e,'text':_0x357c09(0x216)},{'id':0x8f,'text':_0x357c09(0x285)},{'id':0x90,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Onset\x20of\x20symptoms\x20in\x20late\x20adulthood</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2022-year-old\x20male\x20presents\x20to\x20the\x20clinic\x20for\x20a\x20routine\x20evaluation\x20after\x20recent\x20lab\x20results\x20showed\x20elevated\x20blood\x20glucose\x20levels.\x20He\x20reports\x20no\x20symptoms\x20of\x20hyperglycemia,\x20such\x20as\x20polyuria\x20or\x20polydipsia,\x20and\x20has\x20a\x20BMI\x20within\x20the\x20normal\x20range.\x20He\x20does\x20not\x20have\x20a\x20history\x20of\x20diabetic\x20ketoacidosis\x20and\x20has\x20no\x20history\x20of\x20obesity.\x20His\x20family\x20history\x20reveals\x20that\x20his\x20mother\x20and\x20maternal\x20grandfather\x20were\x20diagnosed\x20with\x20diabetes\x20in\x20their\x20early\x20twenties\x20and\x20have\x20been\x20managed\x20on\x20oral\x20hypoglycemic\x20agents\x20rather\x20than\x20insulin.<br>On\x20examination,\x20the\x20patient\x27s\x20fasting\x20blood\x20glucose\x20is\x20135\x20mg/dL,\x20and\x20his\x20HbA1c\x20is\x206.8%.\x20An\x20oral\x20glucose\x20tolerance\x20test\x20shows\x20a\x202-hour\x20glucose\x20of\x20190\x20mg/dL.\x20Given\x20the\x20family\x20history,\x20early\x20onset\x20of\x20hyperglycemia\x20without\x20obesity,\x20and\x20relatively\x20mild\x20hyperglycemia.<br>Which\x20of\x20the\x20following\x20findings\x20would\x20most\x20likely\x20pathology\x20confirms\x20the\x20diagnosis?</span></p>','unique_key':'DT1295442','question_audio':null,'question_video':null,'map_id':0x13c452,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol><li><strong>Presence\x20of\x20pancreatic\x20autoantibodies\x20(Option\x20A)\x20-\x20Incorrect:</strong><ul><li><strong>Explanation:\x20</strong>MODY\x20is\x20a\x20monogenic,\x20non-autoimmune\x20form\x20of\x20diabetes.\x20Unlike\x20Type\x201\x20diabetes,\x20patients\x20with\x20MODY\x20do\x20not\x20have\x20autoimmune\x20markers,\x20such\x20as\x20GAD65\x20or\x20islet\x20cell\x20antibodies.\x20The\x20absence\x20of\x20autoantibodies\x20helps\x20differentiate\x20MODY\x20from\x20autoimmune\x20diabetes.</li></ul></li><li><strong>Positive\x20family\x20history\x20with\x20an\x20autosomal\x20dominant\x20pattern\x20of\x20diabetes\x20inheritance\x20(Option\x20B)\x20-\x20Correct:</strong><ul><li><strong>Explanation:\x20</strong>MODY\x20typically\x20follows\x20an\x20<strong>autosomal\x20dominant\x20inheritance\x20pattern</strong>.\x20This\x20means\x20that\x20the\x20condition\x20is\x20often\x20seen\x20in\x20multiple\x20generations,\x20with\x20early-onset\x20diabetes\x20in\x20each\x20generation.\x20A\x20family\x20history\x20of\x20diabetes,\x20especially\x20in\x20lean\x20individuals\x20without\x20insulin\x20resistance,\x20supports\x20the\x20diagnosis\x20of\x20MODY.</li><li><strong>Genetics:\x20</strong>MODY\x20is\x20caused\x20by\x20single-gene\x20mutations\x20(e.g.,\x20HNF1A,\x20GCK)\x20that\x20impair\x20beta-cell\x20function\x20or\x20glucose\x20metabolism.\x20Genetic\x20testing\x20is\x20required\x20to\x20confirm\x20the\x20mutation\x20and\x20MODY\x20subtype.</li></ul></li><li><strong>Evidence\x20of\x20insulin\x20resistance\x20(Option\x20C)\x20-\x20Incorrect:</strong><ul><li><strong>Explanation:\x20</strong>MODY\x20generally\x20presents\x20with\x20<strong>normal\x20insulin\x20sensitivity</strong>.\x20Patients\x20with\x20MODY\x20are\x20not\x20typically\x20insulin-resistant,\x20unlike\x20those\x20with\x20Type\x202\x20diabetes.\x20Insulin\x20resistance\x20is\x20rare\x20in\x20young,\x20lean\x20patients\x20with\x20MODY.</li></ul></li><li><strong>Onset\x20of\x20symptoms\x20in\x20late\x20adulthood\x20(Option\x20D)\x20-\x20Incorrect:</strong><ul><li><strong>Explanation:\x20</strong>MODY\x20usually\x20presents\x20in\x20<strong>adolescence\x20or\x20early\x20adulthood</strong>\x20(before\x2025\x20years\x20of\x20age)\x20with\x20mild\x20hyperglycemia,\x20often\x20asymptomatic\x20or\x20detected\x20incidentally.\x20Onset\x20in\x20late\x20adulthood\x20is\x20more\x20suggestive\x20of\x20Type\x202\x20diabetes.</li></ul></li></ol><p><strong>Key\x20Points\x20for\x20Diagnosing\x20MODY:</strong></p><ul><li><strong>Age\x20of\x20Onset:\x20</strong>Typically\x20presents\x20before\x20age\x2025\x20but\x20can\x20vary\x20depending\x20on\x20the\x20MODY\x20subtype.</li><li><strong>Family\x20History:\x20</strong>Autosomal\x20dominant\x20inheritance\x20pattern\x20with\x20diabetes\x20in\x20successive\x20generations.</li><li><strong>Insulin\x20Sensitivity:\x20</strong>Generally\x20normal;\x20patients\x20are\x20often\x20lean\x20without\x20insulin\x20resistance.</li><li><strong>Autoantibodies:\x20</strong>Absent,\x20distinguishing\x20MODY\x20from\x20Type\x201\x20diabetes.</li><li><strong>Genetic\x20Testing:\x20</strong>Identifies\x20specific\x20gene\x20mutations\x20associated\x20with\x20MODY\x20subtypes\x20(e.g.,\x20HNF1A,\x20GCK,\x20HNF4A).</li></ul><p><strong>Table:\x20Characteristics\x20of\x20Diabetes\x20Types</strong></p><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025010961cbd8b0-1872-42cd-aa8f-5ab3c2bffa91.jpg\x22><p><strong>Key\x20Takeaways:</strong></p><ul><li>MODY\x20is\x20a\x20<strong>monogenic\x20form\x20of\x20diabetes\x20</strong>that\x20usually\x20presents\x20in\x20young,\x20lean\x20individuals\x20without\x20insulin\x20resistance.</li><li><strong>Family\x20history\x20</strong>with\x20an\x20autosomal\x20dominant\x20inheritance\x20pattern\x20and\x20early-onset\x20diabetes\x20is\x20highly\x20suggestive.</li><li><strong>Genetic\x20testing\x20</strong>is\x20essential\x20for\x20confirming\x20MODY\x20and\x20determining\x20the\x20subtype,\x20which\x20guides\x20management.</li></ul>\x20','correct_choice_id':0x8e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x357c09(0x284)},{'id':0x98,'text':_0x357c09(0x1c3)},{'id':0x99,'text':_0x357c09(0x212)},{'id':0x9a,'text':_0x357c09(0x217)}],'text':_0x357c09(0x2f7),'unique_key':_0x357c09(0x2e6),'question_audio':null,'question_video':null,'map_id':0x13c454,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x318),'correct_choice_id':0x97,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>70\x20mg/dL\x20(3.9\x20mmol/L)</span></p>'},{'id':0xa2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>65\x20mg/dL\x20(3.6\x20mmol/L)</span></p>'},{'id':0xa3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>60\x20mg/dL\x20(3.3\x20mmol/L)</span></p>'},{'id':0xa4,'text':_0x357c09(0x17f)}],'text':_0x357c09(0x192),'unique_key':_0x357c09(0x26a),'question_audio':null,'question_video':null,'map_id':0x13c457,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':'<ol>\x0d\x0a<li><strong>70\x20mg/dL\x20(3.9\x20mmol/L)\x20(Option\x20A):</strong>\x20This\x20level\x20represents\x20<strong>Level\x201\x20hypoglycemia</strong>\x20according\x20to\x20the\x20American\x20Diabetes\x20Association\x20(ADA),\x20which\x20is\x20considered\x20a\x20\x22low\x22\x20but\x20not\x20clinically\x20significant\x20hypoglycemia\x20threshold.\x20Level\x201\x20hypoglycemia\x20requires\x20monitoring\x20but\x20does\x20not\x20indicate\x20a\x20severe\x20risk.</li>\x0d\x0a<li><strong>65\x20mg/dL\x20(3.6\x20mmol/L)\x20(Option\x20B):</strong>\x20Although\x20this\x20level\x20indicates\x20hypoglycemia,\x20it\x20does\x20not\x20meet\x20the\x20ADA\x27s\x20threshold\x20for\x20<strong>Level\x202\x20hypoglycemia</strong>,\x20which\x20is\x20specifically\x20defined\x20as\x20&le;54\x20mg/dL.</li>\x0d\x0a<li><strong>60\x20mg/dL\x20(3.3\x20mmol/L)\x20(Option\x20C):</strong>\x20Like\x20Option\x20B,\x20this\x20value\x20reflects\x20hypoglycemia\x20but\x20does\x20not\x20reach\x20the\x20clinically\x20significant\x20threshold\x20of\x20Level\x202.</li>\x0d\x0a<li><strong>54\x20mg/dL\x20(3.0\x20mmol/L)\x20(Option\x20D):</strong>\x20According\x20to\x20the\x20ADA,\x20<strong>Level\x202\x20hypoglycemia</strong>\x20is\x20defined\x20as\x20a\x20blood\x20glucose\x20level\x20of\x20<strong>54\x20mg/dL\x20(3.0\x20mmol/L)\x20or\x20below</strong>.\x20This\x20threshold\x20is\x20considered\x20<strong>clinically\x20significant\x20hypoglycemia</strong>,\x20necessitating\x20immediate\x20treatment\x20to\x20avoid\x20potential\x20serious\x20health\x20risks,\x20especially\x20in\x20patients\x20with\x20diabetes\x20on\x20insulin\x20or\x20other\x20hypoglycemic\x20agents.</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Detailed\x20Explanation:</strong></p>\x0d\x0a<ol>\x0d\x0a<li><strong>ADA\x20Classification\x20of\x20Hypoglycemia\x20Levels:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Level\x201\x20Hypoglycemia:</strong>\x20Blood\x20glucose\x20of\x20<strong>70-54\x20mg/dL\x20(3.9-3.0\x20mmol/L),</strong>\x20considered\x20\x22low\x22\x20but\x20not\x20immediately\x20dangerous.</li>\x0d\x0a<li><strong>Level\x202\x20Hypoglycemia:</strong>\x20Blood\x20glucose\x20<strong>&le;54\x20mg/dL\x20(3.0\x20mmol/L),</strong>\x20classified\x20as\x20<strong>clinically\x20significant\x20hypoglycemia.</strong>\x20This\x20level\x20requires\x20immediate\x20treatment\x20to\x20avoid\x20further\x20decline\x20and\x20symptoms.</li>\x0d\x0a<li><strong>Level\x203\x20Hypoglycemia:</strong>\x20Defined\x20by\x20a\x20severe\x20event\x20with\x20<strong>altered\x20mental\x20status\x20or\x20physical\x20incapacity\x20</strong>requiring\x20assistance\x20from\x20another\x20person,\x20irrespective\x20of\x20blood\x20glucose\x20level.\x20This\x20is\x20often\x20associated\x20with\x20more\x20severe\x20symptoms,\x20such\x20as\x20unconsciousness\x20or\x20seizures.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Pathophysiology\x20of\x20Hypoglycemia:</strong>\x0d\x0a<ul>\x0d\x0a<li>Hypoglycemia\x20occurs\x20when\x20<strong>blood\x20glucose\x20levels\x20fall\x20below\x20the\x20normal\x20range,</strong>\x20leading\x20to\x20insufficient\x20glucose\x20supply\x20to\x20the\x20brain,\x20which\x20relies\x20on\x20glucose\x20as\x20its\x20primary\x20fuel.</li>\x0d\x0a<li><strong>Causes\x20</strong>include\x20excess\x20insulin\x20(from\x20injections\x20or\x20oral\x20hypoglycemics),\x20inadequate\x20food\x20intake,\x20increased\x20physical\x20activity,\x20or\x20alcohol\x20consumption\x20without\x20adequate\x20food.</li>\x0d\x0a<li>The\x20body\x27s\x20counter-regulatory\x20hormones\x20(epinephrine,\x20glucagon,\x20cortisol)\x20typically\x20respond\x20by\x20increasing\x20blood\x20glucose.\x20However,\x20in\x20individuals\x20with\x20frequent\x20hypoglycemia,\x20this\x20response\x20may\x20be\x20blunted,\x20increasing\x20the\x20risk\x20of\x20severe\x20episodes.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Symptoms\x20of\x20Hypoglycemia:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Mild\x20Hypoglycemia\x20(Level\x201):</strong>\x20Sweating,\x20shakiness,\x20palpitations,\x20hunger,\x20and\x20anxiety.</li>\x0d\x0a<li><strong>Moderate\x20to\x20Severe\x20Hypoglycemia\x20(Level\x202\x20&amp;\x203):</strong>\x20Confusion,\x20blurred\x20vision,\x20slurred\x20speech,\x20irritability,\x20and,\x20if\x20untreated,\x20seizures,\x20or\x20unconsciousness.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Treatment\x20of\x20Hypoglycemia:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Immediate\x20Treatment\x20(Rule\x20of\x2015):</strong>\x0d\x0a<ul>\x0d\x0a<li>For\x20Level\x201\x20and\x20Level\x202\x20hypoglycemia,\x20consume\x20<strong>15\x20grams\x20of\x20fast-acting\x20carbohydrate</strong>(e.g.,\x20glucose\x20tablets,\x204\x20oz.\x20of\x20juice,\x20or\x20regular\x20soda).</li>\x0d\x0a<li>Recheck\x20blood\x20glucose\x20after\x2015\x20minutes.\x20If\x20still\x20below\x2070\x20mg/dL\x20(3.9\x20mmol/L),\x20repeat\x20the\x20treatment.</li>\x0d\x0a<li>Follow\x20up\x20with\x20a\x20small\x20meal\x20or\x20snack\x20to\x20maintain\x20glucose\x20levels,\x20especially\x20if\x20the\x20next\x20meal\x20is\x20not\x20soon.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Severe\x20Hypoglycemia\x20(Level\x203):</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Glucagon\x20Injection:</strong>\x20For\x20those\x20unable\x20to\x20consume\x20glucose\x20orally,\x20glucagon\x20is\x20the\x20primary\x20treatment.\x20It\x20is\x20available\x20as\x20an\x20injection\x20or\x20intranasal\x20powder.</li>\x0d\x0a<li><strong>Emergency\x20Assistance:</strong>\x20If\x20the\x20patient\x20is\x20unconscious,\x20emergency\x20assistance\x20is\x20required.\x20Caregivers\x20or\x20family\x20members\x20should\x20be\x20trained\x20to\x20administer\x20glucagon.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a<li><strong>Preventive\x20Measures:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Adjusting\x20Medications:</strong>\x20Patients\x20with\x20frequent\x20hypoglycemia\x20episodes\x20may\x20need\x20to\x20adjust\x20their\x20insulin\x20regimen\x20or\x20oral\x20hypoglycemic\x20medications\x20in\x20consultation\x20with\x20their\x20healthcare\x20provider.</li>\x0d\x0a<li><strong>Continuous\x20Glucose\x20Monitoring\x20(CGM):\x20</strong>CGM\x20devices\x20can\x20alert\x20patients\x20of\x20impending\x20hypoglycemia\x20and\x20allow\x20timely\x20intervention.</li>\x0d\x0a<li><strong>Educating\x20Patients\x20and\x20Caregivers:</strong>\x20Education\x20on\x20the\x20signs\x20of\x20hypoglycemia,\x20proper\x20treatment,\x20and\x20recognition\x20of\x20factors\x20that\x20increase\x20risk\x20(e.g.,\x20skipped\x20meals,\x20alcohol\x20intake)\x20is\x20essential.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<ol\x20start=\x225\x22>\x0d\x0a<li><strong>Long-Term\x20Management\x20and\x20Prevention:</strong>\x0d\x0a<ul>\x0d\x0a<li><strong>Diet\x20and\x20Activity\x20Adjustments:</strong>\x20Consuming\x20regular\x20meals\x20with\x20balanced\x20carbohydrates,\x20protein,\x20and\x20fats\x20can\x20help\x20maintain\x20steady\x20glucose\x20levels.\x20Avoid\x20excessive\x20exercise\x20without\x20adjusting\x20food\x20or\x20insulin.</li>\x0d\x0a<li><strong>Medication\x20Review:</strong>\x20For\x20those\x20on\x20insulin\x20or\x20sulfonylureas\x20(such\x20as\x20glipizide),\x20which\x20increase\x20hypoglycemia\x20risk,\x20switching\x20to\x20medications\x20with\x20a\x20lower\x20risk\x20(e.g.,\x20DPP-4\x20inhibitors,\x20GLP-1\x20receptor\x20agonists,\x20or\x20SGLT2\x20inhibitors)\x20may\x20be\x20beneficial.</li>\x0d\x0a<li><strong>Recognition\x20of\x20Hypoglycemia\x20Unawareness:</strong>\x20Frequent\x20hypoglycemia\x20can\x20blunt\x20the\x20body&rsquo;s\x20warning\x20signals,\x20leading\x20to\x20<strong>hypoglycemia\x20unawareness.</strong>\x20This\x20requires\x20closer\x20monitoring,\x20potential\x20CGM\x20use,\x20and\x20in\x20some\x20cases,\x20modification\x20of\x20glycemic\x20targets\x20to\x20reduce\x20risk.</li>\x0d\x0a</ul>\x0d\x0a</li>\x0d\x0a</ol>\x0d\x0a<p><strong>Key\x20Takeaways:</strong></p>\x0d\x0a<ul>\x0d\x0a<li><strong>Level\x202\x20hypoglycemia\x20</strong>is\x20defined\x20as\x20blood\x20glucose\x20levels\x20<strong>&le;54\x20mg/dL\x20(3.0\x20mmol/L)</strong>\x20and\x20is\x20considered\x20clinically\x20significant,\x20requiring\x20immediate\x20action.</li>\x0d\x0a<li><strong>The\x20Rule\x20of\x2015</strong>(15\x20grams\x20of\x20carbohydrates,\x20wait\x2015\x20minutes,\x20and\x20recheck)\x20is\x20a\x20critical\x20protocol\x20for\x20treating\x20mild\x20to\x20moderate\x20hypoglycemia.</li>\x0d\x0a<li><strong>Glucagon\x20</strong>is\x20the\x20treatment\x20of\x20choice\x20for\x20severe\x20hypoglycemia\x20when\x20the\x20patient\x20is\x20unable\x20to\x20consume\x20oral\x20glucose.</li>\x0d\x0a<li>Preventive\x20strategies,\x20including\x20dietary\x20adjustments,\x20medication\x20review,\x20and\x20CGM,\x20are\x20essential\x20for\x20high-risk\x20patients.</li>\x0d\x0a<li>The\x20ADA\x20defines\x20<strong>Level\x202\x20hypoglycemia\x20(clinically\x20significant)\x20</strong>as\x20blood\x20glucose\x20levels\x20<strong>&le;54\x20mg/dL\x20(3.0\x20mmol/L).</strong></li>\x0d\x0a<li>This\x20level\x20of\x20hypoglycemia\x20requires\x20prompt\x20intervention,\x20as\x20it\x20presents\x20a\x20higher\x20risk\x20of\x20severe\x20symptoms\x20and\x20complications.</li>\x0d\x0a</ul>\x0d\x0a\x20','correct_choice_id':0xa4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Sulfonylureas\x20and\x20DPP-4\x20inhibitors</span></p>'},{'id':0xac,'text':_0x357c09(0x1f3)},{'id':0xad,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Metformin\x20alone</span></p>'},{'id':0xae,'text':_0x357c09(0x22c)}],'text':_0x357c09(0x322),'unique_key':_0x357c09(0x1fe),'question_audio':null,'question_video':null,'map_id':0x13c45c,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x2c8),'correct_choice_id':0xac,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':_0x357c09(0x255)},{'id':0xb6,'text':_0x357c09(0x270)},{'id':0xb7,'text':_0x357c09(0x37b)},{'id':0xb8,'text':_0x357c09(0x10b)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2052-year-old\x20man\x20with\x20type\x202\x20diabetes\x20mellitus\x20is\x20being\x20educated\x20about\x20the\x20progression\x20of\x20diabetic\x20nephropathy.\x20Arrange\x20the\x20following\x20events\x20in\x20the\x20correct\x20chronological\x20order\x20from\x20first\x20to\x20last\x20in\x20the\x20development\x20of\x20diabetic\x20nephropathy.<br>A.\x20Onset\x20of\x20microalbuminuria<br>B.\x20Development\x20of\x20glomerular\x20hyperfiltration\x20and\x20renal\x20hypertrophy<br>C.\x20Appearance\x20of\x20overt\x20proteinuria\x20(macroalbuminuria)<br>D.\x20Decline\x20in\x20glomerular\x20filtration\x20rate\x20(GFR)\x20leading\x20to\x20renal\x20insufficiency<br>E.\x20Progression\x20to\x20end-stage\x20renal\x20disease\x20(ESRD)</span></p>','unique_key':_0x357c09(0x1a7),'question_audio':null,'question_video':null,'map_id':0x13c467,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x357c09(0x122),'correct_choice_id':0xb5,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':_0x357c09(0x226)},{'id':0xc0,'text':_0x357c09(0x2ea)},{'id':0xc1,'text':_0x357c09(0x290)},{'id':0xc2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>1-A,\x202-J,\x203-C,\x204-E,\x205-H,\x206-D</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Match\x20the\x20following\x20Oral\x20Hypoglycemic\x20Agents\x20in\x20List\x20A\x20with\x20their\x20primary\x20Mechanisms\x20of\x20Action\x20in\x20List\x20B.<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109c865f597-692b-401e-b602-42a35d351275.jpg\x22></span></p>','unique_key':_0x357c09(0x351),'question_audio':null,'question_video':null,'map_id':0x13c470,'difficulty_level':_0x357c09(0x2cb),'subjects_id':[0x1],'solution':_0x357c09(0x164),'correct_choice_id':0xc0,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x357c09(0x38f),'tags':[_0x357c09(0x17a)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x357c09(0x25b);const quizFilename=_0x357c09(0x353);let hierarchy=[_0x357c09(0x33a),_0x357c09(0x20a),_0x357c09(0x10d)];if(window[_0x357c09(0x357)]['pathname'][_0x357c09(0x2f0)](_0x357c09(0x2b0))){const customData=JSON['parse'](localStorage[_0x357c09(0x2b4)]('customQuizData'));customData&&(questionsData=customData[_0x357c09(0x2ce)],quizName=customData['name'],hierarchy=customData['hierarchy'],document[_0x357c09(0x2c1)]=quizName+_0x357c09(0x362),document[_0x357c09(0xe3)](_0x357c09(0x264))['textContent']=questionsData['length'],document['getElementById'](_0x357c09(0x393))[_0x357c09(0x19e)]=hierarchy[_0x357c09(0x147)](_0x357c09(0x1eb)));}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x357c09(0x187),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x357c09(0x3b5)](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x357c09(0x371)])[_0x357c09(0x2ee)](null)[_0x357c09(0x1e2)](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x38fe65=_0x357c09,_0x41b962={'dByiL':_0x38fe65(0x11e),'XVwBj':_0x38fe65(0x20e)};if(isQuizCompleted)return;const _0x40bf8b=JSON[_0x38fe65(0x111)](localStorage['getItem'](_0x41b962[_0x38fe65(0x303)]))||{};_0x40bf8b[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x41b962['XVwBj'],'lastSeen':new Date()[_0x38fe65(0x144)]()},localStorage[_0x38fe65(0x22b)](_0x41b962[_0x38fe65(0x303)],JSON['stringify'](_0x40bf8b));}function loadProgress(){const _0x2c65e8=_0x357c09,_0x51055a={'VQxIq':function(_0x1a0061,_0x3cfc25){return _0x1a0061(_0x3cfc25);},'ZktgV':function(_0x32ad10,_0x37a5c3){return _0x32ad10+_0x37a5c3;},'ZNLzK':function(_0x41c24d,_0xcc4274){return _0x41c24d+_0xcc4274;},'YGtbT':'return\x20(function()\x20','miWmM':'{}.constructor(\x22return\x20this\x22)(\x20)','Seohj':_0x2c65e8(0x11e),'tTfUq':function(_0x316080,_0x510111){return _0x316080===_0x510111;},'mWBrU':_0x2c65e8(0x33d),'OmVKz':_0x2c65e8(0x112),'ExhzG':_0x2c65e8(0x1ec)},_0x498f39=JSON[_0x2c65e8(0x111)](localStorage[_0x2c65e8(0x2b4)](_0x51055a[_0x2c65e8(0x242)]))||{},_0x42425c=_0x498f39[quizFilename];if(_0x42425c){if(_0x51055a[_0x2c65e8(0x2a3)](_0x51055a[_0x2c65e8(0x37c)],_0x2c65e8(0x24e)))_0x4d37be=YRqzXn[_0x2c65e8(0x328)](_0x8f6476,YRqzXn[_0x2c65e8(0x39d)](YRqzXn['ZNLzK'](YRqzXn[_0x2c65e8(0x124)],YRqzXn[_0x2c65e8(0x227)]),');'))();else{const _0x235f65=_0x51055a['OmVKz'][_0x2c65e8(0x1be)]('|');let _0x444f7c=0x0;while(!![]){switch(_0x235f65[_0x444f7c++]){case'0':return!![];case'1':currentQuestionIndex=_0x42425c[_0x2c65e8(0x1b4)];continue;case'2':console[_0x2c65e8(0x123)](_0x51055a[_0x2c65e8(0x119)]);continue;case'3':currentMode=_0x42425c[_0x2c65e8(0x1fd)];continue;case'4':stats=_0x42425c[_0x2c65e8(0x19a)];continue;case'5':questionStates=_0x42425c['questionStates'];continue;}break;}}}return![];}function clearProgress(){const _0x28812e=_0x357c09,_0x1a07d2={'kptDX':'userHistory'},_0x416336=JSON[_0x28812e(0x111)](localStorage[_0x28812e(0x2b4)](_0x1a07d2[_0x28812e(0x17c)]))||{};_0x416336[quizFilename]&&(delete _0x416336[quizFilename],localStorage[_0x28812e(0x22b)]('userHistory',JSON[_0x28812e(0x238)](_0x416336)),console[_0x28812e(0x123)](_0x28812e(0x2a1)));}function markQuizAsCompleted(){const _0x2534c1=_0x357c09,_0x5de048={'axIfC':'userHistory','gIMjf':_0x2534c1(0x2af)},_0x50100d=JSON[_0x2534c1(0x111)](localStorage[_0x2534c1(0x2b4)](_0x5de048[_0x2534c1(0x2fe)]))||{},_0xa467a7=questionsData[_0x2534c1(0x371)],_0x2be351=stats['correctAnswers']||0x0;_0x50100d[quizFilename]={'score':_0x2be351,'total':_0xa467a7,'status':_0x5de048[_0x2534c1(0x134)],'completedOn':new Date()[_0x2534c1(0x144)]()},localStorage[_0x2534c1(0x22b)](_0x5de048[_0x2534c1(0x2fe)],JSON[_0x2534c1(0x238)](_0x50100d));}const urlParams=new URLSearchParams(window[_0x357c09(0x357)]['search']),startAt=parseInt(urlParams[_0x357c09(0x176)](_0x357c09(0x114))),resume=urlParams[_0x357c09(0x176)](_0x357c09(0x202))===_0x357c09(0x1f8);function goBack(){const _0x1db7ea=_0x357c09,_0x970431={'WwCcO':function(_0x1eedc1){return _0x1eedc1();},'ftKhD':_0x1db7ea(0x27f)};if(!isQuizCompleted)_0x970431[_0x1db7ea(0x10c)](saveProgress);window['location'][_0x1db7ea(0xf2)]=document['referrer']||_0x970431[_0x1db7ea(0x37e)];}function selectMode(_0x47cb1b){const _0x4d8d9c=_0x357c09,_0x155507={'tUned':_0x4d8d9c(0x2e5),'mdWbo':_0x4d8d9c(0x332)};currentMode=_0x47cb1b,document[_0x4d8d9c(0xe3)](_0x155507['tUned'])[_0x4d8d9c(0x22d)][_0x4d8d9c(0x36d)]=_0x155507['mdWbo'],initializeQuiz();}function initializeQuiz(){const _0x40c844=_0x357c09,_0x1eca72={'ngdPK':'markReviewBtn','GOtWB':_0x40c844(0x2f4),'XNPBx':function(_0x248574,_0x32d065){return _0x248574===_0x32d065;},'RqAPI':'test','REJLN':_0x40c844(0x332),'Bzzmo':_0x40c844(0xe5),'npvQh':_0x40c844(0x130),'nknsA':_0x40c844(0x271),'bUSrc':_0x40c844(0x314),'AQVju':'timerContainer','qoWMz':function(_0x98a694,_0x47dfbc){return _0x98a694(_0x47dfbc);},'aVRlR':function(_0x4b1f9e,_0x532328){return _0x4b1f9e>=_0x532328;},'ivPQL':function(_0x4c7efb,_0x2c3f66){return _0x4c7efb<_0x2c3f66;},'NmDSc':function(_0x4d81c8){return _0x4d81c8();}};quizStartTime=Date[_0x40c844(0x3b5)]();const _0x1417f2=document[_0x40c844(0xe3)](_0x40c844(0x23b)),_0x4177f0=document[_0x40c844(0xe3)](_0x1eca72[_0x40c844(0x1a4)]),_0x51f3fe=document[_0x40c844(0xe3)](_0x1eca72[_0x40c844(0x294)]),_0x3aefe2=_0x1eca72[_0x40c844(0x266)](currentMode,_0x1eca72[_0x40c844(0x161)])||_0x1eca72[_0x40c844(0x266)](currentMode,_0x40c844(0x314));document['getElementById'](_0x40c844(0x316))['style'][_0x40c844(0x36d)]=_0x3aefe2?_0x1eca72[_0x40c844(0x2a6)]:_0x1eca72[_0x40c844(0x1a0)],document[_0x40c844(0xe3)](_0x1eca72[_0x40c844(0x342)])['style'][_0x40c844(0x36d)]=_0x3aefe2?_0x40c844(0x332):_0x1eca72['Bzzmo'],document[_0x40c844(0xe3)](_0x40c844(0x180))['style'][_0x40c844(0x36d)]=_0x3aefe2?'block':_0x1eca72['REJLN'],document[_0x40c844(0xe3)]('submitSection')[_0x40c844(0x22d)]['display']=_0x3aefe2?_0x40c844(0xe5):_0x1eca72[_0x40c844(0x2a6)],_0x1417f2[_0x40c844(0x22d)][_0x40c844(0x36d)]=_0x3aefe2?_0x40c844(0x332):_0x1eca72[_0x40c844(0x1cf)],_0x4177f0['style'][_0x40c844(0x36d)]=_0x3aefe2?_0x40c844(0x271):_0x1eca72[_0x40c844(0x2a6)],_0x51f3fe[_0x40c844(0x22d)][_0x40c844(0x36d)]=_0x3aefe2?_0x1eca72['nknsA']:_0x1eca72[_0x40c844(0x2a6)],(_0x1eca72[_0x40c844(0x266)](currentMode,_0x40c844(0x2c0))||currentMode===_0x1eca72[_0x40c844(0x233)])&&document[_0x40c844(0xe3)](_0x1eca72[_0x40c844(0x317)])[_0x40c844(0x2e3)][_0x40c844(0x12a)](_0x40c844(0x1e4)),!_0x1eca72[_0x40c844(0x1bb)](isNaN,startAt)&&_0x1eca72[_0x40c844(0x2b5)](startAt,0x0)&&_0x1eca72[_0x40c844(0x11c)](startAt,questionsData[_0x40c844(0x371)])&&(currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x1eca72['NmDSc'](generateQuestionNav),_0x1eca72[_0x40c844(0x256)](updateStats),displayQuestion();}function generateQuestionNav(){const _0x1aabfd=_0x357c09,_0x16b10e={'EgCUu':_0x1aabfd(0x2c3),'wHGrV':function(_0x35e92e,_0x3e3cab){return _0x35e92e<_0x3e3cab;},'yHYzI':'button','PPBji':function(_0x3ee70c,_0xc43ea6){return _0x3ee70c+_0xc43ea6;},'bbfvA':_0x1aabfd(0x397),'HGksj':function(_0x319e43){return _0x319e43();}},_0x5bd6a6=document[_0x1aabfd(0xe3)](_0x16b10e['EgCUu']);_0x5bd6a6['innerHTML']='';for(let _0x718649=0x0;_0x16b10e['wHGrV'](_0x718649,questionsData[_0x1aabfd(0x371)]);_0x718649++){const _0x3e4006=document[_0x1aabfd(0x39c)](_0x16b10e[_0x1aabfd(0x172)]);_0x3e4006[_0x1aabfd(0x19e)]=_0x16b10e[_0x1aabfd(0x291)](_0x718649,0x1),_0x3e4006['className']=_0x16b10e[_0x1aabfd(0x263)],_0x3e4006[_0x1aabfd(0x3a5)]=()=>jumpToQuestion(_0x718649),_0x3e4006['id']=_0x1aabfd(0x300)+_0x718649,_0x5bd6a6['appendChild'](_0x3e4006);}_0x16b10e[_0x1aabfd(0xf1)](updateQuestionNav);}function updateQuestionNav(){const _0x592918=_0x357c09,_0x36a351={'xOICS':_0x592918(0x1b2),'dQZFQ':_0x592918(0x355),'kLTiA':_0x592918(0x2e5),'QNeFG':function(_0x579905,_0x4d661b){return _0x579905<_0x4d661b;},'rcfZZ':function(_0x4dac0f,_0x359dfb){return _0x4dac0f===_0x359dfb;},'erWUk':'VqFiQ','PKqUB':_0x592918(0x28f),'PxRTn':_0x592918(0x2e9),'dcxUc':function(_0x1be826,_0x5216df){return _0x1be826===_0x5216df;},'RdZYv':_0x592918(0x187),'WZpXm':function(_0x5a247a,_0x27cf4b){return _0x5a247a!==_0x27cf4b;},'PlmHD':_0x592918(0x11a),'SUUju':'nav-btn-correct','LqzkX':function(_0x401779,_0x1a43d8){return _0x401779===_0x1a43d8;},'EfOks':'incorrect','mwZHy':_0x592918(0x194),'KQXCV':_0x592918(0x13e),'wUXOO':'nav-btn-answered'};for(let _0x57c142=0x0;_0x36a351['QNeFG'](_0x57c142,questionsData[_0x592918(0x371)]);_0x57c142++){if(_0x36a351[_0x592918(0x398)](_0x36a351[_0x592918(0x1e3)],_0x36a351['PKqUB']))_0x558632();else{const _0x162f32=document[_0x592918(0xe3)](_0x592918(0x300)+_0x57c142),_0x112da7=questionStates[_0x57c142];let _0x25d792='';if(_0x36a351[_0x592918(0x398)](_0x57c142,currentQuestionIndex)){if('QoMxg'!==_0x592918(0x2a4)){_0x3c6079[_0x592918(0xe3)](_0x36a351[_0x592918(0x330)])['innerHTML']=_0x36a351[_0x592918(0x15b)];return;}else _0x25d792=_0x36a351['PxRTn'];}else{if(_0x112da7[_0x592918(0x299)])_0x25d792=_0x592918(0x350);else{if(_0x112da7[_0x592918(0x34d)]){if(_0x36a351[_0x592918(0x2a0)](_0x592918(0xfd),_0x592918(0x1ba))){const _0x4b2f75=_0x44dddd[_0x592918(0x2ed)](_0x3af502,arguments);return _0x59efda=null,_0x4b2f75;}else _0x25d792='nav-btn-marked-review';}else{if(_0x36a351[_0x592918(0x398)](currentMode,_0x36a351['RdZYv'])||_0x36a351['rcfZZ'](currentMode,_0x592918(0x2c0))){if(_0x36a351[_0x592918(0x2da)](_0x592918(0x339),_0x592918(0x385))){if(_0x36a351[_0x592918(0x2a0)](_0x112da7['status'],_0x36a351[_0x592918(0x280)]))_0x25d792=_0x36a351[_0x592918(0x29c)];else{if(_0x36a351[_0x592918(0xfc)](_0x112da7['status'],_0x36a351['EfOks']))_0x25d792=_0x36a351[_0x592918(0x2fa)];else _0x25d792=_0x36a351['KQXCV'];}}else _0x4665f7=_0x4f5740,_0x40bdac[_0x592918(0xe3)](_0x36a351[_0x592918(0x10e)])[_0x592918(0x22d)]['display']=_0x592918(0x332),_0x1c25b7();}else{if(_0x36a351[_0x592918(0x2da)](_0x112da7[_0x592918(0x1c2)],null))_0x25d792=_0x36a351['wUXOO'];else _0x25d792=_0x36a351[_0x592918(0x14c)];}}}}_0x162f32[_0x592918(0x276)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20'+_0x25d792;}}}function jumpToQuestion(_0x52c196){const _0x342b4f=_0x357c09,_0x35be51={'xXCNX':_0x342b4f(0x196),'YOdTB':function(_0x26d4f0,_0x432436){return _0x26d4f0>=_0x432436;},'DBIBl':function(_0x4f6f14,_0x236926){return _0x4f6f14<_0x236926;},'yJMWx':function(_0x45d66b,_0x584cf2){return _0x45d66b!==_0x584cf2;},'THnKj':'qqgjR','ISEjl':_0x342b4f(0x335),'RKGou':function(_0x3bd434,_0x52771f){return _0x3bd434-_0x52771f;},'doJFx':function(_0x4c5a23){return _0x4c5a23();}};_0x35be51[_0x342b4f(0x28e)](_0x52c196,0x0)&&_0x35be51['DBIBl'](_0x52c196,questionsData[_0x342b4f(0x371)])&&(questionStartTime&&(_0x35be51[_0x342b4f(0x277)](_0x35be51[_0x342b4f(0x19c)],_0x35be51['ISEjl'])?questionStates[currentQuestionIndex][_0x342b4f(0x32d)]+=_0x35be51['RKGou'](Date[_0x342b4f(0x3b5)](),questionStartTime):_0x496035['getElementById'](_0x35be51[_0x342b4f(0x1dc)])[_0x342b4f(0x2e3)]['toggle'](_0x342b4f(0x1b1))),currentQuestionIndex=_0x52c196,displayQuestion(),_0x35be51[_0x342b4f(0x346)](saveProgress));}function updateStats(){const _0x231428=_0x357c09,_0x4f9779={'QRTln':function(_0x4fe332,_0x2356d2){return _0x4fe332===_0x2356d2;},'faVJV':_0x231428(0x187),'ARWqH':function(_0x18f6e4,_0x39f870){return _0x18f6e4===_0x39f870;},'vXDUV':_0x231428(0x2c0),'WqPJK':_0x231428(0x106),'jjkwx':_0x231428(0x173),'omUGY':_0x231428(0x386),'HPYyg':function(_0xfdc59,_0x213308){return _0xfdc59>_0x213308;},'QKBum':function(_0x598413,_0x22f9b1){return _0x598413*_0x22f9b1;},'SBGmm':function(_0x3b63e8,_0x335b10){return _0x3b63e8/_0x335b10;},'Hyrwj':'accuracy','doSkG':function(_0x42bdf9,_0x3c8bfd){return _0x42bdf9+_0x3c8bfd;},'PjHSe':function(_0xae3df8,_0x24f4b9){return _0xae3df8/_0x24f4b9;}};if(_0x4f9779[_0x231428(0x1bc)](currentMode,_0x4f9779[_0x231428(0x1d4)])||_0x4f9779[_0x231428(0xe4)](currentMode,_0x4f9779[_0x231428(0x23a)])){document[_0x231428(0xe3)](_0x4f9779[_0x231428(0x1ac)])['textContent']=stats[_0x231428(0x206)],document[_0x231428(0xe3)](_0x4f9779[_0x231428(0x2be)])['textContent']=stats[_0x231428(0x36c)],document['getElementById'](_0x4f9779['omUGY'])[_0x231428(0x19e)]=stats['totalAttempted'];const _0x5b65d9=_0x4f9779[_0x231428(0x1c4)](stats[_0x231428(0x386)],0x0)?Math['round'](_0x4f9779[_0x231428(0x174)](_0x4f9779[_0x231428(0x2fc)](stats['correctAnswers'],stats[_0x231428(0x386)]),0x64)):0x0;document[_0x231428(0xe3)](_0x4f9779[_0x231428(0x190)])[_0x231428(0x19e)]=_0x4f9779[_0x231428(0x151)](_0x5b65d9,'%'),stats[_0x231428(0x1d2)]=questionStates[_0x231428(0x16b)]((_0x392398,_0x521ba4)=>_0x392398+_0x521ba4['timeSpent'],0x0);const _0x63191e=Math[_0x231428(0x2fb)](stats[_0x231428(0x1d2)]/0x3e8),_0xe985c5=Math['floor'](_0x4f9779[_0x231428(0x2d0)](_0x63191e,0x3c)),_0x188619=_0x63191e%0x3c;document[_0x231428(0xe3)](_0x231428(0x32d))[_0x231428(0x19e)]=_0x4f9779['doSkG'](_0x4f9779[_0x231428(0x151)](_0xe985c5,':'),_0x188619[_0x231428(0x35a)]()[_0x231428(0x1b3)](0x2,'0'));}}function setupVideo(_0x406408,_0x179028){const _0x1e9cff=_0x357c09,_0x209e8e={'HrHdb':function(_0xe41bec,_0xca2031){return _0xe41bec>=_0xca2031;},'MjeCQ':function(_0x63c7fc,_0x43160e){return _0x63c7fc<_0x43160e;},'MAiph':function(_0x174467,_0x5eb163){return _0x174467-_0x5eb163;},'ktDYC':function(_0x171940){return _0x171940();},'LmAAU':_0x1e9cff(0x23d),'UaFIa':_0x1e9cff(0x2b8)};if(Hls['isSupported']()){const _0x21544e=new Hls();_0x21544e['loadSource'](_0x179028),_0x21544e[_0x1e9cff(0x120)](_0x406408);}else _0x406408['canPlayType'](_0x209e8e['LmAAU'])&&(_0x1e9cff(0x295)===_0x209e8e['UaFIa']?_0x209e8e[_0x1e9cff(0x273)](_0x337ee3,0x0)&&_0x209e8e[_0x1e9cff(0x35b)](_0x249e41,_0x682545['length'])&&(_0x41af40&&(_0x4745ea[_0x2b289e][_0x1e9cff(0x32d)]+=_0x209e8e[_0x1e9cff(0x142)](_0x484572['now'](),_0x31c469)),_0x2665bb=_0x4fd891,_0x209e8e[_0x1e9cff(0x207)](_0x550e52),_0x209e8e[_0x1e9cff(0x207)](_0x3c7e6e)):_0x406408[_0x1e9cff(0x349)]=_0x179028);}function displayQuestion(){const _0x4d2b1e=_0x357c09,_0x1a2ab8={'ulIab':function(_0x51833e,_0x4e0baa){return _0x51833e!==_0x4e0baa;},'HhtVc':'study','sAPEI':'timed_study','pgNjM':_0x4d2b1e(0x1a5),'EdnSe':_0x4d2b1e(0x219),'yfgNm':function(_0x26b042){return _0x26b042();},'eZeOH':'selected','SfkpQ':function(_0x478f1c,_0x278c30){return _0x478f1c===_0x278c30;},'PWlTi':_0x4d2b1e(0x11a),'YfJmU':'incorrect','gQHjz':function(_0x29536d,_0x5aeb8a){return _0x29536d!==_0x5aeb8a;},'Zevdl':_0x4d2b1e(0x309),'WPfAc':function(_0x4b079f,_0x260e6c){return _0x4b079f+_0x260e6c;},'CXErA':_0x4d2b1e(0x259),'cCLot':_0x4d2b1e(0x39e),'aumjr':function(_0x846b1a,_0x15c04f){return _0x846b1a+_0x15c04f;},'xcWfs':function(_0x5b9312,_0x514990){return _0x5b9312(_0x514990);},'HOROu':_0x4d2b1e(0x2e5),'JMNZB':_0x4d2b1e(0x271),'crwkU':function(_0x3302ef,_0xaeb272){return _0x3302ef===_0xaeb272;},'aERcp':'questionText','aPwOj':'No\x20questions\x20available\x20for\x20this\x20quiz.','xYheH':function(_0x39fac5,_0x9446ec){return _0x39fac5*_0x9446ec;},'XFYjL':function(_0x277307,_0x4ac3e7){return _0x277307/_0x4ac3e7;},'hbmKP':'progressBar','IYfxP':_0x4d2b1e(0x137),'CQZCV':function(_0x51573a,_0x585142){return _0x51573a+_0x585142;},'aCTDI':_0x4d2b1e(0x30b),'UviEY':_0x4d2b1e(0x388),'pIgJj':'hidden','UrRyC':_0x4d2b1e(0x33e),'PozCs':function(_0x432ee6,_0x4af0a6){return _0x432ee6!==_0x4af0a6;},'pxSqS':_0x4d2b1e(0x3a3),'qEsYJ':_0x4d2b1e(0x160),'BYMnk':_0x4d2b1e(0x214),'bfaec':_0x4d2b1e(0x27e),'KzIEt':_0x4d2b1e(0x1cb),'QKVNZ':_0x4d2b1e(0x296),'iRlib':function(_0x49557d){return _0x49557d();},'hqWTN':function(_0x505d96,_0x44d7ae){return _0x505d96!==_0x44d7ae;},'pEAhr':_0x4d2b1e(0x155),'ZBQBn':_0x4d2b1e(0x1f7)};if(!questionsData||_0x1a2ab8['crwkU'](questionsData['length'],0x0)){document[_0x4d2b1e(0xe3)](_0x1a2ab8[_0x4d2b1e(0x29a)])[_0x4d2b1e(0x278)]=_0x1a2ab8['aPwOj'];return;};const _0x38c8d3=questionsData[currentQuestionIndex];questionStartTime=Date[_0x4d2b1e(0x3b5)](),selectedOption=questionStates[currentQuestionIndex][_0x4d2b1e(0x1c2)];const _0x157413=_0x1a2ab8[_0x4d2b1e(0x30f)](_0x1a2ab8[_0x4d2b1e(0x17e)](_0x1a2ab8[_0x4d2b1e(0x139)](currentQuestionIndex,0x1),questionsData[_0x4d2b1e(0x371)]),0x64);document[_0x4d2b1e(0xe3)](_0x1a2ab8[_0x4d2b1e(0x260)])['style']['width']=_0x157413+'%',document[_0x4d2b1e(0xe3)](_0x1a2ab8['IYfxP'])[_0x4d2b1e(0x19e)]=_0x1a2ab8[_0x4d2b1e(0x2d9)](currentQuestionIndex,0x1),updateQuestionNav(),document['getElementById'](_0x1a2ab8[_0x4d2b1e(0x32b)])[_0x4d2b1e(0x1e8)]=_0x1a2ab8[_0x4d2b1e(0x24b)](currentQuestionIndex,0x0),document[_0x4d2b1e(0xe3)](_0x1a2ab8[_0x4d2b1e(0x372)])[_0x4d2b1e(0x2e3)][_0x4d2b1e(0x35f)](_0x1a2ab8['pIgJj']),document['getElementById'](_0x1a2ab8[_0x4d2b1e(0x29a)])[_0x4d2b1e(0x278)]=_0x38c8d3[_0x4d2b1e(0x136)]||_0x1a2ab8['UrRyC'];let _0x5131cb='';if(_0x38c8d3[_0x4d2b1e(0x239)])_0x5131cb+=_0x4d2b1e(0x1c9)+_0x38c8d3[_0x4d2b1e(0x239)]+_0x4d2b1e(0x268);if(_0x38c8d3[_0x4d2b1e(0x185)])_0x5131cb+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x38c8d3[_0x4d2b1e(0x185)]+_0x4d2b1e(0x33b);if(_0x38c8d3[_0x4d2b1e(0x223)]){if(_0x1a2ab8[_0x4d2b1e(0x21a)](_0x1a2ab8['pxSqS'],_0x1a2ab8[_0x4d2b1e(0x1f2)]))_0x38c8d3['question_images']['forEach'](_0x152229=>{const _0x4b86dd=_0x4d2b1e,_0x41fe77={'QnoUY':_0x1a2ab8[_0x4b86dd(0x1ef)],'JuKPk':function(_0x19cdce,_0x59d47c){return _0x1a2ab8['SfkpQ'](_0x19cdce,_0x59d47c);},'yotbE':_0x1a2ab8[_0x4b86dd(0xfe)],'gAQvV':function(_0x533e45,_0x2f955b){const _0x4158a1=_0x4b86dd;return _0x1a2ab8[_0x4158a1(0x179)](_0x533e45,_0x2f955b);},'cdfyl':_0x1a2ab8[_0x4b86dd(0x27a)]};if(_0x1a2ab8['gQHjz'](_0x4b86dd(0x1ad),_0x1a2ab8[_0x4b86dd(0x31b)])){if(_0x152229)_0x5131cb+=_0x4b86dd(0xf9)+_0x152229+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else{if(_0x1a2ab8['ulIab'](_0x95dd4d,_0x1a2ab8[_0x4b86dd(0x27d)])&&_0x1a2ab8[_0x4b86dd(0x1f0)](_0x2c10cc,_0x1a2ab8['sAPEI']))return;const _0x543a8a=_0x3d4a60[_0x4b86dd(0xe3)](_0x1a2ab8[_0x4b86dd(0x31c)]),_0x39fe72=_0x543a8a[_0x4b86dd(0x287)](_0x1a2ab8[_0x4b86dd(0x28d)]),_0x70120a=_0x4c0b83[_0x5f4fc2],_0x38ef15=_0x70120a[_0x4b86dd(0x286)];let _0x47e4de=_0x70120a[_0x4b86dd(0xff)]['findIndex'](_0x4d26c6=>_0x4d26c6['id']===_0x38ef15);_0x543a8a['classList'][_0x4b86dd(0x35f)](_0x4b86dd(0x214)),_0x39fe72[_0x4b86dd(0x146)]((_0x4f32c3,_0x21c38e)=>{const _0x1897eb=_0x4b86dd;_0x4f32c3[_0x1897eb(0x2e3)][_0x1897eb(0x12a)](_0x41fe77[_0x1897eb(0x3a7)]);if(_0x41fe77[_0x1897eb(0x23e)](_0x21c38e,_0x47e4de))_0x4f32c3[_0x1897eb(0x2e3)][_0x1897eb(0x35f)](_0x41fe77[_0x1897eb(0x16f)]);else{if(_0x41fe77[_0x1897eb(0x29d)](_0x21c38e,_0x5ba209)&&!_0x1487e2)_0x4f32c3[_0x1897eb(0x2e3)][_0x1897eb(0x35f)](_0x41fe77['cdfyl']);}}),_0x1a2ab8[_0x4b86dd(0x37d)](_0xc419eb);}});else{if(_0x1a2ab8[_0x4d2b1e(0x1f0)](_0xda8b57['selectedAnswer'],null))_0x3fb67b=_0x4d2b1e(0xf4);else _0x1bd250='nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20';}}document['getElementById']('questionMedia')['innerHTML']=_0x5131cb;const _0x2c32e0=document[_0x4d2b1e(0xe3)](_0x1a2ab8[_0x4d2b1e(0x31c)]);_0x2c32e0['innerHTML']='',_0x2c32e0[_0x4d2b1e(0x2e3)]['remove'](_0x1a2ab8['BYMnk']);if(_0x38c8d3[_0x4d2b1e(0xff)]&&Array['isArray'](_0x38c8d3[_0x4d2b1e(0xff)])){if(_0x1a2ab8[_0x4d2b1e(0x381)]===_0x1a2ab8['KzIEt']){_0x3e7b08[_0x4d2b1e(0x386)]++,_0x4d09ba[_0x4d2b1e(0x251)]--;if(_0x52c6ac)_0x5a3baf[_0x4d2b1e(0x206)]++;else _0xec8a44[_0x4d2b1e(0x36c)]++;}else _0x38c8d3[_0x4d2b1e(0xff)][_0x4d2b1e(0x146)]((_0x5658ce,_0x104a31)=>{const _0x1429b7=_0x4d2b1e,_0x2f2ac3=String['fromCharCode'](_0x1a2ab8['WPfAc'](0x41,_0x104a31)),_0x45481c=_0x1a2ab8[_0x1429b7(0x179)](selectedOption,_0x104a31),_0xd593fa=document['createElement'](_0x1a2ab8[_0x1429b7(0x2d1)]);_0xd593fa[_0x1429b7(0x278)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x45481c?_0x1a2ab8[_0x1429b7(0x1ef)]:'')+_0x1429b7(0x288)+_0x104a31+_0x1429b7(0x2c4)+_0x2f2ac3+_0x1429b7(0x2b2)+(_0x5658ce[_0x1429b7(0x136)]||_0x1a2ab8[_0x1429b7(0x1de)](_0x1a2ab8['cCLot'],_0x1a2ab8[_0x1429b7(0x139)](_0x104a31,0x1)))+_0x1429b7(0x246),_0x2c32e0[_0x1429b7(0x11d)](_0xd593fa);}),_0x2c32e0['addEventListener'](_0x1a2ab8[_0x4d2b1e(0x36b)],function(_0x5f1ae4){const _0x4020f0=_0x4d2b1e,_0x349857=_0x5f1ae4[_0x4020f0(0x15f)][_0x4020f0(0x2b6)](_0x1a2ab8[_0x4020f0(0x28d)]);if(_0x349857){const _0x43333e=_0x1a2ab8[_0x4020f0(0x27c)](parseInt,_0x349857['getAttribute'](_0x4020f0(0x3a2)));_0x1a2ab8[_0x4020f0(0x27c)](selectOption,_0x43333e);}});}updateBookmarkButton(),_0x1a2ab8[_0x4d2b1e(0x343)](updateMarkReviewButton),(currentMode===_0x4d2b1e(0x2c0)||_0x1a2ab8[_0x4d2b1e(0x24b)](currentMode,_0x4d2b1e(0x314)))&&!isQuizCompleted&&(_0x1a2ab8['hqWTN'](_0x1a2ab8[_0x4d2b1e(0x34f)],_0x1a2ab8[_0x4d2b1e(0x2bb)])?startTimer():(_0xeed9c5(),_0x354f48[_0x4d2b1e(0xe3)](_0x1a2ab8[_0x4d2b1e(0x1b0)])[_0x4d2b1e(0x22d)]['display']=_0x1a2ab8[_0x4d2b1e(0x2c2)]));}function selectOption(_0x25d5e1){const _0x3e1588=_0x357c09,_0x1377b5={'xTgTK':_0x3e1588(0x2a8),'MSibm':_0x3e1588(0x219),'bkPBk':function(_0x9ef422,_0x326703){return _0x9ef422(_0x326703);},'zTycK':_0x3e1588(0x3a2),'qJRmG':function(_0x5a2881,_0x53a6cd){return _0x5a2881(_0x53a6cd);},'HRlnR':'Option\x20','AolNf':'click','uUMTa':function(_0x43526f,_0x51557f){return _0x43526f===_0x51557f;},'IDVSE':_0x3e1588(0x13f),'JKCdZ':function(_0x32f8d7,_0x2a9469){return _0x32f8d7-_0x2a9469;},'tUcfU':_0x3e1588(0x187),'OuWwN':function(_0x57e6f4){return _0x57e6f4();},'pfTgH':function(_0x2ea33f,_0x13253c){return _0x2ea33f!==_0x13253c;},'QLSce':'HzXmi','ixdzL':'not_attempted','eVdHR':'answered','sRFlw':function(_0x1f3def){return _0x1f3def();}},_0x3e52ff=document[_0x3e1588(0xe3)]('optionsContainer');if(_0x3e52ff[_0x3e1588(0x2e3)][_0x3e1588(0x2c5)](_0x3e1588(0x214)))return;if(questionStartTime){if(_0x1377b5[_0x3e1588(0x35d)](_0x1377b5[_0x3e1588(0x128)],_0x3e1588(0x13f)))questionStates[currentQuestionIndex]['timeSpent']+=_0x1377b5[_0x3e1588(0x307)](Date[_0x3e1588(0x3b5)](),questionStartTime),questionStartTime=Date[_0x3e1588(0x3b5)]();else{const _0x314af4=_0x169dc1?function(){const _0x825661=_0x3e1588;if(_0x22aea6){const _0xadf54e=_0x2c6547[_0x825661(0x2ed)](_0x3f7422,arguments);return _0x4820a1=null,_0xadf54e;}}:function(){};return _0x2a52ec=![],_0x314af4;}}selectedOption=_0x25d5e1,questionStates[currentQuestionIndex]['selectedAnswer']=_0x25d5e1,document[_0x3e1588(0x287)](_0x1377b5[_0x3e1588(0x265)])['forEach']((_0x2c314f,_0x14fb17)=>{const _0x6565c4=_0x3e1588;_0x2c314f['classList'][_0x6565c4(0x32c)](_0x1377b5['xTgTK'],_0x14fb17===_0x25d5e1);});if(currentMode===_0x1377b5[_0x3e1588(0x34c)]||_0x1377b5[_0x3e1588(0x35d)](currentMode,'timed_study'))_0x1377b5[_0x3e1588(0x35c)](processAnswer);else{if(_0x1377b5[_0x3e1588(0x34a)](_0x1377b5[_0x3e1588(0x186)],_0x1377b5[_0x3e1588(0x186)])){const _0x25dbea={'yMIxe':_0x1377b5[_0x3e1588(0x2f1)],'ZYQMK':_0x1377b5['HRlnR'],'OZmDf':function(_0x52b0e0,_0x1a186e){return _0x52b0e0+_0x1a186e;}};_0x10d742[_0x3e1588(0xff)][_0x3e1588(0x146)]((_0x8c7439,_0x34125b)=>{const _0x38fe41=_0x3e1588,_0x4434ec=_0x10466b[_0x38fe41(0x354)](0x41+_0x34125b),_0x5b5bca=_0x29b7e2===_0x34125b,_0x140009=_0x534685['createElement'](_0x38fe41(0x259));_0x140009['innerHTML']=_0x38fe41(0x258)+(_0x5b5bca?_0x25dbea['yMIxe']:'')+_0x38fe41(0x288)+_0x34125b+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x4434ec+_0x38fe41(0x2b2)+(_0x8c7439[_0x38fe41(0x136)]||_0x25dbea[_0x38fe41(0x1d6)]+_0x25dbea[_0x38fe41(0x2d2)](_0x34125b,0x1))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0xf896f8['appendChild'](_0x140009);}),_0x27f52e[_0x3e1588(0x257)](_0x1377b5[_0x3e1588(0x166)],function(_0x8e2565){const _0x4b4a5a=_0x3e1588,_0x391cb3=_0x8e2565[_0x4b4a5a(0x15f)][_0x4b4a5a(0x2b6)](_0x1377b5[_0x4b4a5a(0x265)]);if(_0x391cb3){const _0x59af19=_0x1377b5['bkPBk'](_0x3ed9bd,_0x391cb3[_0x4b4a5a(0x2cd)](_0x1377b5[_0x4b4a5a(0x2a2)]));_0x1377b5[_0x4b4a5a(0x17b)](_0x2fa60a,_0x59af19);}});}else questionStates[currentQuestionIndex][_0x3e1588(0x298)]===_0x1377b5[_0x3e1588(0x225)]&&(questionStates[currentQuestionIndex][_0x3e1588(0x298)]=_0x1377b5[_0x3e1588(0x12c)],stats['totalAttempted']++,stats[_0x3e1588(0x251)]--),updateQuestionNav();}_0x1377b5[_0x3e1588(0x16a)](saveProgress);}function processAnswer(){const _0x3a671f=_0x357c09,_0x2fd458={'SYCSQ':function(_0x304c3b,_0x2ebb88){return _0x304c3b===_0x2ebb88;},'iSUXr':'not_attempted','nejwi':function(_0x5c7126,_0x584426){return _0x5c7126!==_0x584426;},'MvULI':'IeAqr','LGHff':_0x3a671f(0x198),'inoAh':function(_0x2696ae){return _0x2696ae();}},_0x32c4c4=questionsData[currentQuestionIndex],_0x8d14a5=_0x32c4c4['correct_choice_id'];if(_0x2fd458['SYCSQ'](selectedOption,null))return;const _0x52f55a=_0x32c4c4[_0x3a671f(0xff)][selectedOption],_0x439f9c=_0x2fd458['SYCSQ'](_0x52f55a['id'],_0x8d14a5);if(_0x2fd458['SYCSQ'](questionStates[currentQuestionIndex]['status'],_0x2fd458['iSUXr'])){if(_0x2fd458[_0x3a671f(0x3ac)](_0x2fd458['MvULI'],_0x3a671f(0x36a))){stats[_0x3a671f(0x386)]++,stats[_0x3a671f(0x251)]--;if(_0x439f9c)stats[_0x3a671f(0x206)]++;else stats[_0x3a671f(0x36c)]++;}else{if(_0x191072){const _0x560e5c=_0x10e400[_0x3a671f(0x2ed)](_0x15b427,arguments);return _0x4c4c68=null,_0x560e5c;}}}questionStates[currentQuestionIndex]['status']=_0x439f9c?'correct':_0x2fd458[_0x3a671f(0x1af)],updateStats(),showInlineFeedback(_0x439f9c),_0x2fd458['inoAh'](updateQuestionNav);}function showInlineFeedback(_0x39ba20){const _0x296001=_0x357c09,_0x43dca4={'hdCJZ':_0x296001(0x2a8),'rSuSj':_0x296001(0x11a),'DmeAL':function(_0x4b701b,_0x5a375d){return _0x4b701b===_0x5a375d;},'GfxfY':_0x296001(0x198),'jcWqR':function(_0x401dc8,_0x240db7){return _0x401dc8!==_0x240db7;},'nEZom':_0x296001(0x187),'KdzBw':'timed_study','HaFza':_0x296001(0x219),'SomnX':_0x296001(0x214),'AWhAc':function(_0x5ac193){return _0x5ac193();}};if(_0x43dca4['jcWqR'](currentMode,_0x43dca4[_0x296001(0x380)])&&_0x43dca4[_0x296001(0x2f5)](currentMode,_0x43dca4[_0x296001(0x107)]))return;const _0x548be6=document[_0x296001(0xe3)](_0x296001(0x1a5)),_0x4f989a=_0x548be6[_0x296001(0x287)](_0x43dca4[_0x296001(0x200)]),_0x39fe2b=questionsData[currentQuestionIndex],_0x249470=_0x39fe2b['correct_choice_id'];let _0x2b74a8=_0x39fe2b['choices']['findIndex'](_0x545a79=>_0x545a79['id']===_0x249470);_0x548be6['classList']['add'](_0x43dca4[_0x296001(0x36f)]),_0x4f989a[_0x296001(0x146)]((_0x50c4cc,_0x317cdc)=>{const _0xa3d740=_0x296001;_0x50c4cc[_0xa3d740(0x2e3)]['remove'](_0x43dca4['hdCJZ']);if(_0x317cdc===_0x2b74a8)_0x50c4cc[_0xa3d740(0x2e3)]['add'](_0x43dca4[_0xa3d740(0x308)]);else{if(_0x43dca4[_0xa3d740(0x25a)](_0x317cdc,selectedOption)&&!_0x39ba20)_0x50c4cc['classList']['add'](_0x43dca4['GfxfY']);}}),_0x43dca4[_0x296001(0x2b1)](showSolution);}function showSolution(){const _0x39af1f=_0x357c09,_0x132d59={'NYUcA':function(_0xc44bbb,_0xd90dca){return _0xc44bbb(_0xd90dca);},'niDZV':_0x39af1f(0x230),'hmhqG':function(_0x59f9f7){return _0x59f9f7();},'FveqZ':'bookmarkedQuestions','tXmjw':function(_0x1d6305,_0x1cd7dd){return _0x1d6305!==_0x1cd7dd;},'JlMxA':_0x39af1f(0x2c0),'NZJls':_0x39af1f(0x1d3),'bCXVQ':_0x39af1f(0x275),'cHTsC':_0x39af1f(0x1e1),'SnErk':_0x39af1f(0x3a6),'DIGOT':function(_0x9dc5d5,_0xffcbf3){return _0x9dc5d5===_0xffcbf3;},'Zfvcr':_0x39af1f(0x2cc),'loggo':'VeBjj','imxya':function(_0x17c9cf,_0x322292,_0x58bc1b){return _0x17c9cf(_0x322292,_0x58bc1b);},'UooNm':_0x39af1f(0x1e4),'dpAKO':_0x39af1f(0x35e),'tXXVe':function(_0x1c0822,_0x49a2a2){return _0x1c0822===_0x49a2a2;},'fPmFL':_0x39af1f(0x30d),'Jlula':_0x39af1f(0x320)};if(_0x132d59[_0x39af1f(0x213)](currentMode,'study')&&currentMode!==_0x132d59[_0x39af1f(0x3b2)])return;const _0x41e860=questionsData[currentQuestionIndex];document['getElementById'](_0x132d59[_0x39af1f(0x113)])['innerHTML']=_0x41e860[_0x39af1f(0x2ff)]||_0x132d59['bCXVQ'];const _0x2985b7=document[_0x39af1f(0xe3)](_0x132d59[_0x39af1f(0x110)]),_0x175f42=document['getElementById'](_0x132d59[_0x39af1f(0x218)]),_0x2e5956=_0x41e860[_0x39af1f(0x3aa)];if(_0x2e5956){if(_0x132d59[_0x39af1f(0x109)](_0x132d59['Zfvcr'],_0x132d59[_0x39af1f(0x19d)]))_0x132d59[_0x39af1f(0x2e2)](_0x1466d0,_0x132d59[_0x39af1f(0x1aa)])&&(_0x4eba24=0x0,_0x132d59[_0x39af1f(0x19f)](_0x45db29),_0x28e07e());else{_0x2985b7[_0x39af1f(0x2e3)]['remove'](_0x39af1f(0x1e4));if(_0x2e5956[_0x39af1f(0x269)](_0x39af1f(0x182)))_0x132d59[_0x39af1f(0x18e)](setupVideo,_0x175f42,_0x2e5956);else _0x175f42[_0x39af1f(0x349)]=_0x2e5956;}}else _0x2985b7['classList']['add'](_0x132d59['UooNm']);const _0x11d007=document[_0x39af1f(0xe3)](_0x132d59[_0x39af1f(0x373)]);_0x11d007[_0x39af1f(0x278)]='';if(_0x41e860[_0x39af1f(0x1c8)]){if(_0x132d59[_0x39af1f(0x237)](_0x132d59[_0x39af1f(0x302)],_0x39af1f(0x30d)))_0x11d007['innerHTML']+=_0x39af1f(0x366)+_0x41e860[_0x39af1f(0x1c8)]+_0x39af1f(0x268);else{const _0x5868d9=!_0x24bc0c[_0x566860]['bookmarked'];_0x4e1862[_0x1e00cb][_0x39af1f(0x299)]=_0x5868d9;let _0x73ad47=_0x54ab0a[_0x39af1f(0x111)](_0x24ebdb[_0x39af1f(0x2b4)](_0x132d59[_0x39af1f(0x2c9)]))||[];if(_0x5868d9){const _0x7a6e11={'quizName':_0x53905a,'quizFile':_0x4ba88b[_0x39af1f(0x357)]['pathname'][_0x39af1f(0x1be)]('/')[_0x39af1f(0x39a)](),'questionIndex':_0x37da3c,'question':_0x481d32[_0x413b56],'hierarchy':_0xaca020,'timestamp':_0x2b6a8c[_0x39af1f(0x3b5)]()};_0x73ad47[_0x39af1f(0x14e)](_0x7a6e11);}else _0x73ad47=_0x73ad47[_0x39af1f(0x26c)](_0x632144=>!(_0x632144[_0x39af1f(0x2e4)]['includes'](_0x53471[_0x39af1f(0xed)]()[_0x39af1f(0x1b9)](/ /g,'-'))&&_0x632144[_0x39af1f(0x1f1)]===_0x2047fe));_0x5755ba[_0x39af1f(0x22b)](_0x132d59['FveqZ'],_0xdc0d3b[_0x39af1f(0x238)](_0x73ad47)),_0x132d59[_0x39af1f(0x19f)](_0x281b81),_0xb1a633();}}_0x41e860[_0x39af1f(0x21b)]&&(_0x11d007['innerHTML']+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22'+_0x41e860[_0x39af1f(0x21b)]+_0x39af1f(0x268));const _0x52ff21=document[_0x39af1f(0xe3)](_0x132d59[_0x39af1f(0x2f8)]);_0x52ff21[_0x39af1f(0x278)]='',_0x41e860[_0x39af1f(0xec)]&&_0x41e860[_0x39af1f(0xec)]['forEach'](_0x434270=>{const _0x1a5864=_0x39af1f;if(_0x434270)_0x52ff21['innerHTML']+=_0x1a5864(0x249)+_0x434270+_0x1a5864(0x15c);}),document['getElementById']('solutionContainer')[_0x39af1f(0x2e3)]['remove'](_0x39af1f(0x1e4));}function submitQuiz(){const _0x4cef41=_0x357c09,_0x588ef4={'FCGsQ':function(_0x2736ea,_0x5a62c7){return _0x2736ea!==_0x5a62c7;},'GfuEI':function(_0x4176a5,_0x483dba){return _0x4176a5===_0x483dba;},'EHaLC':'correct','zRaNq':_0x4cef41(0x198),'asEiz':function(_0x4d4628,_0x47f7df){return _0x4d4628(_0x47f7df);},'COmjf':_0x4cef41(0x14b),'TFWwI':function(_0x4f924a,_0x532922){return _0x4f924a-_0x532922;},'SBpNb':_0x4cef41(0x10f),'szlLv':function(_0x212d9e,_0x2d6e8e){return _0x212d9e+_0x2d6e8e;},'ZLvqj':function(_0x59f21e,_0x4bdd1e,_0x25dddc,_0x2efc1a,_0x33f02c){return _0x59f21e(_0x4bdd1e,_0x25dddc,_0x2efc1a,_0x33f02c);},'WpjqV':function(_0x242339,_0x1e2b15){return _0x242339-_0x1e2b15;},'HrWbr':function(_0xf4a62c,_0x294b39){return _0xf4a62c+_0x294b39;}};if(timer)_0x588ef4[_0x4cef41(0x1cd)](clearInterval,timer);if(!_0x588ef4['asEiz'](confirm,_0x588ef4['COmjf']))return;isQuizCompleted=!![];let _0x1f7f9a=0x0,_0x2cb15f=0x0;const _0x40553e=_0x588ef4[_0x4cef41(0x3a0)](Date[_0x4cef41(0x3b5)](),quizStartTime);questionsData[_0x4cef41(0x146)]((_0x3000bb,_0x1a9258)=>{const _0x11bbf2=_0x4cef41,_0x3420e2=questionStates[_0x1a9258];_0x588ef4[_0x11bbf2(0x1bd)](_0x3420e2[_0x11bbf2(0x1c2)],null)&&(_0x588ef4['GfuEI'](_0x3000bb[_0x11bbf2(0xff)][_0x3420e2[_0x11bbf2(0x1c2)]]['id'],_0x3000bb[_0x11bbf2(0x286)])?(_0x1f7f9a++,_0x3420e2['status']=_0x588ef4[_0x11bbf2(0x18d)]):(_0x2cb15f++,_0x3420e2[_0x11bbf2(0x298)]=_0x588ef4['zRaNq']));});const _0x4a6e8f=JSON[_0x4cef41(0x111)](localStorage['getItem'](_0x588ef4[_0x4cef41(0x344)]))||[];_0x4a6e8f[_0x4cef41(0x14e)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x4cef41(0x3b5)](),'totalTime':_0x40553e,'stats':{'correct':_0x1f7f9a,'incorrect':_0x2cb15f,'notAttempted':questionsData['length']-_0x588ef4['szlLv'](_0x1f7f9a,_0x2cb15f)}}),localStorage[_0x4cef41(0x22b)](_0x588ef4[_0x4cef41(0x344)],JSON['stringify'](_0x4a6e8f)),stats['correctAnswers']=_0x1f7f9a,stats['incorrectAnswers']=_0x2cb15f,markQuizAsCompleted(),_0x588ef4['ZLvqj'](showPerformanceAnalysis,_0x1f7f9a,_0x2cb15f,_0x588ef4[_0x4cef41(0x168)](questionsData[_0x4cef41(0x371)],_0x588ef4[_0x4cef41(0x3a9)](_0x1f7f9a,_0x2cb15f)),_0x40553e);}function showPerformanceAnalysis(_0x494bcd,_0x1afa44,_0x1f4965,_0x5b7cf1){const _0x42ec65=_0x357c09,_0x159808={'iWLre':'performanceModal','utCIo':function(_0x181a54,_0x333553){return _0x181a54>_0x333553;},'iDSxT':function(_0x3e6cdc,_0x437de7){return _0x3e6cdc+_0x437de7;},'wsVgr':function(_0x39d39f,_0x5ec68c){return _0x39d39f/_0x5ec68c;},'IeHxK':function(_0x3f8a56,_0xbccbc0){return _0x3f8a56+_0xbccbc0;},'uMaEH':function(_0x43b309,_0x1ab101){return _0x43b309*_0x1ab101;},'PplTE':function(_0x425232,_0x3e80c9){return _0x425232*_0x3e80c9;},'fOavv':_0x42ec65(0x1b7),'UCgtp':function(_0x1af6c8,_0x14360c){return _0x1af6c8-_0x14360c;},'LGwit':function(_0x2bf87c,_0x35f4c6){return _0x2bf87c*_0x35f4c6;},'PyNcR':'accuracyScore','yFDtL':'totalQuestionsResult','SXBoH':_0x42ec65(0x2d6),'FNrwS':'incorrectResult','papfO':_0x42ec65(0x378),'XurOB':_0x42ec65(0x2b3),'ElGDJ':function(_0x442a46,_0x542bbf){return _0x442a46/_0x542bbf;},'ZXFiz':function(_0x30b96e,_0x220d6d){return _0x30b96e%_0x220d6d;}},_0x15a20d=document[_0x42ec65(0xe3)](_0x159808[_0x42ec65(0x12b)]),_0x508bfe=_0x159808[_0x42ec65(0x13a)](_0x159808[_0x42ec65(0x211)](_0x494bcd,_0x1afa44),0x0)?Math[_0x42ec65(0x368)](_0x159808[_0x42ec65(0x1ae)](_0x494bcd,_0x159808[_0x42ec65(0x1fa)](_0x494bcd,_0x1afa44))*0x64):0x0,_0x677fff=_0x159808[_0x42ec65(0x24d)](_0x159808[_0x42ec65(0x245)](0x2,Math['PI']),0x41),_0x2c7e6e=document['getElementById'](_0x159808['fOavv']);_0x2c7e6e[_0x42ec65(0x22d)][_0x42ec65(0x334)]=_0x677fff+'\x20'+_0x677fff,_0x2c7e6e['style']['strokeDashoffset']=_0x159808[_0x42ec65(0x252)](_0x677fff,_0x159808[_0x42ec65(0x18c)](_0x159808[_0x42ec65(0x1ae)](_0x508bfe,0x64),_0x677fff)),document[_0x42ec65(0xe3)](_0x159808[_0x42ec65(0x29f)])[_0x42ec65(0x19e)]=_0x508bfe+'%',document[_0x42ec65(0xe3)](_0x159808[_0x42ec65(0x2b9)])[_0x42ec65(0x19e)]=questionsData[_0x42ec65(0x371)],document['getElementById'](_0x159808[_0x42ec65(0x3a8)])[_0x42ec65(0x19e)]=_0x494bcd,document[_0x42ec65(0xe3)](_0x159808[_0x42ec65(0x1ab)])['textContent']=_0x1afa44,document[_0x42ec65(0xe3)](_0x159808['papfO'])['textContent']=_0x1f4965;const _0x51a397=Math['floor'](_0x159808[_0x42ec65(0x1ae)](_0x5b7cf1,0xea60)),_0x1250db=Math[_0x42ec65(0x2fb)](_0x159808[_0x42ec65(0x1ae)](_0x5b7cf1%0xea60,0x3e8));document[_0x42ec65(0xe3)](_0x159808['XurOB'])[_0x42ec65(0x19e)]=_0x51a397+':'+_0x1250db[_0x42ec65(0x35a)]()[_0x42ec65(0x1b3)](0x2,'0');const _0x5d2901=_0x5b7cf1/questionsData[_0x42ec65(0x371)],_0xad7268=Math['floor'](_0x159808[_0x42ec65(0x1ae)](_0x5d2901,0xea60)),_0x59157d=Math[_0x42ec65(0x2fb)](_0x159808[_0x42ec65(0x1a1)](_0x159808[_0x42ec65(0x22e)](_0x5d2901,0xea60),0x3e8));document[_0x42ec65(0xe3)](_0x42ec65(0x2bd))[_0x42ec65(0x19e)]=_0xad7268+':'+_0x59157d[_0x42ec65(0x35a)]()[_0x42ec65(0x1b3)](0x2,'0'),_0x15a20d[_0x42ec65(0x2e3)][_0x42ec65(0x12a)](_0x42ec65(0x1e4));}function closePerformanceModal(){const _0x5f4846=_0x357c09,_0x4a846a={'eaoRc':_0x5f4846(0x20d),'ZNNGH':_0x5f4846(0x1e4)};document[_0x5f4846(0xe3)](_0x4a846a['eaoRc'])[_0x5f4846(0x2e3)][_0x5f4846(0x35f)](_0x4a846a['ZNNGH']);}function reviewQuestions(){const _0x2e878c=_0x357c09,_0x1abd70={'YSZFY':function(_0x200844,_0x40017a){return _0x200844===_0x40017a;},'sRjKe':_0x2e878c(0x267),'gYmtS':'GVXxE','BCLRE':_0x2e878c(0x1ca),'Ceday':_0x2e878c(0x187),'sNxOs':_0x2e878c(0x2c0),'cOVZO':_0x2e878c(0x106),'mHwhb':_0x2e878c(0x386),'pjoxW':function(_0x2c5727,_0xd15899){return _0x2c5727>_0xd15899;},'HVREL':function(_0x52f411,_0x14219f){return _0x52f411*_0x14219f;},'jovmG':_0x2e878c(0x21f),'flXeC':function(_0x4832e1,_0x3c23cf){return _0x4832e1/_0x3c23cf;},'QfRbG':function(_0x43e330,_0x84252c){return _0x43e330%_0x84252c;},'qwsUP':function(_0x536e38,_0x38ad33){return _0x536e38!==_0x38ad33;},'fCUCo':_0x2e878c(0x1ee),'jIrPD':_0x2e878c(0x13b),'UbJhj':_0x2e878c(0x384),'UorWD':_0x2e878c(0x2f3),'GPTSM':_0x2e878c(0x11a),'WgOIv':_0x2e878c(0x135),'EbDaQ':_0x2e878c(0x198),'LWTmi':_0x2e878c(0x396),'pOMeJ':_0x2e878c(0x259),'pOooh':function(_0x56c11f,_0x59d9eb){return _0x56c11f+_0x59d9eb;},'WtPii':_0x2e878c(0x33f),'dBOgd':function(_0x28e86c,_0x558176){return _0x28e86c===_0x558176;},'OPcwc':_0x2e878c(0x28b),'PhfAD':_0x2e878c(0x329),'thLvc':_0x2e878c(0x1e4),'WAQbU':_0x2e878c(0x210),'xduqT':function(_0x4d31e4){return _0x4d31e4();}};document[_0x2e878c(0xe3)](_0x2e878c(0x12d))[_0x2e878c(0x2e3)][_0x2e878c(0x12a)](_0x1abd70[_0x2e878c(0x15e)]);const _0x31f69e=document['getElementById'](_0x1abd70[_0x2e878c(0x18f)]);_0x31f69e[_0x2e878c(0x278)]='',questionsData[_0x2e878c(0x146)]((_0x3246a9,_0x2517bd)=>{const _0x46b793=_0x2e878c,_0x3e02de={'QXuhv':function(_0x352499,_0xef0d6e){return _0x1abd70['YSZFY'](_0x352499,_0xef0d6e);},'FMKok':_0x1abd70['sRjKe'],'UQVxl':_0x1abd70['gYmtS'],'CtFOe':function(_0x42ebe5,_0x581f72){const _0x4218f4=_0x184b;return _0x1abd70[_0x4218f4(0x117)](_0x42ebe5,_0x581f72);},'OYQWy':function(_0x31cd03,_0x3036c1){return _0x31cd03===_0x3036c1;},'whUCH':_0x1abd70['BCLRE'],'MrbAB':_0x46b793(0x2d4),'ntSJk':function(_0x375701,_0x30c663){return _0x375701+_0x30c663;},'IKSNk':function(_0x2ac845,_0x597f22){const _0x43cb82=_0x46b793;return _0x1abd70[_0x43cb82(0x117)](_0x2ac845,_0x597f22);},'psvLM':_0x1abd70[_0x46b793(0x21d)],'MPSam':_0x1abd70[_0x46b793(0x391)],'COYdt':_0x1abd70[_0x46b793(0x361)],'FrOTo':_0x46b793(0x173),'iLCEb':_0x1abd70['mHwhb'],'JjTNA':function(_0x3c9d6e,_0x12f377){const _0xcd7c15=_0x46b793;return _0x1abd70[_0xcd7c15(0x121)](_0x3c9d6e,_0x12f377);},'VOGQA':function(_0x2032b4,_0x40b0ba){return _0x1abd70['HVREL'](_0x2032b4,_0x40b0ba);},'YccSG':function(_0x57e702,_0x314970){return _0x57e702/_0x314970;},'xhbNR':_0x1abd70['jovmG'],'UqgtP':function(_0x4da1ba,_0x636eaa){const _0x55f1db=_0x46b793;return _0x1abd70[_0x55f1db(0x26d)](_0x4da1ba,_0x636eaa);},'RWgWz':function(_0x9db65b,_0x32754b){const _0x4e7351=_0x46b793;return _0x1abd70[_0x4e7351(0x1c1)](_0x9db65b,_0x32754b);},'CDspZ':_0x46b793(0x32d)};if(_0x1abd70[_0x46b793(0x370)](_0x1abd70['fCUCo'],_0x1abd70[_0x46b793(0x360)])){const _0xaf2588=questionStates[_0x2517bd],_0x181fae=_0x3246a9[_0x46b793(0x286)];let _0x27fc4a=_0x1abd70[_0x46b793(0x208)],_0x16448f=_0x1abd70[_0x46b793(0x177)];if(_0x1abd70[_0x46b793(0x370)](_0xaf2588['selectedAnswer'],null)){const _0x5ba75e=_0x3246a9[_0x46b793(0xff)][_0xaf2588[_0x46b793(0x1c2)]];_0x1abd70[_0x46b793(0x117)](_0x5ba75e['id'],_0x181fae)?(_0x27fc4a=_0x1abd70[_0x46b793(0x1a8)],_0x16448f=_0x1abd70[_0x46b793(0x2e1)]):(_0x27fc4a=_0x1abd70[_0x46b793(0x188)],_0x16448f=_0x1abd70[_0x46b793(0x254)]);}const _0x35857f=document[_0x46b793(0x39c)](_0x1abd70[_0x46b793(0x241)]);_0x35857f[_0x46b793(0x276)]='review-question\x20'+_0x27fc4a;let _0x3ee46d=(_0x3246a9[_0x46b793(0xff)]||[])['map']((_0x53eb00,_0x5da7d7)=>{const _0x481f4b=_0x46b793;if(_0x3e02de[_0x481f4b(0x14d)](_0x3e02de['FMKok'],_0x3e02de[_0x481f4b(0x105)]))_0x172415();else{const _0x1f70bf=_0x3e02de['CtFOe'](_0xaf2588[_0x481f4b(0x1c2)],_0x5da7d7),_0x1a7f01=_0x3e02de[_0x481f4b(0x20b)](_0x53eb00['id'],_0x181fae);let _0x418266=_0x3e02de[_0x481f4b(0x253)];if(_0x1a7f01)_0x418266=_0x3e02de['MrbAB'];else{if(_0x1f70bf)_0x418266=_0x481f4b(0x221);}return _0x481f4b(0x2ba)+_0x418266+_0x481f4b(0x37a)+String[_0x481f4b(0x354)](_0x3e02de['ntSJk'](0x41,_0x5da7d7))+_0x481f4b(0x262)+_0x53eb00[_0x481f4b(0x136)]+_0x481f4b(0x12e);}})[_0x46b793(0x147)]('');const _0x49476f=_0x3246a9[_0x46b793(0x3aa)]?_0x46b793(0x104)+_0x2517bd+_0x46b793(0x382)+_0x3246a9[_0x46b793(0x3aa)]+_0x46b793(0x1d7):'';let _0x3b502c='';if(_0x3246a9[_0x46b793(0x1c8)])_0x3b502c+=_0x46b793(0x369)+_0x3246a9['explanation_audio_eng']+_0x46b793(0x268);if(_0x3246a9['explanation_audio_hin'])_0x3b502c+=_0x46b793(0x2e7)+_0x3246a9[_0x46b793(0x21b)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x172afb=(_0x3246a9[_0x46b793(0xec)]||[])[_0x46b793(0x1e2)](_0x549fa4=>_0x549fa4?_0x46b793(0x249)+_0x549fa4+_0x46b793(0x15c):'')['join']('');_0x35857f[_0x46b793(0x278)]=_0x46b793(0x22a)+_0x1abd70[_0x46b793(0x3af)](_0x2517bd,0x1)+'</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-'+(_0x1abd70[_0x46b793(0x117)](_0x27fc4a,_0x1abd70[_0x46b793(0x1a8)])?_0x1abd70[_0x46b793(0x315)]:_0x1abd70[_0x46b793(0x129)](_0x27fc4a,_0x1abd70[_0x46b793(0x188)])?_0x1abd70[_0x46b793(0x38d)]:_0x46b793(0x3b0))+_0x46b793(0x379)+_0x16448f+_0x46b793(0x152)+_0x3246a9[_0x46b793(0x136)]+_0x46b793(0x1f6)+_0x3ee46d+_0x46b793(0x232)+(_0x3246a9['solution']||_0x1abd70[_0x46b793(0x1e0)])+_0x46b793(0x325)+_0x49476f+_0x46b793(0x163)+_0x3b502c+_0x46b793(0x163)+_0x172afb+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x31f69e[_0x46b793(0x11d)](_0x35857f);}else{if(_0x3e02de[_0x46b793(0x24a)](_0x4be6b1,_0x3e02de[_0x46b793(0x29e)])||_0x3e02de[_0x46b793(0x24a)](_0x337419,_0x3e02de[_0x46b793(0x2e8)])){_0x4c61cb['getElementById'](_0x3e02de[_0x46b793(0x193)])[_0x46b793(0x19e)]=_0x55dc78['correctAnswers'],_0x33d812[_0x46b793(0xe3)](_0x3e02de[_0x46b793(0x250)])[_0x46b793(0x19e)]=_0x504029['incorrectAnswers'],_0x27845a[_0x46b793(0xe3)](_0x3e02de['iLCEb'])['textContent']=_0x7a666b[_0x46b793(0x386)];const _0x26201f=_0x3e02de[_0x46b793(0x154)](_0x4046fe[_0x46b793(0x386)],0x0)?_0x265674['round'](_0x3e02de[_0x46b793(0x12f)](_0x3e02de['YccSG'](_0x160008[_0x46b793(0x206)],_0x3bc556['totalAttempted']),0x64)):0x0;_0x48ed9c[_0x46b793(0xe3)](_0x3e02de[_0x46b793(0x162)])[_0x46b793(0x19e)]=_0x3e02de[_0x46b793(0x2bc)](_0x26201f,'%'),_0x278408[_0x46b793(0x1d2)]=_0x3a6f87[_0x46b793(0x16b)]((_0x500fdb,_0x2bbcef)=>_0x500fdb+_0x2bbcef[_0x46b793(0x32d)],0x0);const _0x2ba422=_0x263ae3[_0x46b793(0x2fb)](_0x3e02de[_0x46b793(0x1c6)](_0x1bc979[_0x46b793(0x1d2)],0x3e8)),_0x2244b7=_0x5068ff[_0x46b793(0x2fb)](_0x3e02de[_0x46b793(0x2ad)](_0x2ba422,0x3c)),_0x34d8b9=_0x3e02de[_0x46b793(0x2dd)](_0x2ba422,0x3c);_0x4dea64['getElementById'](_0x3e02de[_0x46b793(0x1c5)])[_0x46b793(0x19e)]=_0x3e02de[_0x46b793(0x2bc)](_0x2244b7+':',_0x34d8b9[_0x46b793(0x35a)]()[_0x46b793(0x1b3)](0x2,'0'));}}}),_0x1abd70[_0x2e878c(0x2ca)](initializeReviewVideos);}function initializeReviewVideos(){const _0x161464=_0x357c09,_0x23a71f={'aZvOa':function(_0x88b938,_0x4c2adf){return _0x88b938(_0x4c2adf);},'NHdnQ':_0x161464(0x3a2),'kRPvA':function(_0x3eb1e2,_0xa31aaf){return _0x3eb1e2(_0xa31aaf);},'KQPjA':_0x161464(0x182),'OBGOr':function(_0x31221a,_0x600b72){return _0x31221a===_0x600b72;},'OrrZK':_0x161464(0x13c),'uolHD':_0x161464(0x261)};document['querySelectorAll'](_0x23a71f[_0x161464(0x170)])[_0x161464(0x146)](_0x4da77a=>{const _0x4fc627=_0x161464,_0x38535a=_0x4da77a[_0x4fc627(0x103)][_0x4fc627(0x349)];if(_0x38535a&&_0x38535a[_0x4fc627(0x269)](_0x23a71f[_0x4fc627(0x14f)])){if(_0x23a71f[_0x4fc627(0x26e)]('jyKsQ',_0x23a71f[_0x4fc627(0x1dd)])){const _0xbf2e1c=_0x34d6d0[_0x4fc627(0x15f)][_0x4fc627(0x2b6)]('.option-button');if(_0xbf2e1c){const _0x536787=_0x23a71f[_0x4fc627(0x1f4)](_0xc8d160,_0xbf2e1c[_0x4fc627(0x2cd)](_0x23a71f[_0x4fc627(0x3a1)]));_0x23a71f[_0x4fc627(0x28c)](_0x30275e,_0x536787);}}else setupVideo(_0x4da77a,_0x38535a);}else _0x38535a&&(_0x4da77a[_0x4fc627(0x349)]=_0x38535a);});}function retakeQuiz(){const _0x2c58bc=_0x357c09,_0x4ec056={'RLUuo':function(_0x5ada08,_0x3523ab){return _0x5ada08<_0x3523ab;},'BJevc':function(_0x1b8fac,_0x2e997e){return _0x1b8fac(_0x2e997e);},'qHPCB':_0x2c58bc(0x235),'hHCnZ':_0x2c58bc(0x2b0),'yTMOH':function(_0x1af5d9,_0x28d0d2){return _0x1af5d9===_0x28d0d2;},'GUnbr':_0x2c58bc(0x326),'ORLnT':_0x2c58bc(0x2c7)};_0x4ec056['BJevc'](confirm,_0x4ec056['qHPCB'])&&(window[_0x2c58bc(0x357)]['pathname']['endsWith'](_0x4ec056['hHCnZ'])&&(_0x4ec056[_0x2c58bc(0x167)](_0x2c58bc(0x1d8),_0x4ec056[_0x2c58bc(0x150)])?_0x4b9423[_0x2c58bc(0x2e4)]['includes'](_0x95eca0['toLowerCase']()['replace'](/ /g,'-'))&&(_0x4ec056[_0x2c58bc(0x3a4)](_0x2cf8c2[_0x2c58bc(0x1f1)],_0x36e8c9[_0x2c58bc(0x371)])&&(_0x229014[_0x5c5a63[_0x2c58bc(0x1f1)]][_0x2c58bc(0x299)]=!![])):localStorage[_0x2c58bc(0x215)](_0x4ec056[_0x2c58bc(0x39f)])),clearProgress(),location[_0x2c58bc(0x26b)]());}function loadBookmarkedQuestions(){const _0x4ce313=_0x357c09,_0x1c693a={'iobqL':_0x4ce313(0x11e),'oZMDR':function(_0x199980,_0x3d3507){return _0x199980===_0x3d3507;},'wwGwL':_0x4ce313(0x133),'QAcsd':function(_0x375484,_0x3674fe){return _0x375484===_0x3674fe;},'wWyKz':'mgWZd','SdKBZ':'bookmarkedQuestions'},_0x1971ab=JSON[_0x4ce313(0x111)](localStorage[_0x4ce313(0x2b4)](_0x1c693a['SdKBZ']))||[];_0x1971ab[_0x4ce313(0x146)](_0x301ab2=>{const _0x38a77c=_0x4ce313;if(_0x1c693a[_0x38a77c(0x374)](_0x1c693a[_0x38a77c(0x33c)],_0x1c693a[_0x38a77c(0x33c)])){if(_0x301ab2[_0x38a77c(0x2e4)][_0x38a77c(0x269)](quizName[_0x38a77c(0xed)]()[_0x38a77c(0x1b9)](/ /g,'-'))){if(_0x301ab2[_0x38a77c(0x1f1)]<questionsData[_0x38a77c(0x371)]){if(_0x1c693a['QAcsd'](_0x1c693a[_0x38a77c(0x21c)],_0x38a77c(0x1df))){const _0x218f1c=_0x4287b1[_0x38a77c(0x2ed)](_0xb04fd8,arguments);return _0x146d9d=null,_0x218f1c;}else questionStates[_0x301ab2[_0x38a77c(0x1f1)]]['bookmarked']=!![];}}}else{if(_0x889eb7)return;const _0x390649=_0x5b3642[_0x38a77c(0x111)](_0x32bc90[_0x38a77c(0x2b4)](_0x1c693a[_0x38a77c(0x15d)]))||{};_0x390649[_0x16093e]={'questionStates':_0xe20830,'stats':_0x142925,'currentQuestionIndex':_0x5d0a23,'currentMode':_0x121321,'status':_0x38a77c(0x20e),'lastSeen':new _0x137eb8()['toISOString']()},_0x926710[_0x38a77c(0x22b)](_0x38a77c(0x11e),_0x491c04[_0x38a77c(0x238)](_0x390649));}});}function toggleBookmark(){const _0x491cd0=_0x357c09,_0x467f11={'bUUyX':function(_0x1b26e1,_0x533971){return _0x1b26e1-_0x533971;},'PGkUk':function(_0x584065){return _0x584065();},'fLVQl':function(_0x204568){return _0x204568();},'yWqrT':_0x491cd0(0x2de),'AoslS':function(_0x417caf,_0x51caad){return _0x417caf!==_0x51caad;},'xWBMu':_0x491cd0(0x1db),'hKHGD':_0x491cd0(0x143),'StnTV':_0x491cd0(0x2f2)},_0x5d9ab6=!questionStates[currentQuestionIndex][_0x491cd0(0x299)];questionStates[currentQuestionIndex]['bookmarked']=_0x5d9ab6;let _0x49163f=JSON['parse'](localStorage[_0x491cd0(0x2b4)](_0x467f11[_0x491cd0(0x293)]))||[];if(_0x5d9ab6){if(_0x467f11[_0x491cd0(0x31f)](_0x467f11['xWBMu'],_0x467f11[_0x491cd0(0x2eb)])){const _0x28bb62={'quizName':quizName,'quizFile':window['location'][_0x491cd0(0x1d0)][_0x491cd0(0x1be)]('/')[_0x491cd0(0x39a)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x491cd0(0x3b5)]()};_0x49163f['push'](_0x28bb62);}else{const _0x3f954d=_0x3f68ab[_0x491cd0(0x272)][_0x491cd0(0x2f6)][_0x491cd0(0x195)](_0xe2fa1f),_0x137610=_0x46d98b[_0x26bed6],_0x34843c=_0x1d847e[_0x137610]||_0x3f954d;_0x3f954d[_0x491cd0(0x2a9)]=_0x5739c1['bind'](_0x21b409),_0x3f954d[_0x491cd0(0x35a)]=_0x34843c['toString']['bind'](_0x34843c),_0x9ba321[_0x137610]=_0x3f954d;}}else _0x467f11[_0x491cd0(0x31f)](_0x467f11[_0x491cd0(0x175)],'qrRUp')?(_0xcaf668&&(_0x469af2[_0x2858bc]['timeSpent']+=_0x467f11[_0x491cd0(0x2ec)](_0x55e8ab['now'](),_0x1abd7c)),_0x4b5afe--,_0x467f11[_0x491cd0(0xf6)](_0xafbf26),_0x467f11[_0x491cd0(0x1cc)](_0x11a8d8)):_0x49163f=_0x49163f[_0x491cd0(0x26c)](_0x4d9fbd=>!(_0x4d9fbd[_0x491cd0(0x2e4)][_0x491cd0(0x269)](quizName[_0x491cd0(0xed)]()[_0x491cd0(0x1b9)](/ /g,'-'))&&_0x4d9fbd['questionIndex']===currentQuestionIndex));localStorage[_0x491cd0(0x22b)](_0x467f11[_0x491cd0(0x293)],JSON[_0x491cd0(0x238)](_0x49163f)),_0x467f11[_0x491cd0(0xf6)](updateBookmarkButton),_0x467f11[_0x491cd0(0x1cc)](updateQuestionNav);}function updateBookmarkButton(){const _0x2c5269=_0x357c09,_0x334624={'qnFci':_0x2c5269(0x23b),'NzfXC':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','ORxld':_0x2c5269(0x2c6)},_0x204d92=document[_0x2c5269(0xe3)](_0x334624[_0x2c5269(0x222)]),_0x5bb52c=document[_0x2c5269(0xe3)](_0x2c5269(0x23f)),_0x5bddee=questionStates[currentQuestionIndex][_0x2c5269(0x299)];_0x204d92['className']=_0x5bddee?_0x334624[_0x2c5269(0x383)]:_0x334624[_0x2c5269(0x305)],_0x5bb52c['textContent']=_0x5bddee?_0x2c5269(0x289):_0x2c5269(0x38a);}function toggleMarkForReview(){const _0x18f7f7=_0x357c09,_0x372d0f={'lsAoD':function(_0x11a201){return _0x11a201();}};questionStates[currentQuestionIndex][_0x18f7f7(0x34d)]=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),_0x372d0f[_0x18f7f7(0x2ab)](updateQuestionNav);}function updateMarkReviewButton(){const _0x1701c9=_0x357c09,_0x213ca5={'wjAkT':_0x1701c9(0x157),'vxPNa':_0x1701c9(0x203),'jWlWJ':'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','SoegL':_0x1701c9(0x18b),'ssLHC':_0x1701c9(0x310),'NUNnn':_0x1701c9(0x127)},_0x2e0aca=document[_0x1701c9(0xe3)](_0x213ca5[_0x1701c9(0x2aa)]),_0x53b939=document[_0x1701c9(0xe3)](_0x213ca5['vxPNa']),_0x274e78=questionStates[currentQuestionIndex][_0x1701c9(0x34d)];_0x2e0aca[_0x1701c9(0x276)]=_0x274e78?_0x213ca5[_0x1701c9(0x231)]:_0x213ca5['SoegL'],_0x53b939[_0x1701c9(0x19e)]=_0x274e78?_0x213ca5[_0x1701c9(0x220)]:_0x213ca5['NUNnn'];}function previousQuestion(){const _0xf1e8c3=_0x357c09,_0x2085ac={'LEQbB':_0xf1e8c3(0x23b),'ueYiF':'markReviewBtn','SzVhc':_0xf1e8c3(0x2f4),'SJZaB':function(_0x536000,_0x193f89){return _0x536000===_0x193f89;},'IlRQu':_0xf1e8c3(0x3ae),'gLZaW':function(_0x47e3f7,_0x52d516){return _0x47e3f7===_0x52d516;},'ESJZP':'timed_exam','tqTVF':'statsBar','TQYbf':_0xf1e8c3(0x332),'TrVRE':_0xf1e8c3(0xe5),'xOOKs':_0xf1e8c3(0x130),'umZhi':_0xf1e8c3(0x180),'CTHys':_0xf1e8c3(0x271),'Mbcez':function(_0x3b3873,_0xcf709c){return _0x3b3873===_0xcf709c;},'YrIIB':_0xf1e8c3(0x2c0),'kztiR':function(_0x429308,_0x4da058){return _0x429308===_0x4da058;},'asmst':_0xf1e8c3(0xe7),'dnHEz':'hidden','bEACo':function(_0x3054e7,_0x1679af){return _0x3054e7(_0x1679af);},'buHgY':function(_0x1dcd05,_0x3d6316){return _0x1dcd05>=_0x3d6316;},'QtAgc':function(_0x16c2b9,_0x2bf4bd){return _0x16c2b9<_0x2bf4bd;},'JTTDX':function(_0x4c0514){return _0x4c0514();},'piWPS':function(_0x4c5e06,_0x4ee8a5,_0x298f1a){return _0x4c5e06(_0x4ee8a5,_0x298f1a);},'ujMQh':function(_0x562ee2,_0x5e6ee5){return _0x562ee2>_0x5e6ee5;},'ypZcb':function(_0x2780dd,_0x2e91c5){return _0x2780dd===_0x2e91c5;},'DlfFW':_0xf1e8c3(0xfa),'iONQA':_0xf1e8c3(0x181),'tFRTP':function(_0x3bc8bd){return _0x3bc8bd();}};if(_0x2085ac[_0xf1e8c3(0x375)](currentQuestionIndex,0x0)){if(_0x2085ac['ypZcb'](_0x2085ac[_0xf1e8c3(0x31a)],_0xf1e8c3(0xfa))){if(questionStartTime){if(_0x2085ac[_0xf1e8c3(0xf8)]!==_0x2085ac[_0xf1e8c3(0xf8)]){_0x37a323=_0x51cf38[_0xf1e8c3(0x3b5)]();const _0x1d47c5=_0x4cae83['getElementById'](_0x2085ac[_0xf1e8c3(0x38c)]),_0x108a66=_0x2abdd3[_0xf1e8c3(0xe3)](_0x2085ac['ueYiF']),_0x27c105=_0x54aaa5[_0xf1e8c3(0xe3)](_0x2085ac[_0xf1e8c3(0x395)]),_0x4725cd=_0x2085ac['SJZaB'](_0x5cbdea,_0x2085ac[_0xf1e8c3(0x327)])||_0x2085ac['gLZaW'](_0x3cb3b2,_0x2085ac[_0xf1e8c3(0x1f5)]);_0x36fea7[_0xf1e8c3(0xe3)](_0x2085ac[_0xf1e8c3(0x359)])[_0xf1e8c3(0x22d)][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac[_0xf1e8c3(0x390)]:_0x2085ac[_0xf1e8c3(0x306)],_0x31e2c7[_0xf1e8c3(0xe3)](_0x2085ac[_0xf1e8c3(0x197)])['style'][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac['TQYbf']:_0x2085ac['TrVRE'],_0x3ee3a1['getElementById'](_0x2085ac['umZhi'])[_0xf1e8c3(0x22d)][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac[_0xf1e8c3(0x306)]:_0x2085ac[_0xf1e8c3(0x390)],_0x3a2d7c[_0xf1e8c3(0xe3)](_0xf1e8c3(0x26f))['style'][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac[_0xf1e8c3(0x306)]:_0x2085ac[_0xf1e8c3(0x390)],_0x1d47c5[_0xf1e8c3(0x22d)][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac[_0xf1e8c3(0x390)]:_0x2085ac[_0xf1e8c3(0x228)],_0x108a66[_0xf1e8c3(0x22d)]['display']=_0x4725cd?_0x2085ac[_0xf1e8c3(0x228)]:_0x2085ac[_0xf1e8c3(0x390)],_0x27c105['style'][_0xf1e8c3(0x36d)]=_0x4725cd?_0x2085ac[_0xf1e8c3(0x228)]:_0x2085ac['TQYbf'],(_0x2085ac[_0xf1e8c3(0x21e)](_0xca6e3d,_0x2085ac[_0xf1e8c3(0x2db)])||_0x2085ac[_0xf1e8c3(0x1a3)](_0x583bc4,_0x2085ac['ESJZP']))&&_0x3d74dd[_0xf1e8c3(0xe3)](_0x2085ac[_0xf1e8c3(0x25e)])['classList'][_0xf1e8c3(0x12a)](_0x2085ac['dnHEz']),!_0x2085ac[_0xf1e8c3(0x301)](_0x429d21,_0x1cb274)&&_0x2085ac[_0xf1e8c3(0x1e9)](_0x5e7c03,0x0)&&_0x2085ac['QtAgc'](_0x1b382b,_0xfd303d[_0xf1e8c3(0x371)])&&(_0x1a927e=_0x10730d),_0x49e9de(),_0x2085ac[_0xf1e8c3(0x165)](_0x8225e4),_0x2085ac['JTTDX'](_0x4c58cb),_0x2085ac['JTTDX'](_0x377a1b);}else questionStates[currentQuestionIndex][_0xf1e8c3(0x32d)]+=Date[_0xf1e8c3(0x3b5)]()-questionStartTime;}currentQuestionIndex--,_0x2085ac[_0xf1e8c3(0x165)](displayQuestion),_0x2085ac[_0xf1e8c3(0x1fc)](saveProgress);}else{const _0x2aad81=_0x5ec309['dataset'][_0xf1e8c3(0x349)];if(_0x2aad81&&_0x2aad81['includes'](_0xf1e8c3(0x182)))_0x2085ac[_0xf1e8c3(0x274)](_0x16abb1,_0x1f09f7,_0x2aad81);else _0x2aad81&&(_0x537101['src']=_0x2aad81);}}}function nextQuestion(){const _0x290292=_0x357c09,_0x5146c2={'QtftN':function(_0x52f224,_0x3aee6a){return _0x52f224-_0x3aee6a;},'SEZbT':function(_0x5e488c,_0xd8c6a8){return _0x5e488c<_0xd8c6a8;},'KTCYI':function(_0x429f9b,_0x117c5f){return _0x429f9b-_0x117c5f;},'MSfFw':function(_0x59b3a7){return _0x59b3a7();},'fPaig':function(_0x53e3e2,_0x4c8c11){return _0x53e3e2===_0x4c8c11;},'AOsAO':_0x290292(0x3ae),'BPDuQ':function(_0x14f4cc,_0x1a1c12){return _0x14f4cc===_0x1a1c12;},'SNbyC':_0x290292(0x314),'LvybJ':_0x290292(0x247),'PKWwv':function(_0x54e5ea){return _0x54e5ea();},'NXdbs':_0x290292(0x230),'WRNXJ':function(_0x37a444,_0x2920b4){return _0x37a444!==_0x2920b4;},'yOlwf':_0x290292(0x2ef)};questionStartTime&&(questionStates[currentQuestionIndex][_0x290292(0x32d)]+=_0x5146c2[_0x290292(0x1da)](Date[_0x290292(0x3b5)](),questionStartTime));if(_0x5146c2['SEZbT'](currentQuestionIndex,_0x5146c2[_0x290292(0x29b)](questionsData[_0x290292(0x371)],0x1)))currentQuestionIndex++,_0x5146c2[_0x290292(0x100)](displayQuestion),saveProgress();else{if(_0x5146c2[_0x290292(0x3b4)](currentMode,_0x5146c2[_0x290292(0x108)])||_0x5146c2[_0x290292(0x1f9)](currentMode,_0x5146c2[_0x290292(0x279)]))confirm(_0x5146c2[_0x290292(0x1d5)])&&_0x5146c2[_0x290292(0x25c)](submitQuiz);else{if(confirm(_0x5146c2[_0x290292(0x115)])){if(_0x5146c2[_0x290292(0x145)](_0x5146c2[_0x290292(0xfb)],_0x5146c2['yOlwf'])){const _0x5a242b=_0x3cb46f?function(){if(_0x140813){const _0x2abb21=_0x3a2391['apply'](_0x442d1b,arguments);return _0x27eaba=null,_0x2abb21;}}:function(){};return _0x5f2c38=![],_0x5a242b;}else currentQuestionIndex=0x0,displayQuestion(),saveProgress();}}}}function startTimer(){const _0x8c9d8e=_0x357c09,_0x115969={'rWhkq':function(_0x2afbcf){return _0x2afbcf();},'SVuDV':_0x8c9d8e(0x158),'CJkXa':function(_0x4d706e,_0x48a89a){return _0x4d706e<=_0x48a89a;},'PtBUX':function(_0x577878,_0x1120ba){return _0x577878(_0x1120ba);},'qgtup':function(_0x554175,_0x1278d1){return _0x554175===_0x1278d1;},'jYZbS':_0x8c9d8e(0x314),'VBPER':function(_0x17189c){return _0x17189c();},'UOYoD':function(_0xf21d4d){return _0xf21d4d();}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x115969[_0x8c9d8e(0x336)](updateTimerDisplay),timer=setInterval(()=>{const _0x14516b=_0x8c9d8e;'qIpCk'===_0x115969[_0x14516b(0x394)]?(_0x3f34fb++,_0x3b062a(),_0x115969[_0x14516b(0x364)](_0x5d0858)):(timeRemaining--,_0x115969['rWhkq'](updateTimerDisplay),_0x115969[_0x14516b(0x312)](timeRemaining,0x0)&&(_0x115969[_0x14516b(0x377)](clearInterval,timer),_0x115969[_0x14516b(0x31e)](currentMode,_0x115969[_0x14516b(0x2d3)])?_0x115969['VBPER'](submitQuiz):_0x115969[_0x14516b(0x338)](nextQuestion)));},0x3e8);}function updateTimerDisplay(){const _0x3794b1=_0x357c09,_0x3dadb8={'PrpZg':function(_0x307e55,_0x13b3e7){return _0x307e55%_0x13b3e7;},'EKftl':_0x3794b1(0x389),'rGVkg':function(_0x79a4f1,_0xcc25cf){return _0x79a4f1+_0xcc25cf;},'SNJAq':function(_0xd09105,_0x248378){return _0xd09105+_0x248378;}},_0x4ea462=Math[_0x3794b1(0x2fb)](timeRemaining/0x3c),_0x5730e8=_0x3dadb8[_0x3794b1(0x324)](timeRemaining,0x3c);document[_0x3794b1(0xe3)](_0x3dadb8[_0x3794b1(0x171)])[_0x3794b1(0x19e)]=_0x3dadb8['rGVkg'](_0x3dadb8['SNJAq'](_0x4ea462,':'),_0x5730e8[_0x3794b1(0x35a)]()[_0x3794b1(0x1b3)](0x2,'0'));}function toggleSidebar(){const _0x311b65=_0x357c09,_0x2b6288={'WKbIF':_0x311b65(0x196),'ygVYJ':'open'};document[_0x311b65(0xe3)](_0x2b6288['WKbIF'])[_0x311b65(0x2e3)][_0x311b65(0x32c)](_0x2b6288[_0x311b65(0x1fb)]);}document[_0x357c09(0x257)](_0x357c09(0x2fd),()=>{const _0x41a5ce=_0x357c09,_0x9ae9ff={'cLdgg':_0x41a5ce(0x106),'orezj':'totalAttempted','nOdKR':function(_0x57b118,_0x50598b){return _0x57b118>_0x50598b;},'sstXs':function(_0xe9b96f,_0x2ced18){return _0xe9b96f*_0x2ced18;},'heVDO':'accuracy','NmePS':function(_0x1931a0,_0x3f9e44){return _0x1931a0+_0x3f9e44;},'aXAyl':function(_0x1b6073,_0x1fb0dd){return _0x1b6073/_0x1fb0dd;},'rsBPM':function(_0x5e8dc8,_0x148136){return _0x5e8dc8/_0x148136;},'YQeUF':function(_0x8095dc,_0x3c5330){return _0x8095dc%_0x3c5330;},'hBtNo':function(_0x26b6bb){return _0x26b6bb();},'OYGxm':_0x41a5ce(0x140),'mhmRW':'modeModal','Ydfgm':'none','MEYvu':function(_0x462afd){return _0x462afd();},'WDcfU':'custom_quiz.html','LDrVx':'flex','DgvbP':function(_0xabf9d8,_0x12ef5f){return _0xabf9d8===_0x12ef5f;},'LTETe':_0x41a5ce(0x30a),'dHYlI':function(_0x4741e3){return _0x4741e3();}};if(resume){if(_0x9ae9ff[_0x41a5ce(0x1c7)](loadProgress)){if(_0x41a5ce(0x140)!==_0x9ae9ff[_0x41a5ce(0x347)]){_0x3ff689[_0x41a5ce(0xe3)](_0x9ae9ff[_0x41a5ce(0xef)])[_0x41a5ce(0x19e)]=_0x313db3[_0x41a5ce(0x206)],_0x429b4d[_0x41a5ce(0xe3)](_0x41a5ce(0x173))['textContent']=_0x39a0e6[_0x41a5ce(0x36c)],_0x5d9fae['getElementById'](_0x9ae9ff['orezj'])[_0x41a5ce(0x19e)]=_0x2ec2ae[_0x41a5ce(0x386)];const _0x1ea9d3=_0x9ae9ff[_0x41a5ce(0x244)](_0x43045a['totalAttempted'],0x0)?_0xca5e2e[_0x41a5ce(0x368)](_0x9ae9ff[_0x41a5ce(0x24c)](_0x5ddf46[_0x41a5ce(0x206)]/_0x2783ef['totalAttempted'],0x64)):0x0;_0xdc0ff2['getElementById'](_0x9ae9ff[_0x41a5ce(0x2dc)])[_0x41a5ce(0x19e)]=_0x9ae9ff[_0x41a5ce(0x1d9)](_0x1ea9d3,'%'),_0x4df9fd['totalTime']=_0x404b33[_0x41a5ce(0x16b)]((_0x253044,_0x13e238)=>_0x253044+_0x13e238[_0x41a5ce(0x32d)],0x0);const _0x27b0df=_0x69ff92[_0x41a5ce(0x2fb)](_0x9ae9ff[_0x41a5ce(0x1e7)](_0x39fe0c['totalTime'],0x3e8)),_0x17469a=_0x3d17e4[_0x41a5ce(0x2fb)](_0x9ae9ff[_0x41a5ce(0x365)](_0x27b0df,0x3c)),_0x2f87fe=_0x9ae9ff[_0x41a5ce(0x11b)](_0x27b0df,0x3c);_0x5304af[_0x41a5ce(0xe3)]('timeSpent')[_0x41a5ce(0x19e)]=_0x9ae9ff[_0x41a5ce(0x1d9)](_0x9ae9ff[_0x41a5ce(0x1d9)](_0x17469a,':'),_0x2f87fe[_0x41a5ce(0x35a)]()['padStart'](0x2,'0'));}else document[_0x41a5ce(0xe3)](_0x9ae9ff[_0x41a5ce(0x132)])[_0x41a5ce(0x22d)][_0x41a5ce(0x36d)]=_0x9ae9ff[_0x41a5ce(0x3ad)],_0x9ae9ff['hBtNo'](initializeQuiz);}else _0x9ae9ff[_0x41a5ce(0x25f)](clearProgress),document[_0x41a5ce(0xe3)](_0x41a5ce(0x2e5))['style'][_0x41a5ce(0x36d)]=_0x41a5ce(0x271);}else!window[_0x41a5ce(0x357)]['pathname']['endsWith'](_0x9ae9ff[_0x41a5ce(0x345)])?(_0x9ae9ff[_0x41a5ce(0x25f)](clearProgress),document[_0x41a5ce(0xe3)](_0x9ae9ff[_0x41a5ce(0x132)])[_0x41a5ce(0x22d)][_0x41a5ce(0x36d)]=_0x9ae9ff[_0x41a5ce(0x189)]):_0x9ae9ff[_0x41a5ce(0x17d)](_0x41a5ce(0x16c),_0x9ae9ff[_0x41a5ce(0x1a6)])?_0x45fb13[_0x41a5ce(0x215)]('customQuizData'):_0x9ae9ff[_0x41a5ce(0x319)](initializeQuiz);}),document[_0x357c09(0x257)](_0x357c09(0x348),function(_0x146b97){const _0x368996=_0x357c09,_0x165c61={'wTOxs':function(_0x7aab53){return _0x7aab53();},'abxBb':function(_0x389a45,_0x295761){return _0x389a45!==_0x295761;},'Efymt':'modeModal','IxoMe':_0x368996(0x332),'cVMZq':function(_0x527f9f,_0x2ad13f){return _0x527f9f===_0x2ad13f;},'YVbdq':_0x368996(0x20d),'GQnSB':'hidden','koksa':function(_0x130054,_0x93452){return _0x130054>=_0x93452;},'sHhvC':function(_0x11fc61,_0x52248f){return _0x11fc61<=_0x52248f;},'gLINc':function(_0x3db137,_0x35f00e){return _0x3db137-_0x35f00e;},'IwWrZ':function(_0x52ee38,_0x3e749b){return _0x52ee38(_0x3e749b);},'MerfQ':_0x368996(0x219),'YRVGO':function(_0x408572,_0x4a4773){return _0x408572<_0x4a4773;},'QjzuH':function(_0x465944,_0x257f54){return _0x465944===_0x257f54;},'hoNSP':function(_0x1c3bc9){return _0x1c3bc9();},'HDFve':function(_0x2779b9,_0x6a5398){return _0x2779b9===_0x6a5398;},'vFRsf':function(_0x326fd3,_0x344ed9){return _0x326fd3===_0x344ed9;},'sPQQi':_0x368996(0x187),'UCgte':function(_0x32b3bf,_0x19f787){return _0x32b3bf===_0x19f787;},'LArRH':_0x368996(0x2c0),'OXHsl':_0x368996(0x3ae),'nihuf':function(_0x432aa4,_0x43e1d5){return _0x432aa4===_0x43e1d5;},'xCNkE':function(_0x4b9221){return _0x4b9221();},'oZZxl':_0x368996(0x102)};if(_0x165c61[_0x368996(0x1bf)](document[_0x368996(0xe3)](_0x165c61[_0x368996(0xe6)])[_0x368996(0x22d)][_0x368996(0x36d)],_0x165c61[_0x368996(0xe9)]))return;if(_0x165c61[_0x368996(0xf5)](document['getElementById'](_0x165c61[_0x368996(0x148)])[_0x368996(0x2e3)][_0x368996(0x2c5)](_0x165c61[_0x368996(0x352)]),![]))return;if(_0x165c61['koksa'](_0x146b97['key'],'1')&&_0x165c61['sHhvC'](_0x146b97[_0x368996(0x2d8)],'4')){const _0x1b73dc=_0x165c61['gLINc'](_0x165c61[_0x368996(0x191)](parseInt,_0x146b97[_0x368996(0x2d8)]),0x1),_0x54dac6=document[_0x368996(0x287)](_0x165c61[_0x368996(0x28a)]);if(_0x165c61['YRVGO'](_0x1b73dc,_0x54dac6['length']))_0x165c61[_0x368996(0x191)](selectOption,_0x1b73dc);}else{if(_0x165c61[_0x368996(0x399)](_0x146b97[_0x368996(0x2d8)],_0x368996(0x159)))_0x165c61[_0x368996(0x367)](previousQuestion);else{if(_0x165c61['cVMZq'](_0x146b97[_0x368996(0x2d8)],'ArrowRight')||_0x165c61['HDFve'](_0x146b97['key'],'\x20'))_0x146b97['preventDefault'](),_0x165c61[_0x368996(0x367)](nextQuestion);else{if(_0x146b97[_0x368996(0x2d8)][_0x368996(0xed)]()==='b'&&(_0x165c61[_0x368996(0x1d1)](currentMode,_0x165c61[_0x368996(0x23c)])||_0x165c61['UCgte'](currentMode,_0x165c61[_0x368996(0x30e)])))toggleBookmark();else{if(_0x165c61[_0x368996(0x358)](_0x146b97[_0x368996(0x2d8)]['toLowerCase'](),'m')&&(_0x165c61[_0x368996(0xf5)](currentMode,_0x165c61[_0x368996(0x2ae)])||_0x165c61[_0x368996(0x1ce)](currentMode,_0x368996(0x314))))_0x165c61['xCNkE'](toggleMarkForReview);else _0x146b97[_0x368996(0x2d8)][_0x368996(0xed)]()==='s'&&(currentMode===_0x165c61[_0x368996(0x2ae)]||currentMode==='timed_exam')&&(_0x165c61['abxBb'](_0x165c61[_0x368996(0x292)],_0x165c61[_0x368996(0x292)])?_0x165c61['wTOxs'](_0x35aa73):_0x165c61['hoNSP'](submitQuiz));}}}}});</script>

</body></html>